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hyperpolarized 13C magnetic resonance imaging (MRI) to quantitatively interrogate lung metabolism. The 
pulmonary system plays a major role in performing a variety of biochemical functions that maintain body 
homeostasis, but that undergo significant detrimental alteration in the setting of lung injury and/or 
inflammation. Such changes cause lactic acid to be released from the lungs and are associated with 
increased patient mortality. The ability to directly measure both changes in lung metabolism and its 
spatial heterogeneity can provide insight into the relationship between abnormal mechanics and 
cellularity in diseased lung tissue. This work primarily focuses on small and large mammalian species as 
a stepping stone toward translation to human subjects. The key deliverables of this project are acquisition 
and quantification tools for the regional assessment of hyperpolarized pyruvate’s conversion to lactate in 
lung tissue. 
To demonstrate the utility of our method, we used a two-hit animal model of acid aspiration and 
ventilator-induced lung injury that mimics a variety of inflammatory pulmonary diseases including acute 
lung injury (ALI) and acute respiratory distress syndrome (ARDS). We measure the conversion of pyruvate 
to lactate using hyperpolarized lactate-to-pyruvate ratio, and show that this ratio is significantly correlated 
with inflammatory activity in the lung tissue as well as the degree of systemic hypoxemia. To further 
investigate hypoxia’s contribution to increased pulmonary lactate production, we assessed overall lung 
metabolism in non-injured hypoxic animals: while pulmonary pyruvate metabolism is resilient to moderate 
levels of hypoxemia, it changes significantly as a result of severe hypoxemia. Our data suggest that the 
increased lactate-to-pyruvate ratio in injured lungs is predominantly caused by inflammation. 
Next, we used our techniques to image both healthy and injured pigs on a clinical scanner in order to 
demonstrate the potential clinical translatability of hyperpolarized 13C imaging. Finally, we explored the 
possibility of using other imaging pulse sequences to achieve higher spatial and temporal resolution in 
both small and large animals, concluding that our method can serve as a future basis for rapid, high-
resolution metabolic imaging of the lungs. 
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ABSTRACT 
 
METABOLIC IMAGING OF ACUTE LUNG INJURY USING HYPERPOLARIZED 13C 
MAGNETIC RESONANCE IMAGING 
 
Mehrdad Pourfathi 
Rahim R. Rizi, Ph.D. 
 
This project’s main objective was to develop and implement a molecular imaging tool based on 
hyperpolarized 13C magnetic resonance imaging (MRI) to quantitatively interrogate lung metabolism. The 
pulmonary system plays a major role in performing a variety of biochemical functions that maintain body 
homeostasis, but that undergo significant detrimental alteration in the setting of lung injury and/or 
inflammation. Such changes cause lactic acid to be released from the lungs and are associated with increased 
patient mortality. The ability to directly measure both changes in lung metabolism and its spatial 
heterogeneity can provide insight into the relationship between abnormal mechanics and cellularity in 
diseased lung tissue. This work primarily focuses on small and large mammalian species as a stepping stone 
toward translation to human subjects. The key deliverables of this project are acquisition and quantification 
tools for the regional assessment of hyperpolarized pyruvate’s conversion to lactate in lung tissue. 
To demonstrate the utility of our method, we used a two-hit animal model of acid aspiration and 
ventilator-induced lung injury that mimics a variety of inflammatory pulmonary diseases including acute 
lung injury (ALI) and acute respiratory distress syndrome (ARDS). We measure the conversion of pyruvate 
to lactate using hyperpolarized lactate-to-pyruvate ratio, and show that this ratio is significantly correlated 
with inflammatory activity in the lung tissue as well as the degree of systemic hypoxemia. To further 
investigate hypoxia’s contribution to increased pulmonary lactate production, we assessed overall lung 
metabolism in non-injured hypoxic animals: while pulmonary pyruvate metabolism is resilient to moderate 
levels of hypoxemia, it changes significantly as a result of severe hypoxemia. Our data suggest that the 
increased lactate-to-pyruvate ratio in injured lungs is predominantly caused by inflammation.  
 vi 
Next, we used our techniques to image both healthy and injured pigs on a clinical scanner in order 
to demonstrate the potential clinical translatability of hyperpolarized 13C imaging. Finally, we explored the 
possibility of using other imaging pulse sequences to achieve higher spatial and temporal resolution in both 
small and large animals, concluding that our method can serve as a future basis for rapid, high-resolution 
metabolic imaging of the lungs. 
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showing typical ground glass opacities, indicating severely decreased 
aeration but without complete loss of gas content. (D) Computed 
tomography scan of a patient 16 days after ARDS-onset, showing diffuse 
interstitial thickening predominantly at the lung bases, suggesting evolving 
fibrosis; in addition, ventral bullae (yellow arrow), pneumomediastinum 
(blue arrow), and soft tissue emphysema (red arrow) represent barotrauma 
from mechanical ventilation. Reproduced with permission from. 
Figure 3.6 Representative images of cross-registered computed tomography (CT) and 
[18F]-fluorodeoxyglucose (18F-FDG) positron emission tomography from 
two patients with ALI/ARDS. The CT image was acquired during a 
respiratory pause at mean airway pressure: the gray scale is centered at -500 
Hounsfield Units with a width of 1250 Hounsfield Units. Positron emission 
tomographic images represent the average pulmonary 18F-FDG 
concentration during the last 20 minutes of acquisition (from 37 to 57 
minutes after 18F-FDG administration): the color scale represents 
radioactivity concentration (kBq/mL). (A) 18F-FDG distribution parallels 
that of the opacities detected on CT. (B) Intense 18F-FDG uptake can be 
observed in normally aerated regions (square 1), while activity is lower in 
the dorsal, “nonaerated” regions of both lungs (square 2). Reproduced with 
permission from. 
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Figure 3.7 (Top Row) Coronal images of the lungs in a human subject obtained using 
conventional MRI. (Bottom Row) Images from the same subject after 
inhalation of hyperpolarized 3He gas to allow visualization of the airways. 
74 
Figure 4.1 (Left) The k-space trajectory used in the proposed acquisition technique, 
where the acquisition returns to the center of the k-space every 11th 
acquisition. (Right) Signal obtained during the course of imaging shows the 
exponential signal decay due to the T1 relaxation of the sample as well as the 
destructive effect of RF excitation on magnetization. The blown-up view of 
the initial 1.5 seconds of the data shows the FID obtained during each phase-
83 
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encoded acquisition and every 11th FID from the center of the k-space; this 
has a larger amplitude due the absence of spatial phase distortion across the 
object due to the phase encoding gradients. 
Figure 4.2 Study design for hyperpolarized pyruvate studies. Three cohorts of rats (5 
each) were used. Each rat received 3 injections of hyperpolarized [1-13C] 
pyruvate (Pyr) at approximately 60, 130 and 240 minutes after the start of 
ventilation. The injured-1 cohort received 1 ml/kg HCl (A1), while the 
injured-2 cohort received 2 ml/kg HCl (A2) intratracheally 10 minutes after 
the first pyruvate injection. Compliance was measured before each pyruvate 
injection. 
87 
Figure 4.3 Representative 13C MRSI overlay on 1H images in (A) healthy, (B) injured-
1 and (C) injured-2 rats. The bottom panels show the close-up view of the 
average of spectra in the posterior (D, F, H) and anterior voxels (E, G, I) 
outlined in (A-C) for healthy, injured-1 and injured-2 lungs. The pyruvate 
and lactate signal in both anterior and posterior voxels of the control rat 
appear similar. In the injured-1 rat, the overall pyruvate and lactate signal 
increased in the posterior voxels (F), while the lactate signal increased in the 
interior voxels (G); the pyruvate signal increased significantly in the injured-
2 rat in both areas (H, I). At the same time, the linewidth in the injured-2 rat 
became narrower, likely due to the formation of edema and consequent 
improvement in local field homogeneity. 
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Figure 4.4 Representative pyruvate and lactate maps overlaid on their corresponding 
proton images. The left panel shows a healthy rat 60 (baseline) and 240 
(follow-up) minutes after the start of ventilation. The middle and right panels 
show representative metabolite maps in injured-1 and injured-2 animals at 
the same time points, before (baseline) and 240 minutes after (follow-up) 
acid aspiration injury. The color bar maps the intensity of each metabolite 
image as a fraction of the maximum value in the same image. 
94 
Figure 4.5 (A) Average pulmonary lactate-to-pyruvate ratio in control (white), injured-
1 (light gray) and injured-2 (dark gray) cohorts for all injections. Average 
(dark filled circles) and individual (gray hollow circles) pulmonary lactate-
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to-pyruvate ratios in (B) control, (C) injured-1 and (D) injured-2 cohorts for 
all three injections. (*** p<0.001, ** p <0.01, * p <0.05, † p <0.1) 
Figure 4.6 Average (A) pyruvate and (B) lactate signals, corrected for solid-state 
polarization levels, for all three cohorts at all three injections. 
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Figure 4.7 (A) Average pulmonary compliance in control (white), injured-1 (light gray) 
and injured-2 (dark gray) cohorts for all injection time points. Average (dark 
filled circles) and individual (gray hollow circles) pulmonary compliance in 
(B) control, (C) injured-1 and (D) injured-2 cohorts for all injections. (**** 
p <0.0001, *** p <0.001, ** p <0.01, * p <0.05) 
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Figure 4.8 Lactate-to-pyruvate vs. pulmonary compliance for control (circles), injured-
2 (triangles) and injured-2 (crosses) cohorts at the first (A), second (B) and 
third (C) injection time points. Inner and outer ellipses represent 95% and 
99% confidence intervals, respectively. 
98 
Figure 4.9 T2-weighted axial scan over the lungs, showing the primary tumor as well as 
a secondary tumor protruding out of the thoracic cavity. Metabolite maps are 
overlaid on the T2 scan, and the lactate map shows enhanced lactate signal 
over both primary and secondary tumors (white arrows). 13C spectra 
averaged over the non-cancerous lung tissue next to the tumor (A), the 
primary tumor (B) and the secondary tumor (C) are shown on the right. The 
spectra show elevated lactate-to-pyruvate ratio over the tumors relative to 
the healthy lung tissue. 
106 
Figure 4.10 Pyruvate and lactate maps overlaid on the corresponding T2-weighted axial 
scans over the lungs in four mice with different presentations of lung tumor. 
The white arrow shows regions with elevated lactate signal that are 
colocalized with the lung tumors. 
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Figure 5.1 Summary of hyperpolarized 13C imaging studies. A healthy baseline 13C 
image was initially acquired. Rats received 0.5ml/kg of either hydrochloric 
acid (N=14) or saline (N=7) 10 minutes after the baseline scan; positive-end 
expiratory pressure (PEEP) was then immediately increased to 10 cmH2O 
during a 10-minute stabilization period before being lowered back to 5 
cmH2O. The first follow-up 13C image was acquired 1 hour after instillation. 
115 
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PEEP was then lowered to 0 cmH2O in all rats receiving saline (Sham group) 
and in seven injured rats (ZEEP group). Subsequent 13C images were 
acquired 2.5 and 4 hours after acid/saline instillation. (Note that four animals 
from the ZEEP group did not receive the third injection. Statistics are 
corrected for the unbalanced data.) 
Figure 5.2 Representative pyruvate and lactate maps overlaid on their corresponding 
proton images. The left panels show the images acquired at healthy baseline 
and 4 hours after acid/saline instillation in a sham rat. The middle and right 
panels show similar maps for the PEEP and ZEEP rats. Note the dramatic 
increase in lactate signal in the ZEEP rat 4 hours after acid instillation. For 
display, the pyruvate and lactate maps are normalized to their own maximum 
intensity for each pulmonary map. 
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Figure 5.4 (A) Pyruvate, lactate and lactate-to-pyruvate segmented maps overlaid on 
their corresponding proton image of a ZEEP rat 4 hours after the acid 
instillation shows injury to the posterior right lung marked by increased 
intensity in the proton image (white arrow). The metabolite maps show 
increased lactate signal intensity and lactate-to-pyruvate ratio colocalized 
with the injured area. (B) Hematoxylin and Eosin (H&E) axial slide of the 
whole lung clearly shows damaged lung tissue in the same area (black 
arrow). Magnified images taken from the injured area (black box) with (C) 
10´ and (D) 40´ magnifications show severe damage and inflammatory 
infiltrates in the tissue. The bar in (C) is 100 µm. 
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Figure 5.4 (A) Average lactate-to-pyruvate ratio was significantly higher in the ZEEP 
group compared to sham and PEEP groups 2.5 (p<0.01 for both 
comparisons) and 4 hours (p<0.001 for both comparisons) after acid/saline 
instillation. There was no significant difference between the latter two 
groups at either 2.5 or 4 hours. (B) Pulmonary compliance (Cdyn) declined in 
the injured rats 1 hour after acid instillation, and continued to decline in the 
ZEEP group compared to the sham and PEEP groups (p<0.001). Cdyn was 
not statistically different between sham and PEEP rats during the rest of the 
experiment. (C) Oxygen saturation (SpO2) was similar among all groups at 
healthy baseline and 1 hour after acid/saline instillation, but declined over 
time in the ZEEP group while remaining unchanged in sham and PEEP 
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groups. Groups were statistically different 4 hours after acid/saline 
instillation (c2(2) = 10.004, p=0.006), with the ZEEP group having 
significantly lower oxygen saturation than sham (p=0.003) and PEEP 
(p=0.035) groups, which did not differ from one another (p=0.804). ($ p<0.1, 
* p<0.05, ** p <0.01, *** p <0.001), (1ZEEP vs. Sham, 2PEEP vs Sham, 
3PEEP vs. ZEEP). (Note that for lactate-to-pyruvate ratio at 2.5 hours, N=3 
for the ZEEP group. For all groups and all other time-points, N=7). 
Figure 5.5 Correlation between average lactate-to-pyruvate ratio and (A) pulmonary 
compliance (r=-0.581, p<0.001) and (B) oxygen saturation (r=-0.687, 
p<0.001). 
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Figure 5.6 (Top) Hematoxylin and Eosin (H&E) stained lung sections of rats from each 
group. Representative images shown are at 10´ and 40´. In ZEEP lungs, 
arrows show the presence of fluid within the alveolar space; solid arrows 
delineate infiltrates and debris. In lungs subjected to PEEP, alveolar structure 
is more intact; infiltrates are shown by solid arrows. The scale bar is 100 µm. 
(Middle) Average injury scores for various morphological features for 
different groups. ANOVA showed a significant difference among groups 
(infiltration: c2(2)= 11.273, p=0.003, alveolar damage: c2(2)= 10.000, 
p=0.007, hyaline membrane deposition: c2(2)= 10.678, p=0.005 and edema: 
c2(2)= 12.154, p=0.002). Infiltration (A) and alveolar damage scores (B) 
were significantly higher in the ZEEP group than in the sham group 
(p=0.001, p=0.012), while infiltration was significantly higher in the ZEEP 
group than the PEEP group (p=0.035). Hyaline membrane deposition (C) 
and edema severity (D) were both significantly higher in the ZEEP group 
relative to both PEEP (p=0.048, p=0.041) and sham (p=0.014, p=0.006) 
groups. (Bottom) Among the histological features, hyaline membrane 
deposition (r=0.612, p=0.003) (G) and edema severity (r=0.663, p=0.001) 
(H) were strongly correlated with lactate-to-pyruvate ratio. (* p<0.05, ** p 
<0.01, *** p <0.001). 
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Figure 5.7 (Top) ICAM-1 expression in lung sections measured by fluorescence 
microscopy (40´ magnification). Green fluorescence denotes ICAM-1 
expression, which is higher in the ZEEP group in response to inflammatory 
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stimuli. Additionally, the green fluorescence is higher along the endothelial 
layer that lines the vessels (indicated by white arrows (V)). (Middle) MPO 
expression in the lung sections measured by fluorescence microscopy (40´ 
magnification). Red fluorescence denotes higher MPO expression, which is 
similar in both sham and PEEP lungs, but much higher in ZEEP lungs. The 
white arrows illustrate the punctate staining from neutrophils. The phase 
images for the same sections show the structure of the lung tissue. The scale 
bar is 50 µm. (Bottom) ICAM-1 expression was significantly different 
among groups (F2,18= 37.76, p<0.001), and was significantly higher in the 
ZEEP group relative to PEEP (p=0.002) and sham (p=0.002) groups (A). 
ICAM-1 expression was strongly correlated with the average lactate-to-
pyruvate ratio measured 4 hours after acid/saline instillation (r=0.782, 
p<0.001) (B). There was significantly different MPO expression among 
groups (c2(2)= 16.416, p<0.001); the measured activity was significantly 
higher in the ZEEP group compared to PEEP (p=0.002) and sham (p=0.002) 
groups (C), and was strongly correlated with average lactate-to-pyruvate 
(r=0.817, p<0.001) (D). The activity was also significantly different between 
PEEP and sham groups (p=0.004). (** p<0.01, *** p <0.001). 
Figure 5.8 The right panel shows a selection of the voxels in the hyperpolarized 13C 
spectroscopic image overlay. Lactate-to-pyruvate ratio was similar at 
baseline in all regions across all groups, and increases 2.5 hours after acid 
instillation in all lung regions in ZEEP rats. The ratio continues to increase 
in the posterior region on both sides 4 hours after acid instillation. The 
lactate-to-pyruvate ratio measured in the myocardium and heart chambers 
remains unchanged over time in all groups (AL: anterior left, PL: posterior 
left, AR: anterior right and PR: posterior right). 
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Figure 6.1 Summary of hyperpolarized 13C imaging studies. Arterial blood gases (ABG) 
were obtained first. A healthy baseline 13C image was initially acquired. 
Fraction of inspired oxygen (FiO2) was reduced to 0.17 (N=8) and 0.1 (N=8) 
to induce moderate and severe hypoxia, respectively, throughout the rest of 
the experiment. Follow-up 13C images were acquired after 1 hour, 2.5 and 4 
hours. 
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Figure 6.2 Representative pyruvate and lactate maps overlaid on their corresponding 
proton image acquired at healthy baseline and 4 hours after start of systemic 
hypoxia. FiO2 was kept at 1.0 in the control group. Lactate to pyruvate ratio 
and lactate signal remained unchanged over time in the control rats. While 
the lactate signal did not change noticeably after 4 hours of moderate 
hypoxia, it increased dramatically after 4 hours of severe hypoxia. 
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Figure 6.3 (A) Average lactate-to-pyruvate remained unchanged in the control group 
but increased in both hypoxic groups over time. This ratio increased much 
more significantly in the severely hypoxic rats (Hyp75), and was 
significantly higher than in both moderately hypoxic (Hyp90) and control 
rats 2.5 and 4 hours after the start of hypoxia. The ratio was slightly higher 
in the moderately hypoxic rats than the control rats, but this difference did 
not reach the level of statistical significance. (B) Pulmonary compliance 
(Cdyn) remained unchanged in all rats. (C) Oxygen saturation (SpO2) 
remained unchanged in the control group but declined in both moderately 
and severely hypoxic groups to around 90% and 75%, respectively (p<0.01 
for all group-wise comparisons at any time except the first time point). (* 
p<0.05, ** p <0.01, *** p <0.001), (1Hyp75 vs. control, 2Hyp75 vs Hyp90). 
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Figure 6.4 (A) Arterial lactate concentration measured from arterial blood samples in 
control (N=3), Hyp90 (N=3) and Hyp75 (N=5) groups before and after 
imaging. Post-imaging arterial blood lactate was significantly higher in the 
Hyp75 group than in both Hyp90 and control groups. (B) Pulmonary 
hyperpolarized lactate-to-pyruvate ratio is strongly correlated with arterial 
blood lactate concentration (** p<0.01, *** p<0.005). 
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Figure 6.5 Average lactate-to-pyruvate ratios in all groups for different injections in the 
(A) lungs and (B) heart; (C) oxygen saturation 4 hours after the start of injury 
or hypoxia. Post-hoc analysis results are included in Table 6.2. The error bars 
represent the standard error for each measurement. (D) The pulmonary 
hyperpolarized lactate-to-pyruvate ratio vs. oxygen saturation at individual 
timepoints shows the overall trend of each cohort during the course of the 
experiment. The lactate-to-pyruvate ratio significantly increases in injured 
rats (dark gray box) 2.5 hours after acid instillation, while oxygen saturation 
declines to ~90%. In moderately hypoxic rats, the lactate-to-pyruvate does 
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not increase despite oxygen saturation decreasing to 90%, suggesting that the 
source of increased lactate-to-pyruvate ratio is not hypoxia but severe 
inflammatory response. The lactate-to-pyruvate ratio increases 1 hour after 
the start of severe hypoxia, consistent with other findings suggesting that the 
lung tissue produces high concentrations of lactate if exposed to severe but 
not moderate hypoxia. (Note that intervention for ZEEP and PEEP groups is 
acid instillation, for Sham group is saline instillation, and for Hyp75 and 
Hyp90 groups is reducing the fraction of inspired oxygen) (* above a bar 
indicates that data is significantly different from all other groups. Groups 
with letters “a” or “b” on top are statistically different from groups with “a*” 
or “b*” on top, respectively. Finally, “ab” on top of a bar indicates statistical 
difference from both groups with “a*” and “b*” on top.). 
Figure 6.6 (Top) Hematoxylin and Eosin (H&E) stained lung sections of rats from each 
group. Representative images shown are at 10´. The scale bar is 100 µm. 
Average injury scores for various morphological features for different 
groups assessed from H&E stained lung sections. (Groups with letters “a” or 
“b” on top are statistically different from groups with “a*” or “b*” on top, 
respectively; “ab” on top of a bar indicates statistical difference from both 
groups with “a*” and “b*” on top.) 
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Figure 7.1 (A) Representative axial T2-weighted image obtained over the lungs and the 
location of the receive channels of the 13C RF coil around the pig. Time-
course of each metabolite obtained by (B) individual channels and (C) the 
combined channels shows that the maximum lactate signal in an axial slice 
over the lungs is attained 45 seconds after the start of injection. The inset 
shows the spectrum obtained 50 seconds after the start of injection. 
167 
Figure 7.2 13C MRSI acquired by (A) individual channels and (B) all channels 
combined together, overlaid on the corresponding T2-weighted proton 
image. The spectra are from two voxels outlined with white boxes over the 
vessel and the left lung, labeled with V and L. (C) Metabolite maps obtained 
from the area under their corresponding peaks. 
169 
Figure 7.3 T2-weighted proton images as well as overlaid [1-13C] pyruvate and [1-13C] 
lactate maps of the non-injured pigs (pigs 1-4). 
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Figure 7.4 T2-weighted proton images as well as overlaid [1-13C] pyruvate and [1-13C] 
lactate maps of the injured pigs (pigs 4-7). Pig 4 was imaged 140 minutes 
after acid instillation, while Pigs 5-7 were imaged approximately 8 hours 
after acid instillation. White arrows show the areas in the lungs with visible 
injury and edema. 
172 
Figure 7.5 (Left) The 13C MRSI overlaid on the axial T2-weighted image obtained 2 
hours after acid instillation in pig 4. The average spectra in the posterior (red) 
and middle (blue) sections of the lung before and after acid instillation show 
a ~20% and ~50% increase in the lactate-to-pyruvate ratio in these areas, 
respectively; the linewidth became narrower in the posterior region due to 
the presence of edema. (Right) Two images were obtained within 15 minutes 
of injury induction. Spectra in the posterior lungs shows an approximately 
10% difference in lactate signal between the repeated scans. 
174 
Figure 7.6 13C MRSI overlaid on the T2-weighted image of pigs with long-term injury 
(pigs 5-7). On the right, spectra obtained by averaging the signal over four 
voxels positioned in the anterior right (AR), anterior left (AL), posterior right 
(PR) and posterior left (PL) regions of the lungs are shown. The linewidth of 
the NMR peaks is significantly narrower in bright regions in the T2-weighted 
images, suggesting the presence of edema. Although the lactate-to-pyruvate 
ratio is higher than in an average healthy pig across the entire the lung, this 
ratio is highest in the injured right lung. 
176 
Figure 8.1 Excitation with a 90° RF pulse followed by a series of 180o refocusing pulses 
forms a spin-echo train. The transverse magnetization initially generated 
after the excitation decays with a T2* relaxation time constant. Each 
refocusing pulse recovers the part of transverse magnetization lost due to 
magnetic field inhomogeneity. The signal generated via the spin-echo train 
therefore decays with T2 relaxation time constant. Since T2 >> T2* in the lung 
tissue, the spin-echo formation can recover a major fraction of the transverse 
magnetization that is otherwise de-phased due to field inhomogeneity. Note 
that while the refocusing can occur with any flip angle, it is most efficient 
with 180o RF pulses. 
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Figure 8.2 The HASTE pulse sequence used for hyperpolarized 13C imaging in mice. 
Each readout loop forms an echo train, followed by the flip-back module that 
used an additional refocusing and excitation pulses to transfer the leftover 
transverse magnetization to longitudinal magnetization. Higher resolution 
imaging (48×48 matrix size) was performed using the single-echo imaging 
confirmation, where only the first readout loop was used. T2 maps were 
calculated from the two lower resolution images (32×32 matrix size) 
acquired using the dual-echo imaging configuration of the sequence, where 
both readout loops were used to generated two images per excitation. 
186 
Figure 8.3 (A) T2-weighted proton image, (B) representative high resolution 
hyperpolarized 13C image overlaid on the T2 image, and (C) the grey scale 
13C image of the lungs. 
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Figure 8.4 Dynamic high resolution hyperpolarized 13C imaging of the lungs; t=0s is the 
moment from the first image acquisition. 
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Figure 8.5 First (left) and second (middle) echo images obtained from a mouse lung 
after injection of hyperpolarized [1-13C] pyruvate. Images were obtained 
using the dual-echo version of the sequence with 32×32 matrix size. The 
effective echo times were TE1 = 2.98ms and TE2 = 50.66ms. An estimated 
masked T2 map of [1-13C]-pyruvate in the lungs (right) is also shown. 
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Figure 8.6 13C Imaging using a multi-slice TrueFISP sequence in one healthy (pig 2) 
and one injured pig (pig 6). The signal intensity in the injured areas of the 
posterior lung (pig 6; outlined areas) was 3×higher than in the anterior lung. 
The white arrow shows the signal in the descending thoracic aorta. 
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Figure 8.7 Proposed HASTE pulse sequence implementation with SPSP excitation and 
flip-back RF pulses. The SPSP pulse individually excites pyruvate and 
lactate peaks. 
194 
Figure 8.8 Proposed HASTE pulse sequence implementation with a multi-echo readout 
for Dixon reconstruction. The initial saturation pulse minimizes the 
contributions of the alanine and pyruvate hydrate peaks, located between the 
pyruvate and lactate peaks, for more effective use of the IDEAL approach. 
196 
 xxix 
Figure 9.1 Proposed study design to assess metabolic changes in injured and non-
injured ex-vivo perfused rat lungs. 
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Figure 9.2. Representative hyperpolarized 129Xe and hyperpolarized 13C MRI scans 
obtained 6 and 8 hours after acid aspiration lung injury in an injured pig (pig 
5, chapter 7). Lactate signal is elevated in posterior region of both lungs, 
however, the 129Xe scan shows low ventilation and gas uptake only in the 
right lung (white arrow). While 13C MRI highlight regions with abnormal 
metabolism, 129Xe MRI can provide additional information regarding gas 
uptake and ventilation, thereby differentiating hypoxic and inflamed regions. 
129Xe and 13C images were acquired using two different clinical scanners at 
1.5T and 3T field-strength respectively since RF coils were only available at 
those fields for each nucleus. However, both scans can be performed in a 
single session within minutes of each other with RF coils designed for the 
same field-strength. 
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Chapter 1: Introduction 
 
1.1. Background and Significance   
Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) is 
diagnosed in approximately 200,000 patients each year in the US, proving fatal 
approximately 40% of the time1-3. Lung injury in ARDS/ALI is characterized by an 
inflammatory response that propagates in the lungs, causing capillary leakage and impaired 
gas exchange. While ARDS/ALI is managed in the intensive care unit through careful 
optimization of mechanical ventilation to protect the lungs from ventilator-induced 
injury3,4, existing ventilator protocols are not currently designed to limit the spread of 
inflammation3,5. Early detection of ARDS-related lung injury through cellular changes may 
therefore lead to improved outcomes by suggesting appropriate interventions.  
Several imaging modalities have been used to investigate lung injury, including 
computed tomography (CT), contrast-enhanced proton MRI and hyperpolarized MRI4,6-9. 
In our previous studies using serial CT imaging4, we were able to visualize the spatial 
propagation of radiological abnormalities in the early stages of experimental injury. Other 
studies used hyperpolarized gas MRI to quantify alterations in the lung microstructure 
during mechanical ventilation10 or assess alveolar wall thickness caused by 
inflammation11,12. Although these imaging modalities elucidate the structural and 
functional manifestations of inflammation, they do not probe the metabolic and molecular 
processes that drive these changes. Positron emission tomography (PET) enables the 
visualization of metabolic changes due to lung inflammation13-18 but is limited to 
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examining abnormalities in the uptake of the glucose analogue fluorodeoxyglucose and is 
therefore unable to reveal changes in downstream metabolism that may be crucial to the 
evolution of inflammation and injury19-21. Understanding these downstream pathways may 
open up new therapeutic approaches aimed at mitigating lung injury progression at early 
stages at attenuating its consequences22. 
Hyperpolarized 13C MRI is an emerging non-radioactive molecular imaging 
technique that provides an over 10,000-fold temporary signal enhancement over 
conventional MRI, highlighting changes in cellularity and metabolic pathways by 
quantifying downstream metabolites through their unique 13C resonance frequencies 
(chemical shifts)23. Hyperpolarization of the 13C nuclei is typically achieved through a 
process called dynamic nuclear polarization (DNP), which transfers spin alignment from 
the sparse unpaired electrons of an electron paramagnetic agent (EPA) to the adjacent 13C 
labeled nuclei using resonant microwave irradiation at high magnetic fields (~3.3T) at ~1K 
temperature24. Once the sample reaches the desired polarization level (usually within 1-3 
hours), it is dissolved rapidly using a hot isotonic buffer to yield a highly polarized 
neutralized solution for injection. After administering the probe, data must be obtained 
quickly using rapid imaging techniques, as the signal enhancement decays at a rate 
determined by the T1 relaxation time constant of the probe (10-120s, depending on the 
probe).  
The most widely used hyperpolarized DNP probe is [1-13C] pyruvate, a small and 
highly soluble molecule with high polarizability (up to 60% polarization reported) and a 
long T1 relaxation time constant (40-60s). Because it acts as a central branching point in 
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several key metabolic pathways, pyruvate can be used to study a wide variety of metabolic 
perturbations in tissues with inflammatory diseases or cancer25-28. These physical and 
biological properties make [1-13C] pyruvate perhaps the most attractive hyperpolarized 13C 
imaging probe to date.  
Hyperpolarized [1-13C] pyruvate has been used extensively to study metabolic 
alterations in heart29, liver30, kidneys31 and tumors32 in intact animals and has more recently 
been used in a number of human studies33-35. In our earlier ex-vivo perfused lung studies, 
we showed a significantly increased rate of hyperpolarized lactate labeling after injection 
of hyperpolarized [1-13C] pyruvate in inflamed lungs25. Unfortunately, extending the use 
of this technology to in-vivo metabolic imaging of the lungs is challenging due to the 
limited metabolic signal and rapid spin de-phasing at air-tissue interfaces. The lungs remain 
a diagnostically attractive target, however, as they receive the full blood supply during each 
circulation and perform a variety of biochemical functions to maintain body homeostasis. 
These functions can undergo substantial and detrimental changes in patients suffering from 
ARDS or other conditions such as pulmonary fibrosis or sepsis, resulting in the release of 
lactic acid from the lungs22,36 as part of a spectrum of multi-organ dysfunctions associated 
with high mortality3,37,38. The development of molecular imaging techniques that facilitate 
the direct interrogation of pulmonary metabolism and its spatial heterogeneity can provide 
increased insight into the relationship between abnormalities in the mechanics and 
cellularity of diseased lung tissue. Addressing this knowledge gap is also relevant to 
clinical efforts to improve evaluation of lung disorders and could potentially result in more 
effective and targeted early intervention. Despite the inherent challenges, then, 
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hyperpolarized 13C technology provides us with unique opportunities to characterize 
metabolic flux in acute lung injury models. 
 
1.2. Objective and Specific Aims 
The goal of this project is to implement hyperpolarized [1-13C] pyruvate MRI 
acquisition and quantification techniques to characterize in-vivo lung tissue metabolism in 
small animals and to test its feasibility in large species. The key deliverables of this project 
are 1) an MRI acquisition method for metabolic imaging of the lungs using hyperpolarized 
[1-13C] pyruvate, 2) characteristics of lung metabolism under various ventilation protocols 
in small animals, and 3) feasibility testing of hyperpolarized 13C MRI’s clinical 
translatability. These goals were pursued by completing the following specific aims: 
 
I. Development of an imaging technique for hyperpolarized 13C MRI of the lungs 
a. Develop a chemical shift imaging pulse sequence for lung imaging using 
hyperpolarized [1-13C] pyruvate 
b. Develop a quantification method to assess alterations in pulmonary pyruvate 
metabolism  
c. Demonstrate hyperpolarized [1-13C] pyruvate MRI’s ability to assess alterations in 
pyruvate to lactate conversion in injured lungs and lung cancer 
 
II. Characterization of ALI using hyperpolarized [1-13C] pyruvate MRI 
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a. Investigate the impact of positive end-expiratory pressure on pulmonary pyruvate 
metabolism during progression of ALI 
b. Study the role of systemic hypoxemia on lung metabolism 
 
III. Translation of the studies to larger animals and human subjects 
a. Test feasibility of lung imaging using hyperpolarized 13C in large animals  
b. Develop a high-resolution imaging pulse sequence framework for future studies 
 
1.3. Thesis Organization 
The remainder of this dissertation is organized as follows: 
 
Chapter 2 provides an overview of the fundamentals of nuclear magnetic resonance 
(NMR), NMR signal dynamics, T1 and T2 relaxation mechanisms and RF pulse excitation 
and signal reception. It then introduces the concept of chemical shift and its ability to 
differentiate different molecular species using spectroscopy. It then introduces the concept 
of hyperpolarization and discusses its utility in medical imaging. An overview of different 
hyperpolarization methods is given, including optical pumping, parahydrogen-induced 
polarization (PHIP) and dynamic nuclear polarization (DNP). Practical aspects of 
developing 13C hyperpolarized biomarkers are then discussed before moving on to the use 
of hyperpolarized 13C to assess metabolic pathways: e.g., for the detection and 
characterization of diseases such as cancer and inflammation. It the continues to present 
the foundations of NMR signal spatial encoding and introducing the concept of k-space to 
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acquire and reconstruct MRI and spectroscopic images. The chapter ends by presenting a 
brief overview of current state-of-the-art imaging methods and pulse sequences and 
provides important imaging considerations for the effective and efficient use of irreversible 
hyperpolarized signal. 
Chapter 3 begins by offering a brief overview of lung physiology and biochemistry 
and goes on to describe both gas-exchange and pulmonary glycolytic metabolism. ARDS 
is then introduced, and its etiologies, clinical manifestations and current clinical guidelines 
are summarized. The concept of protective ventilation and the role of PEEP as a therapeutic 
and preventative measure in ARDS/ALI progression are then discussed, followed by the 
animal models commonly used to study lung injury. The chapter ends with a summary of 
the radiological methods used to diagnose and characterize ARDS/ALI. 
Chapter 4 presents our implementation of a modified free-induction decay chemical 
shift imaging (FID-CSI) pulse sequence for imaging pulmonary metabolism in small 
animals using hyperpolarized 13C MRI, including results of our serial lactate-to-pyruvate 
measurements in healthy and injured lungs during the course of ventilation. In addition to 
demonstrating the reproducibility of our measurement in heathy animals, the data also 
shows hyperpolarized 13C MRI’s ability to assess alterations in lung pyruvate metabolism 
in animals injured using a two-hit model of acid aspiration and ventilator-induced lung 
injury (VILI). Finally, in order to show that our imaging method is extendable to other 
diseases characterized by altered lung metabolism, we demonstrate our technique’s ability 
to detect higher conversion of pyruvate to lactate in cancerous tissue in a murine model of 
lung cancer.  
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Chapter 5 covers the experimental methodologies developed to assess the impact 
of PEEP on lung pyruvate metabolites, demonstrating that PEEP contains the progression 
of inflammatory injury during the course of ventilation in the presence of mild lung injury. 
The chapter also highlights the strong correlation between glycolytic and neutrophilic 
activity in the lungs, as well as a strong correlation between the former and reduced 
systemic oxygenation as measured by oxygen saturation. These results indicate that 
inflammation and hypoxia are the likely causes of altered pyruvate metabolism in the lung. 
Chapter 6 describes of our methodology for investigating the role of systemic 
hypoxia on lung metabolism and presents our results: although mild hypoxemia (SpO2 ~ 
90%) contributes negligibly to increased lactate-to-pyruvate ratio, severe hypoxemia (SpO2 
<80%) leads to significant changes in pulmonary pyruvate metabolism. Our data further 
suggests that the increased metabolic activity observed in the injured lungs in data 
presented in the previous chapter is primary caused by inflammatory injury rather than 
systemic hypoxemia.  
Chapter 7 details the methodology for implementing our imaging technique for 
imaging large species (i.e. pigs) to demonstrate the potential clinical translatability of 
hyperpolarized 13C imaging and presents the results of several such studies in healthy and 
injured pigs. We show elevated lactate signal intensity and lactate-to-pyruvate ratio in areas 
colocalized with injured lung.  
Chapter 8 describes the use of a half-Fourier acquisition single-shot turbo spin-echo 
(HASTE) imaging pulse sequence, as a general platform for high-resolution dynamic 13C 
MRI of the lungs in mice and pigs. We then conclude by offering a number of strategies to 
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implement high-resolution hyperpolarized 13C metabolic lungs to map spatial distributions 
of pyruvate and lactate using the HASTE pulse sequence. 
Finally, chapter 9 summarizes key results of this project and outlines the limitations 
of our findings. We then propose a number of studies to perform in future aimed to address 
these limitations and to demonstrate the potential of hyperpolarized 13C MRI to assess 
response to potential treatments for ARDS/ALI. We move on to discussing technical 
obstacles to the continued use hyperpolarized 13C MRI for research and its clinical 
translation for pulmonary metabolic imaging and discuss ideas that can be implemented to 
address these challenges. We conclude by discussing the potential use of hyperpolarized 
13C MRI for imaging other pulmonary diseases. 
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Chapter 2: Magnetic Resonance Imaging and Hyperpolarization 
 
2.1. Introduction 
Magnetic resonance imaging (MRI) is a relatively new, versatile imaging and 
spectroscopy tool used in a variety of applied sciences. It is wildly used in medicine, both 
to visualize soft tissue with superb contrast and to monitor metabolic processes with great 
sensitivity primarily by visualizing the hydrogen nuclei (protons). Perhaps most exciting 
about this technology, however, is the fact that it is safe and non-invasive by nature. Unlike 
other imaging modalities such as x-ray radiographs or computed tomography, MR imaging 
does not expose the patient to harmful ionizing radiation. Today, MRI scans are performed 
routinely on patients of any age, and are considered one of the most important radiological 
tools available to physicians for the diagnosis and treatment of numerous diseases. MRI is 
also a valuable scientific instrument with a variety of applications including drug 
development, the study of disease models, food screening and elucidating the molecular 
structure of proteins and various biological media. 
Despite its advantages, MRI suffers from an intrinsically low sensitivity that limits 
its clinical utility to imaging significantly abundant molecules in the body, such as water 
and fat, within a reasonable timeframe. Hyperpolarization is a method to dramatically 
increase the sensitivity of the NMR/MRI signal by a factor of 10,000-100,000, thereby 
enabling the detection of numerous molecules and their biochemical reactions in the body 
despite their very low natural concentration. The life-time of hyperpolarization is limited 
by irreversible molecular interactions that decrease this temporary signal enhancement to 
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its thermal equilibrium, creating challenges and opportunities in the field of hyperpolarized 
MRI to develop new data acquisition methods with promising applications for molecular 
imaging. 
 
2.2. A Brief History 
MRI is based on the nuclear magnetic resonance (NMR) phenomena discovered by 
Felix Bloch (Stanford) and Edward Purcell (Harvard) in 19461, for which both shared the 
1952 Nobel Prize in Physics. More sophisticated spectroscopic methods were developed 
in the 1950s, including spin echo by Eriwn Hahn in 19502. In 1954, Carr and Purcell used 
magnetic field gradients for the first time to study the impact of diffusion on the NMR 
signal of compounds 3. The first in vivo data was generated almost a decade later in 1968 
by Jackson and Langham4, who produced a proton spectrum for a rat using their home-
built low-frequency NMR spectrometer. Raymond Damadian’s work in 1971 demonstrated 
the utility of NMR in medicine by showing that its measurements were capable of 
discriminating between malignant tumors and healthy tissue in rats5. 
The first MRI images were produced in samples Paul Lauterbur in 19736 and later 
in animals by Raymond Damadian in 19777 by using a magnetic field gradient together 
with a back-projection technique to generate images, in a method dubbed magnetic 
resonance zeugmatography. This worked earned Lauterbur the Nobel Prize in Medicine in 
2003. In 1974, Richard Earnst discovered Fourier reconstruction of images by controlling 
the timing and the intensity of the magnetic field gradients in a particular sequence to 
collect data, for which he received the 1991 Nobel Prize in Chemistry. Substantial 
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advancement has since been made to MRI hardware and imaging methods, significantly 
improving image quality and reducing overall scan time; sub-millimeter high quality 
images can now be generated in a matter of minutes, real-time functional images of the 
cardiovascular system can be obtained, and diffusion-weighted MRI can visualize neutral 
tracts at high resolution.  
These advances have made MRI one of the most ubiquitous tools for the anatomical 
assessment of soft tissues. However, recent developments show that MRI is also capable 
of delivering functional and cellular information about tissue. Today, molecular imaging 
using MRI is an active and multifaceted area of clinical and preclinical research, with many 
applications for drug development and delivery, as well as early diagnosis and non-invasive 
monitoring of response to treatment. 
 
2.3. Fundamentals of Nuclear Magnetic Resonance 
The source of NMR signal is the interaction between an ensemble of atomic nuclei 
in objects with a main magnetic field (B0). The nuclei with an odd number of protons and 
neutrons have a non-zero nuclear spin, which can result in a net magnetic moment (µ). In 
the absence of the main magnet field, magnetization of the atomic nuclei in objects is 
randomly oriented, resulting in a net zero magnetization. In the presence of the main 
magnetic field, for spin-1/2 nuclei such as 1H, 3He, 13C and 129Xe, the nuclei can exist in 
either a +1/2 or -1/2 spin state, as shown in Figure 2.1. The discussion of systems with higher 
spin orders is omitted here, as all the nuclei discussed in this thesis are spin-1/2 systems.  
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Figure 2.1. Classical picture of the distribution of nuclear spins (spin 1/2) in the presence of the main 
magnetic field, B0. The difference in quantum energy between these states increases with the magnetic field 
and at any field is specific to each atomic species. 
 
The two quantum states have different quantum energy levels. Under thermal 
equilibrium, the lower energy state is slightly more populated that the higher one. The ratio 
between the excess number of spins populating the lower energy state (usually +1/2) to the 
total number of spins is referred to as polarization8: 
𝑃 = 𝑁& − 𝑁(𝑁& + 𝑁( 																				[2.1] 
where N+ and N- are the number of +1/2 and -1/2 spins in an ensemble of nuclei. The classical 
description states that the nuclear spins populating these states have magnetic moments 
that are aligned in the same or opposite direction in relation to the main magnetic field: 
polarization describes the degree to which the spins are aligned with the main magnetic 
field, and depends on the temperature, main magnetic field strength and magnetic moment 
of the nucleus. At thermal equilibrium, polarization can be calculated as:  
𝑃 = tanh	 3𝛾ℏ𝐵72𝑘𝑇 	: ≈ 	𝛾ℏ𝐵72𝑘𝑇 														[2.2] 
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where γ is the gyromagnetic ratio of the nucleus in units of MHz/T and is unique to each 
atom ,  ℏ is Planck’s constant (6.63 × 10-34 m2.kg.s-1), k is the Boltzmann constant (1.38 × 
10-23 m2.kg.s-2.K-1) and T is the temperature in kelvin. Because thermal polarization is 
typically a very small number, the approximation in equation 2.2 is valid. For example, at 
room temperature (~300K) and the field strength of a typical clinical MRI system (B0=3T), 
polarization (P) for hydrogen atoms or protons (g=42.58 MHz/T) is 10.2 × 10-6, or 
approximately 0.001%. Despite such low polarization levels, thermal polarization is the 
basis of every MRI/NMR study and is what generates the NMR/MRI signal, as the 
abundance of molecules that contain hydrogen atoms with a spin-1/2 nuclei, such as water 
and fat, lead to a detectable NMR/MRI signal. 
The polarization of an ensemble of spins in the presence of the main magnetic field 
along the z-axis leads to a net magnetization vector M in the same direction as B0. The 
time-evolution of vector M in the presence of the main magnetic field B0 can be represented 
using a simplified version of the Bloch equation9: 𝑑𝑴???⃗ (𝑡)𝑑𝑡 = 	𝛾𝑴???⃗ (𝑡) × 𝑩??⃗ (𝑡)																	[2.3] 
The magnetization vector can be divided into two components: the longitudinal 
component Mz, which has the same orientation as static magnetic field B0 along the z-axis, 
and the transverse component Mxy =Mx +iMy in a plane perpendicular to the static magnetic 
field. The solution to equation 2.3 describes the clockwise rotation of the transverse 
magnetization about the z-axis at a radial frequency w, known as the Larmor precession 
frequency, expressed as: 𝜔7 = 2𝜋𝑓7 = 𝛾𝐵7													[2.4] 
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This precession is graphically depicted in Figure 2.2. The Larmor frequency 
determines the frequency at which the NMR signal is detected and depends on the strength 
of the static magnetic field as well as the nucleus. 
 
Figure 2.2. Graphical representation of Larmor precession frequency. 
 
2.3.1. T1 and T2 Relaxation Mechanisms 
In an ideal system where there is no interaction between the individual neighboring 
nuclei and the magnetization remains undisturbed, the longitudinal magnetization and the 
intensity of the transverse magnetization remain unchanged, so equation [2.5] is valid. In 
practice, however, random molecular motion inevitably causes fluctuations in the local 
magnetic field. As a result, spins interact with their local environment and the net 
magnetization returns to a state of thermal equilibrium, aligning with the main magnetic 
field B0. This dynamic process is called relaxation and involves two mechanisms.  
The spin-lattice relaxation, also known as the longitudinal or T1 relaxation, is the 
process of magnetization’s return to its thermal equilibrium value in the direction of the 
main field B0, which occurs with an exponential time constant of T1. This relaxation 
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mechanism is due to the gradual loss of energy of the spins to other nuclei and electrons in 
the lattice. 
The spin-spin relaxation, also known as the transverse or T2 relaxation, is the 
mechanism by which the net transverse component of magnetization returns to zero. This 
is the result of the interaction of the spins with the local fluctuations in the magnetic field. 
These fluctuations alter the local precessional frequency of the neighboring spins, causing 
them to gradually become out of phase in time. A graphical description of the T2 relaxation 
mechanism is shown in Figure 2.3: 
 
Figure 2.3: (A) At t=0, the ensemble of spins in the transverse plane are all in phase. (B) The local 
fluctuations in the field cause spins to precess at slightly different frequencies, resulting in dispersion of the 
spins and loss of precessional coherence. 
 
T2 relaxation is generally caused by the molecular environment. However, 
imperfection of the main magnetic field, or distortions caused by the presence of a variety 
of material with different magnetic properties in the sample or tissue, can lead to magnetic 
field inhomogeneities. These cause additional dephasing of the transverse component of 
the magnetization which shortens the T2 relaxation time constant. The effective transverse 
relaxation time constant is characterized by the exponential time constant T2* and can be 
expressed as: 
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1𝑇K∗ = 1𝑇K + 1𝑇KM 																[2.5] 
where T2` is the contribution of the magnetic field inhomogeneity to the overall relaxation 
time constant. This equation implies that T2 > T2*. In pulmonary imaging, T2` is the 
dominant factor due to the abundance of air-tissue interfaces in the lung structure, which 
causes severe magnetic field fluctuations10. However, because this structurally-induced 
inhomogeneity is not random, its effect can be recovered using the refocusing RF pulses 
discussed in the next section. 
 
2.3.2. Radio-frequency Excitation and Signal Detection 
As previously discussed, magnetization always reaches a thermal equilibrium state 
by relaxation mechanisms. In order to perturb this equilibrium state, an oscillating radio 
frequency (RF) pulse must therefore be applied to the sample, and must have the same 
frequency as the Larmor precession frequency in order to excite the nuclear spins from a 
low to a higher energy state. This process is called RF excitation and be visually depicted 
as tipping the longitudinal magnetization vector to generate a precessing transverse 
magnetization component (Figure 2.4). The angle at which this vector is tipped relative to 
the z-axis angle is called the flip angle and is a function of the total energy of the RF pulse 
used. An RF pulse with a 180° flip angle is called a refocusing RF pulse (Figure 2.4) and 
is commonly used in NMR and MRI after an excitation pulse in order to flip the spins and 
recover the part of transverse magnetization that was de-phased due to static field 
inhomogeneity. RF pulses are generated by a transmit RF coil situated near the sample or 
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region of interest9. The coil is oriented such that this generated magnetic field is 
perpendicular to B0 and Mz,  and is denoted by B1. 
 
 
Figure 2.4. Pictorial description of an (left) excitation RF pulse and (right) an inversion RF pulse. 
 
The return of the excited spins to their original equilibrium state generates an RF 
signal called a free induction decay (FID) that can be detected with a receive RF coil. As 
shown in Figure 2.5, a typical FID is an oscillating decaying exponential. The Fourier 
transform of the FID is the NMR spectrum that can be mathematically described by a 
Lorentzian function. 
 
 
Figure 2.5. (A) A typical free induction decay acquired after excitation; the signal decays exponentially. (B) 
The Fourier transform of the FID leads to the NMR spectrum. 
 21 
2.3.3. Chemical Shift 
The Larmor precession frequency depends on the effective magnetic field to which 
nuclei are subjected. However, the magnetic environment of the nuclei is impacted by the 
orbital motion of the surrounding electrons. The electron cloud around the nucleus creates 
a shielding effect by inducing an additional magnetic field that opposes the main field B0, 
as shown in Figure 2.6. The effective magnetic field to which the nucleus is subjected is 
therefore described as: 𝐵OPP = (1 − 𝜎)𝐵7													[2.6] 
where Beff is the effective magnetic field and 𝜎 is the shielding constant. We can rewrite 
the Bloch equation described by Equation 2.4 to calculate the effective resonant frequency 
of the nucleus as:  𝜔OPP = (1 − 𝜎)𝜔7													[2.7] 
 
 
Figure 2.6. The isolated nucleolus (A) is subject to the external magnetic field B0. However, atomic nuclei 
are surrounded by an electron cloud which generates a weak magnetic field in the opposite direction to the 
external field (B). This shields the nucleus from the external field, so the nucleus is subject to a smaller 
effective magnetic field. 
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The degree of shielding depends the atomic structure and the adjacent atoms in the 
molecule, and can be used as a molecular signature in NMR spectroscopy. This is more 
commonly described by chemical shift of the nuclei defined in units of parts per million 
as: 𝛿[ppm] = 	𝜔OPP − 𝜔WOP𝜔WOP 	× 	10Y													[2.8] 
where d is the chemical shift in ppm and wref is the Larmor precession frequency of a 
reference molecule. The chemical shift and the shielding constant are mathematically 
related by: 𝛿[ppm] ≈ 	 (𝜎WOP − 𝜎OPP) × 10Y													[2.9] 
Tetramethylsilane (TMS) is the generally accepted reference molecule for 1H and 
13C spectroscopy, with a chemical shift of 0 ppm. Figure 2.7 shows a sample 13C spectrum 
obtained from ethanol and TMS. The chemical shift of the peaks in the spectrum provides 
information about the molecular composition of the sample, and the area under each peak 
is indicative of the relative concentration of different molecules in the sample. 
 
Figure 2.7. 13C NMR spectrum of ethanol. The carbons on the carboxyl (label 1) and the methyl (label 2) 
groups have chemical shifts of 200ppm and 30ppm respectively. The NMR spectrum of the reference 
molecule TMS appears at 0 ppm.  
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2.4. Hyperpolarization 
MRI has a very low intrinsic sensitivity; the population difference between the +1/2 
and -1/2 spin states, which is the source of NMR signal, is on the order of 0.001%. This 
limits the use of MRI as a clinically viable molecular imaging tool to detect molecules 
other than water and fat in the body, as the signal from these dominates that of other 
endogenous biomolecules and metabolites. A number of methods have been developed to 
suppress the strong background signal from water and fat11,12. However, since the chemical 
shift of protons in biological molecules is spread across a limited range (~10ppm), 
detecting of such molecules is only possible in tissues with long T2 and T2* relaxation time 
constants, as several NMR peaks need to be resolved within a small range in the NMR 
spectrum.  
While MRI of non-proton nuclei such as carbon has potential for molecular 
imaging, it is similarly challenging due to the low concentration of biomolecules in the 
body. This challenge is further exacerbated by the lower natural abundance of isotopes that 
are detectable with MRI. For example, while all organic biomolecules have carbon atoms,  
~1% of them consist of 12C nuclei which have a spin angular momentum of 0 and are thus 
undetectable via MRI. Lastly, non-proton nuclei have a smaller magnetic moment, further 
limiting their detection sensitivity. As Figure 2.8 shows, however, hyperpolarization can 
overcome these challenges by temporarily enhancing the sensitivity of the NMR signal 
several thousand-fold by increasing the population difference between nuclear spin states.  
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Figure 2.8. Orientation of the nuclear spins at thermal equilibrium (A) and in the hyperpolarized state (B). 
The population difference of the spins significantly increases in the hyperpolarized state, resulting in 
increased NMR signal. 
 
This dramatically increases the NMR signal beyond what is otherwise available by 
just placing the object in the magnetic field, thereby enabling different applications 
including imaging biological molecules present at low concentrations. The lifetime of 
hyperpolarization is limited by an irreversible T1 relaxation that decreases polarization 
levels to thermal equilibrium, limiting the available imaging window. Imaging 
hyperpolarized nuclei therefore requires special considerations to ensure maximum utility 
of the available signal. 
 
2.4.1. Methods of Hyperpolarization 
There are three methods to hyperpolarize a variety of atomic nuclei. Optical 
pumping-based methods can be used on molecules in gas phase and are most commonly 
used to hyperpolarize inert gases for functional lung imaging. Parahydrogen-induced 
polarization (PHIP)-based methods are used to polarize samples in their liquid states. 
Lastly, dynamic nuclear polarization (DNP) polarizes samples in their solid state. Both 
PHIP and DNP methods are capable of polarizing a broad range of molecules discussed in 
section 2.5, but DNP is the method primarily used to hyperpolarize 13C species. As the 
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primary focus of this thesis is the use of hyperpolarized 13C MRI for pulmonary imaging, 
DNP is discussed in more detail and its potential for molecular and metabolic imaging is 
highlighted. 
 
2.4.2. Optical Pumping 
In optical pumping, circularly polarized laser light is used to transfer the electronic 
spins from alkali metal vapors to the atomic nuclei of inert gases such as 3He and 129Xe. 
The target gas typically flows into a glass cell covered with rubidium (Rb); the cell is then 
heated to 150-170°C to vaporize the metal, dramatically increasing the probability of 
collisions between the rubidium and gas atoms. A laser light is then emitted on the glass 
cell for several hours, allowing for the gas atoms to hyperpolarize through collisional spin-
exchange with the rubidium atoms. Details of this process are described in13,14. 
Polarization levels ranging from 30-50% have been reported for 3He and 129Xe 
species—a sufficiently high level of enhancement to obtain high resolution images of 
human lungs. Many regional functional parameters of the lung can be obtained from these 
images such as specific ventilation, gas diffusion, alveolar oxygen tension using 3He15 and 
functional alveolar thickness, and gas exchange and transport16-18 using hyperpolarized 
129Xe imaging. 
Optical pumping is capable of generating large quantities of highly-polarized inert 
gases for biomedical imaging. However, it is not suitable for the polarization of liquid state 
samples for molecular imaging. 
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2.4.3. Parahydrogen Induced Polarization 
Parahydrogen induced polarization (PHIP) uses a chemical reaction between an 
unsaturated substrate and the parahydrogen molecules to increase nuclear polarization19. 
Parahydrogen is a spin isomer of the hydrogen molecule (H2) in which the spins of the 
protons in the molecule are anti-parallel20. At room temperature, "normal hydrogen" gas 
consists of 25% parahydrogen molecules21, although this increases at lower temperatures 
(T<298K) or as a result of the paramagnetic catalysis of the hydrogen.   
In PHIP, hydrogenation must occur such that the parahydrogen molecule is 
transferred onto the target substrate as a unit. Parahydrogen has a large spin order which 
can be transferred to the substrate using special polarization transfer NMR pulse 
sequences22,23. Alternatively, this high spin order can be transferred to the adjacent atomic 
nucleus using a diabetic field cycling method described by24. Although the parahydrogen 
molecule itself is not hyperpolarized in this process, the transfer of the large spin order in 
the parahydrogen molecule hyperpolarizes the nearby spin-1/2 nucleus (e.g. 13C, 15N) to a 
large degree. In fact, the use of hyperpolarized 13C MRI was first demonstrated using 
PHIP25. 
 
2.4.4. Dynamic Nuclear Polarization 
Dynamic nuclear polarization (DNP) is used to hyperpolarize solid state samples. 
The process involves transfer or spin polarization via cross-relaxation from a source of 
highly polarized spin bath (paramagnetic impurity) to the target nuclei nearby. This is 
achieved via the Overhauser effect, described thoroughly in26,27: unpaired electrons have a 
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significantly larger magnetic moment than atomic nuclei, and thus have thermal 
polarization of approximately 100% at low temperature and high magnetic field, as can be 
graphically presented from Equation 2.2 as shown in Figure 2.9. Unpaired electrons are 
thus an ideal polarization source in DNP, which is performed at >2K temperatures and <3T 
field strengths. 
 
Figure 2.9. Thermal polarization of electron, proton and 13C species as a function of temperature over 
magnetic field. At T/B < 0.1 Kelvin/Tesla, electrons are 100% polarized. This condition can be achieved at 
temperatures of T<2K and magnetic fields greater than 3T. The high degree of magnetization can be 
transferred from electrons to 13C or proton species via dynamic nuclear polarization (DNP). 
 
A suitable sample for DNP contains a homogenous mixture of the target molecule, 
a glassing agent (e.g. glycerol) and approximately 1% stable free radical to supply the 
unpaired electron 28. The sample is prepared in its aqueous form and is subsequently 
inserted into the DNP polarizer, where it is submerged into liquid helium and freezes. 
Sample homogeneity is imperative to enable effective transfer of spin order from the 
unpaired electrons to the target nuclei. The glassing agent prevents crystallization of the 
sample at low temperatures, which is known to expel foreign molecules from the mixture 
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and thus results in poor polarization28-30. However, no glassing agent is necessary certain 
target molecules (e.g pyruvic acid) which are amorphous at low temperatures.  
Within several minutes to hours, the polarization from the unpaired electron is 
transferred to the target nucleus by microwave irradiation at the resonance frequency of the 
unpaired electron at the magnetic field of the polarizer. However, the precise mechanism 
of DNP may vary depending on the sample characteristics. DNP was originally described 
by two distinct electron-nuclear interactions: solid effect and cross effect31. Solid effect 
involves dipolar coupling between a nearby nucleus and an electron, while cross effect is 
the interaction between two electrons and one nucleus. The contribution of each process is 
complex and mainly depends on the characteristics of the frozen mixture. DNP is therefore 
best characterized by the theory of thermal mixing, which describes the process by 
thermodynamic state transitions in the coupled electron-nuclear system32. 
Once the sample is polarized in its solid state, it is rapidly melted using a hot 
dissolution buffer to yield a 37°C liquid solution. The latter is typically chosen to yield a 
neutral isotonic hyperpolarized substrate28 that is suitable for administration into biological 
species. For samples that are gaseous at room temperature and pressure (e.g. 129Xe, 15N2O), 
the solution leads to sublimation of the gas, which can be collected for imaging and 
spectroscopy33. 
While DNP and PHIP are both capable of producing highly polarized liquid 
substrates for metabolic imaging, PHIP is far more cost efficient and requires shorter 
polarization times34. Despite these advantages, however, a number of technical challenges 
limit the use of PHIP in molecular imaging, chief among which is the fact that many 
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precursors for producing biologically relevant molecules (e.g. pyruvate and acetate) are 
unstable or toxic35, thereby limiting the number of molecules which can be polarized using 
PHIP. Yet many of these technical challenges can be addressed by an appropriate choice 
of precursors and catalysts as described in the literature36-38. DNP, on the other hand, 
requires an expensive polarizer device (shown in Figure 2.10); it has nevertheless been 
more commonly used for metabolic imaging since it is capable of directly polarizing the 
substrates. In fact, DNP was the method of choice for demonstrating the utility of 
hyperpolarized 13C imaging in human subjects39,40. 
 
Figure 2.10. (Left) Preclinical commercial polarizer (HyperSense, Oxford Inc.) and clinical polarizer 
(SpinLab, GE Healthcare).  
 
2.5. DNP: Practical Aspects for Medical Imaging 
The practicality of imaging hyperpolarized nuclei by any method relies on 
sufficiently long T1 relaxation time. For this, magnetic interactions between the target 
nuclei and other magnetic moments present in its vicinity must be minimized. A number 
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of conditions must therefore be met. First, only atomic nuclei with spin-1/2 must be used. 
Nuclei with a spin number zero (e.g. 12C, 16O, etc.) have no magnetic moment and thus do 
not interact with the magnetic field, while nuclei with higher spin numbers (2H, 14N, 23Na, 
etc.) have an electric quadrupole moment and therefore strongly interact with the local 
electric field gradients, considerably shortening the relaxation time constants8. Second, the 
intramolecular distance between the target nuclei and other magnetic moments, including 
unpaired electrons and other nuclei within the molecule, must be sufficiently large so as to 
minimize dipolar interactions8. Lastly, all residual magnetic interactions with the target 
atomic nuclei must be randomly oriented or limited in duration in order to prevent 
hyperpolarization loss35. 
The biological safety of molecules is also crucial in choosing appropriate 
biomarkers for imaging. All conditions combined, then, hyperpolarization becomes 
effectively limited to a few nuclear species. Inert non-toxic gases such as 3He and 129Xe 
are suitable for lung functional imaging—however, discussion of gas-MRI is beyond the 
scope of this work and is therefore omitted. For molecular imaging, the study of 13C, 15N 
and 31P nuclei are all valuable due to their abundance in organic molecules in vivo. 
However, the use of 13C-labeled molecules is preferred due their larger gyromagnetic ratio 
compared to 15N based molecules, which leads to improved sensitivity, as well as their 
significantly larger range of chemical shifts compared to 31P species, enabling the detection 
of a wider range of biomolecules.  
Smaller 13C labeled molecules are preferred over larger molecules due to a more 
rapid molecular reorientation rate which minimizes intermolecular magnetic interactions 
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and leads to longer T1 relaxation times35. The optimal position of the 13C nucleus is on a 
magnetically isolated carboxyl or carbonyl group to minimize intramolecular magnetic 
interactions35. Lastly, solubility of the target molecule is crucial for proper DNP sample 
preparation. Because many biologically relevant molecules have low solubility in water, 
the solvent must be chosen carefully to provide both sufficient sample solubility as well as 
glassing-like properties at low temperatures41. 
 
2.6. Molecular Imaging Using Hyperpolarized 13C MRI 
The enhanced sensitivity of hyperpolarized 13C nuclei facilitates sub-second 
imaging of exogenous substrates. What is more, once the substrate is metabolized by the 
cells, the product molecules, also known as downstream metabolites, can be distinguished 
from the substrate by their distinct resonance frequencies. While absolute quantification of 
the concentration of molecules is challenging due to variability in polarization levels and 
T1 relaxation times of the substrates after injection, relative concentrations of the 
exogenous hyperpolarized substrate and its downstream metabolites can be used to 
highlight alterations in metabolic pathways. Furthermore, enzymatic and reaction 
conversion rate constants can be quantified in real-time35. 
Other molecular imaging methods such as positron emission tomography (PET) 
and single-photon emission computed tomography (SPECT) can provide absolute 
quantification and uptake of the radioactively labeled exogenous substrates with high 
sensitivity42, but do not report the fate of the substrate. This ability is unique to 
hyperpolarized 13C MRI, making it a powerful, non-invasive imaging platform for both 
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diagnosis and monitoring therapeutic response, and which is capable of providing 
complementary information to PET and SPECT35,43. 
 
2.6.1. Hyperpolarized [1-13C] Pyruvate: Probing Glycolysis  
Several substrates have been successfully polarized and used for perfusion imaging 
as well as to assess various metabolic pathways44. [1-13C] pyruvate is the most commonly 
used probe for several reasons: it is a safe and small molecule that can be highly polarized, 
the first carbon on the carboxyl group has a long T1 relaxation time constant (40-60s ex-
vivo and 15-25s in-vivo) 35,45,46, and, lastly, pyruvate is a byproduct of glycolysis, the 
pathway by which glucose is converted to pyruvate, and is also an intermediate in several 
important metabolic pathways for energy production35. Figure 2.11 illustrates pyruvate’s 
metabolic properties.  
Pyruvate is catalyzed to lactate and alanine by enzymes lactate dehydrogenase 
(LDH), also known as glycolysis, and alanine transaminase (ALT), respectively. Pyruvate 
is also metabolized to CO2 and acetyl coenzyme A (Acetyl-CoA); this process, also known 
as oxidative phosphorylation, is the preferred pathway for energy production when oxygen 
is available in healthy cells. The conversion of the pyruvate to CO2 is facilitated by the 
enzyme pyruvate dehydrogenase (PDH), and the CO2 is subsequently converted to 
bicarbonate by the enzyme carbonic anhydrase (CA). The conversion of pyruvate to each 
of the metabolites depends on the activity of their corresponding enzymes and the 
availability of cofactors (e.g. nicotinamide adenine dinucleotide (NAD) in its oxidized 
(NAD+) and reduced (NADH) forms that is participates in the conversion of pyruvate to 
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lactate). While this conversion can be probed using [1-13C] pyruvate, conversion of the 
pyruvate to acetyl-CoA and beyond in the tricarboxylic acid cycle requires the use of [2-
13C] pyruvate, as discussed further in35,44. 
 
 
Figure 2.11. Metabolites and their biochemical pathways that can be interrogated using [1-13C] pyruvate. 
MRI. The red circle indicates atoms with 13C labeled nuclei. The fate of the pyruvate beyond Acetyl-CoA 
into the Tricarboxylic Acid (TCA) cycle cannot be probed using [1-13C] pyruvate as the 13C labeled nucleolus 
remains on the 13CO2 molecule. Cofactors are not shown in this diagram for simplicity (LDH: lactate 
dehydrogenase, ALT: alanine transaminase, PDH: pyruvate dehydrogenase, CA: carbonic anhydrase). 
 
Figure 2.12.A shows a representative 13C NMR spectrum obtained from a rat 25 
seconds after the injection of hyperpolarized [1-13C] pyruvate via the tail vein: the 
downstream metabolites of pyruvate are distinguished by their unique chemical shifts. In 
this case, the signal-to-noise of the CO2 peak was too small to be visible. Data acquisition 
started at the beginning of the 12-second injection and was repeated every second for 2 
minutes, as shown in the waterfall plot of Figure 2.12.B. We can obtain the time-course of 
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the individual metabolites by calculating the area under the peak for each metabolite at all 
time points, as demonstrated in Figure 2.12.C. 
 
Figure 2.12 (A) NMR spectrum obtained from a mouse after administration of hyperpolarized [1-13C] 
pyruvate via the tail-vein. (B) Spectra obtained every second shows how different peaks vary over time. (C) 
Area under each peak depicted as a function of time to represent the relative concentration of each peak. 
 
Conversion of pyruvate to lactate is referred to as anaerobic glycolysis since in the 
absence of oxygen, pyruvate is preferentially converted to lactate. However, in numerous 
pathologies including many types of cancers and inflammation LDH activity and thus 
pyruvate to lactate conversion is upregulated even when oxygen is sufficiently availability; 
in cancer, anaerobic glycolysis is the preferred pathway to produce energy for 
proliferation47,48. Similarly, anaerobic glycolysis and thus lactate production increases 
during inflammation as the activation of the immune system increases the bioenergetic 
needs of the tissue49-53. Elevated anaerobic glycolysis can be highlighted by hyperpolarized 
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13C MRI by measuring the lactate-to-pyruvate ratio as a marker for conversion of [1-13C] 
pyruvate to [1-13C] lactate. [1-13C] pyruvate is thus a versatile molecular imaging probe, 
and has been used in several animal studies35,44,54  as well as more recently in human 
patients40,43,55. 
 
2.7. Spatial Encoding, K-Space and Image Formation 
The NMR signal has no inherent spatial information, and therefore cannot be used 
to produce an image. In order to spatially encode the spins, three sets of gradient coils are 
built into MRI machines to spatially-vary the magnetic field, thereby altering the Larmor 
precession frequency in a spatially dependent fashion. The magnetic field can be 
represented as:  𝐵\(𝒓) = 𝐵7 + 𝐺_𝑥a + 𝐺b𝑦a + 𝐺\?̂?																										[2.10] 
In the presence of the gradient fields, the transverse magnetization precesses with 
a spatially dependent Larmor frequency, accruing a different amount of phase that depends 
on the location of the spins as well as the intensity and duration of the gradient field: 𝜑(𝒓, 𝑡) = h𝜔7 + 𝛾𝑮??⃗ . 𝒓jkklkkmn 𝑡																𝜔(𝒓) 								[2.11] 
Omitting the w0 term, we can define the following parameters for a two-
dimensional image in the xy plane: 𝑘_(𝑡) = 𝛾2𝜋 𝐺_𝑡				,				𝑘bo𝑡bp = 𝛾2𝜋 𝐺b𝑡																					[2.12] 
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Given this, we can mathematically describe the NMR signal obtained for each 
acquisition with the gradients on for a total duration of t9: 
𝑆Kro𝑘_, 𝑘bp = s𝑚_b	 (𝑥, 𝑦)𝑒(Kvwoxy(z)_&x{(z)bp𝑑𝑥	𝑑𝑦	|}~ 													[2.13] 
where mxy(x,y) is the spatial distribution of the magnetization in the xy plane. Equation 
[2.13] suggests that Fourier transform of this distribution in space describes the NMR 
signal represented in k-space. The duality property of the Fourier transform implies that 
the two-dimensional inverse Fourier transform of the k-space yields the spatial distribution 
of the spins, which is the image: 
𝑚_b	 (𝑥, 𝑦) = s 𝑆Kro𝑘_, 𝑘bp𝑒Kvwoxy_&x{bp𝑑𝑘_	𝑑𝑘b	(~O 													[2.14] 
This equation implies that MR image acquisition involves obtaining enough 
information in the k-space and calculating its inverse Fourier transform, as shown in Figure 
2.13. The range of k-space covered by the acquisition method controls the resolution of the 
image along the x and y axes: 
Dx = 12𝑘_,_ 	,													Dy = 12𝑘b,_ 																						[2.15] 
The sampling interval k-space, Dkx and Dky, determine the field-of-view (FOV) of 
the image along the x and y axes:         
FOV_ = 1D𝑘_ 	 , FOVb = 1D𝑘b 																										[2.16] 
As data in k-space are obtained in a discrete fashion, the Nyquist criterion must be taken 
into account when selecting the sampling interval. This dictates that the selected FOV must 
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be equal to or larger than the desired object, otherwise the signal outside of the FOV folds 
back onto itself and creates an artifact known as aliasing. The relationship between the 
sampling interval and the FOV along the x and y axes is: 
D𝑘	 ≤ 	 1FOV 																					[2.17] 
 
Figure 2.13. MRI data acquired in the k-space represents the Fourier transform of the object. The actual 
image (right) can be obtained by applying inverse Fourier transform to the k-space data.        
 
2.7.1. Acquisition Methods and MRI Pulse Sequences 
The order by which an acquisition method covers the k-space is called the k-space 
trajectory. A few commonly used k-space trajectories are shown in Figure 2.14. The 
method by which the k-space data is acquired is described by an MRI pulse sequence, which 
describes the timing, shape and strength of the gradient fields, the shape and the power of 
the RF pulses with pulse sequence diagram, an example of which is shown in Figure 2.15.  
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The majority of MRI pulse sequences have a number of components in common 
including slice selection, phase encoding, frequency encoding and data acquisition.  
 
Figure 2.14. (A) gradient-echo and (B) echo-planar readout trajectories are basic cartesian trajectories 
commonly used in both preclinical and clinical settings. Commonly used non-cartesian trajectories include 
(C) radial and (D) spiral trajectories. The imaging methods in this thesis obtain the data in a Cartesian grid. 
 
To obtain data to form a two-dimensional image, the first step is to excite the spins 
selectively in a given slice by turning the gradient on in the direction that slices are 
arranged. The thickness of the slice is determined by the bandwidth of the RF pulse, its 
shape and the strength of the gradient. Data is then spatially encoding using phase encoding 
or frequency encoding gradients. Phase encoding occurs between excitation and data 
acquisition, and spatially alters the phase of the transverse magnetization. Frequency 
encoding, on the other hand, occurs during the data readout and spatially alters the 
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frequency of the transverse magnetization. This acquisition method, called a gradient-echo 
(GRE) acquisition, is repeated every TR until the desired section of the k-space is traversed 
and is the most common method for collecting MRI data.  
 
 
Figure 2.15. Basic gradient-echo pulse sequence with a cartesian read-out trajectory. The components shown 
by the pulse sequence diagram are repeated regularly at the repetition time (TR) interval until the desired 
portion of the k-space is covered.  
 
The time between the center of the excitation pulse and the point at which the 
maximum signal is formed during spatial encoding is called the echo time (TE) and is 
crucial for generating images with different types of tissue contrast. For instance, the signal 
from tissues with a short T2* time constant, such as the lungs, decay much more rapidly, 
and therefore require the use of a short TE. The MRI pulse sequences and other acquisition 
methods are discussed more thoroughly in9. 
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2.8. Chemical Shift Imaging 
The spatial encoding described in the previous section ignores the presence of molecular 
species with different chemical shifts. However, effective use of hyperpolarized 13C MRI 
for molecular imaging requires methods that can resolve the spatial distribution of the 
individual metabolites (e.g. pyruvate and lactate) with different chemical shits. This 
method is known as chemical shift imaging (CSI) or magnetic resonance spectroscopic 
imaging (MRSI). Sample metabolite maps obtained from a human heart using chemical 
shift imaging is shown in Figure 2.1640. 
 
 
Figure 2.16. (A) Proton cardiac MRI, (B) 13C-bicarbonate, (C) [1-13C] lactate and (D) [1-13C] pyruvate maps 
after administration of hyperpolarized [1-13C] pyruvate to a healthy human subject. (Reproduced with 
permission from40) 
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Several imaging and spectroscopic pulse sequences have been developed to address 
challenges and limitations associated with hyperpolarized 13C imaging.  A number of these 
exploit the long T2, and T2*relaxation times of 13C species in many organs [refs from paper], 
while others take advantage of 13C species’ large range of the chemical shift to selectively 
excite individual metabolites56. The various methods are briefly described below. 
 
2.8.1. Spectroscopic Imaging Approaches 
The most basic spectroscopic method encodes the magnetization spatially and 
spectrally. Similar to Equation 2.14, the spectroscopic image can be described by 
mxy(x,y,f), where f is the resonance frequency. We can rewrite Equation 2.14 as: 
𝑚_b	 (𝑥, 𝑦, 𝑓) =  𝑆Kro𝑘_, 𝑘b, 𝑘p𝑒Kvwoxy_&x{b&zp𝑑𝑡𝑑𝑘_	𝑑𝑘b		(~O 												[2.18] 
This suggests that the spectroscopic imaging data can be resolved if the k-space 
data is repeatedly acquired over time after each excitation. The Fourier transform along the 
time dimension resolves the spectral information for each image voxel. 
The most basic method for performing this acquisition to obtain the necessary 
(kx,ky,t) points is to apply a phase-encoding gradient after excitation in order to traverse to 
(kx,ky) in the k-space and acquire an FID for a duration of Tacq. This simple pulse sequence 
is called the free induction decay-chemical shift imaging (FID-CSI) pulse sequence and its 
diagram is shown in Figure 2.17. The Nyquist criterion applies along the t as well; the 
spectral bandwidth of the NMR spectrum obtained by the pulse sequence is given by: 
			𝐵𝑊 =	 1∆𝑡 												[2.19] 
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The FID-CSI pulse sequence is one of the most frequently used CSI pulse 
sequences due to its simplicity and availability on all MRI scanners. In fact, due to its 
ability to image organs with short T2* relaxation time constants such as the lungs, the pulse 
sequence primarily used in this thesis is a modified version of the FID-CSI pulse sequence. 
It suffers from a long acquisition time, however, as obtaining each point on the (kx,ky)  
plane requires a single RF excitation. This is not ideal, especially for imaging 
hyperpolarized media, where a large number of excitations cause severe and irreversible 
RF-induced hyperpolarization decay  
 
Figure 2.17. (A) 2D FID-CSI chemical shift imaging pulse sequence diagram, and (B) its associated k-space 
trajectory along the (kx,t) plane. The dashed lines with arrowheads show the direction of data acquisition per 
one excitation. 
 
An alternative approach is to take advantage of long T2 relaxation time of the 13C 
species by combining the acquisition of both spatial and spectral information into one 
single excitation using an echo-planar readout strategy57. This pulse sequence is known as 
the Echo-Planar Spectroscopic Imaging (EPSI) sequence, and its pulse sequence diagram 
is shown in Figure 2.18. The effective combination of spatial and spectral encoding during 
each acquisition significantly accelerates data acquisition compared to the FID-CSI pulse 
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sequence; for example, acquiring a 16´16 spectroscopic image using the EPSI pulse 
sequence requires 16 times fewer excitations. However, implementing EPSI is challenging, 
as it requires optimization due to rapid cycling of the gradients during data acquisition. 
Additionally, acquiring spatial and spectral data together necessarily increases the duration 
of data collection, which may not be feasible for imaging tissues with short T2 or T2* r 
relaxation time constants, such as the lungs or bones.  
 
Figure 2.18. (A) Pulse sequence diagram of the EPSI sequence and (B) its k-space trajectory. The gradients 
along the readout result in data acquisition with an echo-planar trajectory in the (kx,t) plane.  
 
2.8.2. Iterative Decomposition Using Echo Asymmetry and Least Square Estimation  
The previous methods relied on general knowledge of the peaks in the spectrum. 
However, given a prior knowledge of the exact frequency of the NMR peaks, chemical 
shift imaging can be performed more efficiently. For the basic case in which two NMR 
peaks are separated by a chemical shift Df, a gradient-echo sequence with two echoes 
separated by DTE = Df-1 can be used to acquire two images where the NMR peaks are in 
phase (IP) or out-of-phase (OP) shown Figure 2.19. The image of each peak can then be 
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reconstructed by either summing or subtracting the (IP) and (OP) images. This method is 
known as Iterative Decomposition with Echo Asymmetry and Least Square Estimation 
(IDEAL) and is used regularly to separate water and fat signals in proton MRI images58,59. 
 
 
Figure 2.19. Magnetization of both water and fat molecules is excited and an in-phase image (IP) is acquired. 
After a certain delay, the water (Mwater) and fat (Mfat) magnetizations become out of phase due to their 
different chemical shifts, at which point an out-of-phase (OP) image is acquired. Separate images of water 
and fat then can be reconstructed from the IP and OP images. 
 
The IDEAL method can be extended to a larger number of resonance frequencies 
provided that the number of echoes obtained per excitation exceeds the number of spectral 
peaks60. This method can be combined with a variety of acquisition schemes and has been 
used with gradient echo-based pulse sequences with both cartesian61-63 or spiral readout 
trajectories64, as well as with a single-shot spin-echo based pulse with multiple Cartesian 
readouts45. 
The use of IDEAL-based pulse sequences eliminates the need to obtain full spectral 
information by shortening the overall readout time relative to spectroscopic methods, 
thereby shortening the overall scan time. For example, the combining the IDEAL method 
with a single-shot spin-echo pulse sequence was shown to provide a 30-fold reduction in 
imaging time compared to the standard FID-CSI pulse sequence65, enabling dynamic 
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imaging of the metabolites. One major limitation of this method is that, even with prior 
knowledge of the chemical shifts, it remains susceptible to 𝐵7 inhomogeneities. However, 
this problem can be addressed by acquiring a field-map image before the start of the 
acquisition and incorporating it into the reconstruction. 
 
2.8.3. Spatial-Spectral Excitation for Chemical Shift Imaging 
The last approach is to exploit the sparse nature of the 13C NMR spectrum to 
selectively excite individual metabolites using narrow-band spatial spectral (SPSP) 
composite pulses while only spatially encoding the produced signal using an imaging pulse 
sequence. SPSP pulses consist of multiple lobes of short RF excitations accompanied by 
time-varying slice selection gradients. The spatial selectivity is determined by the shape of 
each lobe and its gradient, while the spectral selectivity depends on the envelope of the 
lobes. This strategy enables separate excitation of individual NMR peaks, allowing one to 
only detect the contribution of the desired peak to the MRI image; it is extensively 
discussed in66,67 A sample imaging pulse sequence with SPSP RF pulse is shown in Figure 
2.20. 
The frequency of the excitation pulse can be shifted to selectively excite the other 
NMR peaks individually, thereby obtaining images specific to each one. This approach 
eliminates the need to spectrally encode the NMR signal; it therefore considerably reduces 
the total acquisition time, enabling dynamic imaging68,69. However, similar to the IDEAL 
method, it requires a priori knowledge of the exact chemical shifts, which may not always 
be feasible due to the inherent inhomogeneity of the main field causing spatial variations 
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in the frequency of the NMR peaks. Furthermore, SPSP pulses are generally very long (10-
20ms) and are not suitable for imaging tissues with short T2 or T2*, such as the lungs. Many 
newer multiband RF pulses that offer superior spectral selectivity with minimal duration 
have been designed specifically for hyperpolarized 13C imaging. However, the design and 
optimization of such RF pulses is still an ongoing area of research and development. 
 
 
Figure 2.20. Pulse sequence diagram for an EPI sequence with spectral-spatial excitation (SPSP). The SPSP 
excitation pulse consist of multiple RF pulses accompanied by an EPI-type slice selection gradient (Gz). 
 
2.9. Imaging Considerations 
Previous sections provided an overview of the fundamentals of MRI and MRSI, as 
well as principles of image formation. In practice, a number of issues must be taken into 
consideration that affect the quality of MRI images. Given the short availability of the 
signal, additional considerations need to be taken into account for imaging hyperpolarized 
media, several of which are discussed here. 
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2.9.1. General Considerations 
Generally, the major consideration in MRI is the signal-to-noise ratio (SNR). The major 
sources of noise are the body, the RF coil and the electronics. The dominant source is the 
body itself, since it is a conductive medium and generates random fluctuating magnetic 
fields that are near the coil. The overall noise intensity is approximately proportional to the 
main field strength B0. In practice, it is extremely challenging to manufacture MRI systems 
to operate and very high field strengths. Today, the majority of the clinical systems operate 
at 3T field strength.  
The imaging parameters also impact the overall SNR. In summary, this relationship 
can be described as: 
			𝑆𝑁𝑅	 ∝ (∆𝑥)(∆𝑦)(∆𝑧)o𝑇po𝑁p									[2.20] 
where Dx, Dy and Dz are the size of voxels in each direction, Tacq is the acquisition time, 
and Navg is the number of times the image is obtained9. A smaller voxel size or slab 
generally improves the resolution; however, it also compromises the SNR. To obtain higher 
resolution images, signal averaging can be used or the acquisition time can be increased. 
However, the impact of increased acquisition time is only effective as long as it is shorter 
than the transverse relaxation time constant (Tacq < T2*). Data acquisition beyond this only 
increases the noise. This is especially critical for imaging tissues with short T2* such as the 
lungs, where increasing the acquisition time can lower the SNR.  
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2.9.2. Special Considerations for Hyperpolarized MRI 
The significant enhancement in sensitivity after hyperpolarization is only 
temporary and the magnetization decays back to thermal equilibrium due to irreversible 
signal loss caused by T1 relaxation. Additionally, the RF pulse excitation needed to produce 
detectable NMR signal causes additional non-recoverable decay of the longitudinal 
magnetization. This limits the availability of signal for imaging to a brief period after 
administration of the hyperpolarized substrate. A number of considerations are therefore 
necessary to ensure optimal use of the enhanced signal. 
First, the timing of the data acquisition is of key importance for obtaining images 
with maximum signal-to-noise ratio. Generally, the optimal time to start acquiring the 
signal is when the amplitude of the downstream metabolite of interest has the maximum 
signal. For many hyperpolarized substrates, this has been found to occur approximately 25-
seconds after the start of injection. This is demonstrated in Figure 2.14, panel C, which 
shows the lactate and time-course of hyperpolarized [1-13C] pyruvate and its downstream 
metabolites obtained from a mouse using NMR spectroscopy of the abdominal area. The 
initial build-up of the pyruvate signal occurs as the substrate is administered and its 
concentration builds up. This is followed by its subsequent conversion to its downstream 
metabolites lactate, alanine and bicarbonate, marked by the increase in their corresponding 
signals. The peak signal of the metabolites occurs about 25s after the start of injection, after 
which the signal of all the metabolites decease due to T1 relaxation. 
The second consideration is that the signal dynamics must be taken into account for 
image reconstruction. Typically, a constant longitudinal magnetization is assumed for each 
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excitation. However, due to the T1 relaxation effects as well as the RF-induced signal 
decay, this does not hold true for imaging hyperpolarized substrates. Such changes in the 
signal dynamic introduce blurring artifacts into the image, effectively lowering the 
resolution70. One strategy is to use a small excitation flip-angle to minimize RF-induced 
signal loss. However, this carries a significant signal-to-noise penalty. A more effective 
strategy is to gradually increase the flip-angle over time to compensate for reduction in 
available longitudinal magnetization and have a fixed transverse magnetization after each 
excitation70. Another method that we introduce in chapter 5 of this thesis is to repeatedly 
acquire the spectrum from the center of the k-space and compensate for the signal decay 
by adjusting the signal intensity of the data acquired over time. This has the advantage of 
allowing us to independently correct the signal decay for various metabolites.  
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Chapter 3: Lungs and Acute Respiratory Distress Syndrome 
 
3.1. Introduction 
As the primary respiratory organ, the main function of the pulmonary system is to 
transfer oxygen from the air to the bloodstream and to remove carbon dioxide from the 
blood through gas exchange. In addition to this primary task, however, the lungs also 
perform a variety of critical metabolic and cellular functions that can alter rapidly due to 
increased energy demand of the tissue in the presence of various lung pathologies such as 
cancer and lung injury1-11. 
Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) occurs in 
approximately in 10% of the patients admitted to the intensive care unit (ICU)12,13, and is 
characterized by increased endothelial permeability in the alveoli, pulmonary edema, 
impaired gas exchange and inflammation13,14. Despite being defined approximately fifty 
years ago15, ARDS/ALI remains a significant source of mortality in critically ill patients12: 
it has a reported mortality rate of 40%12, and survivors may experience numerous 
difficulties including physical and psychological sequelae, exercise limitation and 
increased use of health care services12,16. The availability of several mammalian animal 
models that mimic ARDS/ALI in humans17 has led to significant progress in understanding 
this condition’s pathogenesis, and imaging tools has played a major role in defining the 
characteristics of ARDS/ALI. Unfortunately, there are currently limited treatment options 
available for improving survival significantly once ARDS/ALI has developed18; according 
to the protocol recommended by the ARDS network trial19, current therapeutic approaches 
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are primarily limited to supportive mechanical ventilation and, more recently, prone 
positioning of patients18,20.  
This chapter begins with an overview of the physiology and respiratory mechanics 
of healthy lungs before moving on to a short summary of ARDS/ALI, its clinical 
manifestations and pathogenesis. Mechanical ventilation and the concept of protective 
ventilation as a supportive strategy to minimize progression of ARDS/ALI is then 
discussed, and the chapter ends with a brief overview of state-of-the-art imaging tools used 
in the study and clinical management of ARDS/ALI. 
 
3.2. Healthy Lungs 
 
3.2.1. Anatomy and Physiology 
The lungs are a spongy organ that consist of a highly branched structure of airways 
and vessels. The airways consist of two zones: conducting and respiratory. The conducting 
zone includes the larger airways, starting from the trachea at the top before branching into 
two smaller airways called the main bronchi, which conduct air into the left and right lung, 
respectively. The airways in the conducting zone branch down (sixteen generations in 
humans), becoming progressively smaller until reaching the terminal bronchioles, where 
the respiratory zone of the lung begins. In this zone, the airways branch down further (seven 
more generations in humans) into alveolar ducts where air travels into the alveolar sacs, 
each consisting of several alveoli. The main vessels are the pulmonary artery and vein, 
which carry the blood from the heart to the lungs and from the lungs back the heart. The 
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pulmonary artery and vein divide into left and right pulmonary arteries along the bronchi 
and, similar to the airway, branch down into progressively smaller vessels, eventually 
reaching the small arterioles and venules that carry the blood to a network of capillaries 
surrounding the exterior of the alveoli. The structure of the airways, lung vasculature and 
alveoli is shown in Figure 3.1.A. 
 
Figure 3.1. Pulmonary vessels branch in the same treelike fashion as the airways. (A) Systemic venous blood 
flows through the pulmonary arteries into the alveolar capillaries and back to the heart via the pulmonary 
veins, to be pumped into systemic circulation. (B) A mesh of capillaries surrounds each alveolus. As the 
blood passes through the capillaries, it gives up carbon dioxide and takes up oxygen. (C) Blood–gas interface, 
formed by pulmonary capillaries and alveoli, is the site of gas exchange. Thick arrows indicate the direction 
of blood flow and ventilation, while thin arrows indicate the diffusion paths for O2 and CO2. The alveolar–
capillary membrane is thin (∼0.5μm), and therefore the diffusion distance for gases is small. Reproduced 
with permission from21. 
 
Gas exchange in the lungs occurs via passive diffusion of gases through the 
alveolar-capillary membrane from the alveolar space into the capillaries, where the gas 
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binds to the hemoglobin molecule in the red blood cell and vice versa (Figure 3.1.B). The 
alveolar-capillary membrane consists of three layers: the alveolar epithelium, interstitial 
fluid (also known as the blood-air barrier) and the capillary endothelium. The alveolar 
epithelium primary consists of thin cells known as type I pneumocytes (Figure 3.2, AECI). 
The blood circulatory system returns non-oxygenated blood from other organs to 
the lungs via the pulmonary artery. The carbon-dioxide (CO2) carried by red-blood cells 
diffuses through the alveolar-capillary membrane into the alveolar air-space and is replaced 
by the oxygen molecule that passes through this membrane to oxygenate the blood. The 
oxygenated blood then returns to the heart via the pulmonary vein and is delivered to the 
rest of the body via the aorta and major arteries.  
The lungs’ overall capacity to oxygenate can be assessed by performing arterial 
blood gas (ABG) analysis to measure the arterial blood oxygen tension (PaO2). PaO2 can 
also be estimated by measuring oxygen saturation (SpO2), which is defined as the fraction 
of oxygen-bound hemoglobin relative to total hemoglobin available. This measurement can 
be performed non-invasively using infrared pulse oximeters that are widely available. In 
healthy subjects, the oxygen saturation remains above 95% when breathing air with ~21% 
fraction of inspired oxygen (FiO2) 21. The state of reduced oxygen availably (SpO2 < 95%) 
is known as hypoxia. 
 
3.2.2. Respiratory Mechanics 
Breathing is an active process that uses the chest and diaphragm muscles to expand 
or contract the pleural cavity for respiration. During inhalation, the expansion of the pleural 
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cavity generates a negative pressure that expands the lungs and conducts air into them 
through the nasal cavity. Exhalation, on the other hand, is a passive process whereby lung 
recoil pushes the air out of the lungs until the pressure in the pleural cavity and the 
environment equilibrate.   
The mechanics of respiration can be assessed via the pressure-volume curve of the 
lungs. This curve describes the lungs’ ability to expand, known as pulmonary compliance, 
and is defined as the ratio between the change in the volume of inhaled gas and the change 
in the pleural pressure21. In healthy lungs, the secretion of pulmonary surfactants by type 
II pneumocytes (Figure 3.2. AECII) reduces the alveolar surface tension, thereby 
increasing pulmonary compliance. The surfactant also prevents the alveoli from collapsing 
of the alveoli—also known as atelectasis—which can result in reduced gas-exchange. 
Pulmonary compliance is reduced in many lung pathologies, however, due various factors 
including loss of the lung’s elastic recoil, the presence of edema, and surfactant depletion 
in the lungs21. 
 
3.3. Acute Respiratory Distress Syndrome and Acute Lung Injury 
 
3.3.1. Characterization and Clinical Definition  
Acute respiratory distress syndrome and acute lung injury (ARDS/ALI) is 
characterized by sudden onset of respiratory failure, pulmonary edema, diffused alveolar 
damage and widespread inflammation of the lung12. Primary injury to the lungs is caused 
by a direct (pneumonia, gastric aspiration, traumatic injury or toxin inhalation) or indirect 
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(sepsis, burn injury or cardiopulmonary bypass) insult to the lung tissue which may 
progress to ARDS, as shown in Figure 3.2. Such progression is followed by resolution of 
ARDS/ALI in response to treatment or further progression into severe respiratory and 
multi-organ failure. 
 
Figure 3.2. Etiologies, manifestations and sequelae of ARDS/ALI. Upon diagnosis, patients undergo 
supportive therapy using protective ventilation (described in section 3.4.2). The patient’s overall condition is 
assessed by chest radiography, computed tomography, ventilatory parameters and ABG. Treatment either 
results in resolution of ARDS/ALI or in the syndrome’s progression into severe respiratory failure, 
pulmonary fibrosis and eventual multi-organ failure.  
 
ARDS/ALI patients are nearly always admitted to the intensive care unit (ICU), where 
they receive mechanical ventilation. The most recent clinical definition of ARDS, the 
Berlin definition, was proposed in 2012 and consists of four criteria for diagnosis13: 
a) Occurrence of lung injury within seven days of the insult 
b) Presence of pulmonary edema detected by bilateral diffused opacities in chest 
radiographs or chest computed tomography images  
c) Hypoxemia diagnosed by PaO2 / FiO2 < 300mmHg 
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d) Mechanical ventilation with a minimum positive end-expiratory pressure (PEEP) 
of 5 cmH2O (described in section 3.4.2) 
The severity of ARDS can be categorized by the degree of hypoxemia as12: 
a) 201 mmHg <PaO2 / FiO2 < 300mmHg, with ~27% mortality rate 
b) 201 mmHg <PaO2 / FiO2 < 200mmHg, with 32% mortality rate 
c) PaO2 / FiO2 < 100mmHg, with 45% mortality rate 
 
3.3.2. Mechanical Ventilation 
While it is crucial to identify the underlying cause of lung injury in order to provide 
the appropriate course of treatment, supportive therapy in is required the limit the 
progression of lung injury12. The primary supportive approach for ARDS/ALI patients is 
mechanical ventilation, which allows the respiratory muscles to rest while providing 
adequate oxygenation and minimizing lung injury22. In mechanical ventilation, a ventilator 
is directory connected to the trachea using either an endotracheal tube inserted through the 
mouth or a tracheostomy tube inserted into the trachea through an incision in the anterior 
neck.  
Although used as a supportive therapy, mechanical ventilation can cause injury in 
patients with healthy lungs, or lead to secondary injury in ARDS/ALI patients by 
exacerbating the primary injury. Ventilator-induced lung injury (VILI) is caused when 
large mechanical forces are applied to the lung microstructure, and can occur either when 
ventilation with large tidal volumes (barotrauma) leads to alveolar rupture or when 
ventilation with small tidal volumes (atelectrauma) results in regional hypoxia and repeated 
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opening and closing of the alveoli (unstable inflation)22. Careful selection of ventilation 
parameters is therefore essential to limit progression and resolve injury. 
The protective ventilation strategy recommended by the ARDS network 
(ARDSNet) trial consists of ventilation with 4-6ml/kg tidal and use of a minimum positive 
end-expiratory pressure (PEEP) of 5 cmH2O such that SpO2 > 88%19. The PEEP/FiO2 ratio 
can be adjusted to maintain oxygenation as needed. 
PEEP is alveolar pressure at the end of expiration that is higher than the 
atmospheric pressure, and is applied using a ventilator to improve overall oxygenation by 
preventing atelectasis from recruiting the collapsed regions of the lungs23,24. However, 
while PEEP has been shown to reduce tidal lung strain and the incidence of VILI, it can 
lead to decreased cardiac output and increased pulmonary vascular resistance24. Several 
strategies have therefore been proposed for the optimal titration of the PEEP in ARDS/ALI 
patients; one commonly used strategy is to minimize either the peak inspiratory pressure 
(PIP) or the driving pressure (the difference between the end-inspiratory pressure and 
PEEP). However, because trials have shown similar outcomes among the various 
strategies24, the optimal titration of PEEP and its impact on lung injury progression remains 
an important area of ongoing research in ARDS.  
 
3.3.3. Pathogenesis  
In the acute, or exudative, phase of ARDS/ALI (Figure 3.3), the alveoli become 
filled with protein-rich edema fluid and resident macrophages (a type of white blood cell) 
secrete pro-inflammatory proteins and cytokines (e.g. interleukin-8 (IL-8)), which recruit 
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the innate immune cells (primarily neutrophils). Neutrophils adhere to the endothelial 
lining of the vessels and roll on this lining until they migrate through the alveolar-capillary 
membrane into the airspace, thereby damaging it. Neutrophil adherence to the endothelial 
wall can be measured via markers of endothelial injury such as soluble intercellular 
adhesion molecule-1 (sICAM-1 or ICAM-1)25. Neutrophils are activated in the alveolar 
space, releasing toxic mediators, granula proteins and reactive oxygen species (ROS) into 
this space which and causing further epithelial and alveolar injury as well as the formation 
of hyaline membranes. Neutrophil activity can be measured by the expression of enzymes 
and proteins released by activated neutrophils, such as elastase or myeloperoxidase 
(MPO)25.  The pathogenesis of ARDS/ALI is described in more detail in12. 
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Figure 3.3. The healthy lung (left), and the acute phase of ARDS/ALI (right). In ARDS/ALI, injury is 
initiated by either direct or indirect insults to the delicate alveolar structure of the distal lung and associated 
micro-vasculature. In the exudative phase, resident alveolar macrophages are activated, leading to the release 
of potent pro-inflammatory mediators and chemokines that promote the accumulation of neutrophils and 
monocytes. Activated neutrophils further contribute to injury by releasing toxic mediators. The resultant 
injury leads to loss of barrier function as well as interstitial and intra-alveolar flooding. (AECI: type I alveolar 
epithelial cell (pneumocyte), AECII: type II alveolar epithelial cell, MPO: myeloperoxidase, ROS: reactive 
oxygen species and sICAM: soluble intercellular adhesion molecule). More detailed information can be 
found in12. Reproduced with permission from12. 
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3.3.4. Pulmonary Lactate Production 
Healthy lung tissue predominantly relies on glucose utilization to sustain function, 
although its energy and metabolic needs are relatively modest compared to other organs 
such as the heart and liver26. Approximately 50% of the glucose utilized by the lung tissue 
converts to lactate27. The lungs typically maintain the glycolytic intermediary balance 
(lactate-to-pyruvate ratio) in the blood by utilizing the excess blood lactate, which results 
in a negligible difference in transpulmonary lactate concentration28. However, this function 
of the lung is compromised in many lung pathologies—especially in ARDS/ALI—
resulting in a systemic release of lactate by the lung, as shown in Figure 3.4.A2,3, which 
has been shown to be strongly correlated with lung injury score as shown in Figure 3.4.B. 
The injury score is representative of the severity of opacities observed in chest radiographs 
and computed tomography images, as well as the severity of overall respiratory failure 
measured by PaO2/FiO2 ratio and loss of pulmonary compliance29. 
Although increased lactate production by the lung tissue may reflect the presence 
of hypoxia due to elevated anaerobic metabolism, several studies suggest that the elevated 
lactate production by the lungs in ARDS/ALI is primarily associated with increased lung 
inflammation and neutrophil activity, and can occur even in the absence of tissue hypoxia. 
This suggests that increased lactate concentration and lactate-to-pyruvate ratio in the lung 
tissue may be a surrogate for lung injury and inflammation1,2,8. 
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Figure 3.4. (A) Lung lactate production measured by the difference in the lactate concentration across the 
lungs (arteriovenous difference in lactate) in various groups of patients shows that lungs of ALI patients 
produce significant amounts of lactate. (B) Lung lactate production measured in 43 patients with acute injury 
showed that it is proportional to injury severity as determined by Murray’s lung injury score29. (ALI: acute 
lung injury, CPE: acute pulmonary edema, BPN: bronchopneumonia, LTx: lung transplantation, Other: other 
types of respiratory failure, mEq/min.M2: mmoles per minute per square meter). Reprinted with permission 
of the American Thoracic Society. Copyright © 2019 American Thoracic Society from2. The American 
Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society. 
 
3.3.5. Animal Models of ALI and ARDS 
Nearly fifty years of research in human ARDS patients have significantly improved 
our understanding of the mechanisms of lung injury and its progression to ARDS/ALI30, 
which in turn has led to significantly improved patient care. Nevertheless, ARDS is a 
complex and heterogenous disorder that remains a common and lethal syndrome in ICUs. 
Further hypothesis-driven studies are therefore required to better elucidate the 
physiological and cellular mechanisms involved in ARDS/ALI and to better evaluate the 
efficacy of novel therapeutic strategies. Conducting such studies in humans is challenging, 
however, due to a myriad of clinical variables (e.g. different etiologies, severities and 
patient history). Alternatively, studies using animal or in-vitro laboratory models that 
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mimic the pathophysiology of ARDS/ALI in humans while tightly controlling such 
variables offer the opportunity to generate additional insights. 
There are several rodent models (e.g. acid aspiration, bleomycin-induction and 
chlorine inhalation) used to study mechanisms of acute lung injury17. To be sure, none of 
these models perfectly reproduce the characteristics and pathophysiology of lung injury in 
humans, which has various etiologies and depends on clinical variables including 
comorbidities and genetic factors for its progression. There are also significant differences 
between the innate immune response in humans and rodents17. Nevertheless, rodent models 
can be chosen to appropriately to mimic particular features of ARDS/ALI for study. 
Many studies utilize two-hit models of lung injury, in which first model of primary 
injury is followed by second model to exacerbate the injury4,17,30. In this thesis, we used 
acid instillation as our direct injury model, followed by VILI for injury exacerbation 
(sections 4.2 and 5.2.1). The acid instillation causes alveolar/capillary barrier disruption 
and neutrophilic infiltration within an hour. Although its closest clinical correlate is gastric 
aspiration, the features of this injury model are common to most ARDS/ALI and acute lung 
injury patients17,31. What is more, the severity of the primary injury in this model can be 
controlled reproducibly by adjusting the volume and pH of the acid instilled31. Since 
patients with acute lung injury and ARDS/ALI are often mechanically ventilated, the 
second model we used in our study is also clinically relevant in addition to enabling us to 
control the trajectory of the primary injury by adjusting the ventilator parameters (section 
5.2.1). 
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3.3.6. Emerging Treatments 
Protective ventilation is the primary supportive therapy approach used clinically in 
ARDS/ALI patients, while prone positioning has also recently been shown to be an 
effective strategy for improving ARDS survival18, possibly due to its ability to minimize 
regions with unstable alveolar inflation32. Nevertheless, ARDS/ALI remains a highly lethal 
condition. 
A number of pharmacologic therapeutics have been explored for treating 
ARDS/ALI. However, few has been shown to improve patient outcomes: e.g., inhalation 
of nitric oxide briefly improves oxygenation but does not appear to improve survival rate. 
A number of small trials have also attempted to use anti-inflammatory medications to 
inhibit neutrophilic activity, but have not produced conclusive evidence of improved 
outcome. Another recently investigated approach is the inhibition of the calcium channel 
transient receptor potential vanilloid 4 (TRPV4) substantially mitigates pulmonary injury 
and edema. TRPV4 channel has been implicated in initialing acute endothelial 
hyperpermeability resulting in disruption of alveolar/capillary membrane and edema33.  
Finally, the use of stem cell therapeutic approaches is another method currently under 
investigation.  
Recent data has revealed ARDS/ALI to be a condition characterized by substantial 
heterogeneity12. For instance, approximately 30% of ARDS/ALI patients are considered to 
have a hyper-inflammatory phenotype marked by elevated systemic levels of inflammatory 
markers and carrying a mortality rate that is double the average rate for all ARDS/ALI 
patients12. In another study, two distinct phenotypes of ARDS/ALI patients were found that 
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responded differently to different PEEP settings and fluid management strategies34. These 
findings suggest that identifying more phenotypes of ARDS/ALI based on their molecular 
and biological characteristics may be a promising approach for identifying the therapeutic 
approaches that can improve outcomes for specific phenotypes. 
 
3.4. Current Lung Imaging Tools 
Chest radiography has been an integral part of the clinical definition of ARDS13. At 
the same time, several other imaging modalities such as computed tomography (CT), 
proton and hyperpolarized gas MRI have been used to investigate lung injury for clinical 
and preclinical applications that are further discussed in this section. 
 
3.4.1. Radiography 
Radiography is among the most accessible and commonly used imaging techniques 
in the clinic. A generator produces x-ray beams that are projected toward the patient from 
one side and detected on the other side by sensors. The signal intensity depends on the 
amount of x-ray energy absorbed by the tissue. Chest radiography is extensively used for 
the diagnosis and clinical management of ARDS/ALI. The healthy lungs have a large 
contrast in the image relative to the surrounding tissues and rib cage. In ARDS/ALI 
patients, however, non-aerated regions of the lungs due to edema and infiltrates can be 
conveniently detected as opacities in the image (Figure 3.5.A)35. According to the Berlin 
definition, the detection of bilateral infiltrates in the lung via x-ray is one criteria for 
ARDS/ALI diagnosis13.  
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Chest radiography is an inexpensive, quick and safe imaging modality which, with 
the development of portable imagers, can now be performed on ARDS/ALI patients whom 
it is difficult to transport for imaging due to severe illness and or mechanical ventilation. 
Despite these advantages, however, chest radiography can only provide a projection image 
of the lungs, making the detection of vascular, cardiac and diaphragmatic margins from 
opacities caused by edema and infiltrates challenging. 
 
 
Figure 3.5. Chest imaging in patients with acute respiratory distress syndrome (ARDS). (A) A plain chest 
radiograph demonstrates symmetric widespread hazy infiltrates. (B) A computed tomography scan in the 
same patient confirms the bilateral infiltration observed on plain chest radiograph; however, the infiltrate is 
predominantly in the dorsal lung (black arrow), while the ventral lung regions are aerated (green arrow). (C) 
Computed tomography scan showing typical ground glass opacities, indicating severely decreased aeration 
but without complete loss of gas content. (D) Computed tomography scan of a patient 16 days after ARDS-
onset, showing diffuse interstitial thickening predominantly at the lung bases, suggesting evolving fibrosis; 
in addition, ventral bullae (yellow arrow), pneumomediastinum (blue arrow), and soft tissue emphysema (red 
arrow) represent barotrauma from mechanical ventilation. Reproduced with permission from34. 
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3.4.2. Computed Tomography (CT) 
Computed tomography (CT) uses x-ray energy similar to radiography. In CT, 
however, the x-ray energy is emitted through the patient from multiple directions using a 
rotating x-ray source and detectors. The data can then be reconstructed into three-
dimensional images to visualize anatomical structures. CT is widely used for lung imaging 
and is critical to the management of many lung pathologies, including ARDS. Figure 3.5.B-
D shows representative CT images obtained in three ARDS patients with different 
radiological presentations. Since CT images can be reconstructed in three dimensions, they 
enable much better localization of non-aerated regions of the lungs and opacities in ARDS 
patients compared to chest radiographs. However, CT may still be unable to distinguish 
opacities caused by infiltration, edema or atelectasis35.  
The use of quantitative CT methods can provide more insight into the progression 
of lung injury. For example, recent studies have demonstrated that CT images acquired 
from ventilated rats and pigs at both end-inspiration and end-expiration can be registered 
and compared to assess lung aeration during the ventilation cycle20,36. This methodology 
was able to identify regions of the injured lungs that were more prone to injury progression 
as a result of overdistension during ventilation. What is more, this methodology was also 
able to predict mortality in previously imaged ARDS patients better that qualitative 
assessments of routinely performed CT scans36. These findings suggest that quantitative 
approaches using CT could significantly improve the clinical management of ARDS/ALI.  
Contrast-enhanced dual-energy CT, which employs an x-ray source that operates 
at two energy levels, is another approach that has recently been used for quantitative lung 
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imaging. Because the lung tissue has similar photo absorption at these energy levels, a 
contrast agent (e.g. iodine) that has a different photon absorption at these two energy levels 
is administered intravenously. This difference can be used to obtain images before and after 
injection of the contrast in order to quantify blood flow and volume in the lungs35,37. 
Despite its capabilities, however, the fact that CT exposes patients to a significant dose of 
ionizing radiation limits its repeated use in patients over a short period of time.  
 
3.4.3. Positron Emission Tomography (PET) 
In positron emission tomography (PET), radiolabeled analogues of specific 
molecules (e.g. [18F]-fluorodeoxyglucose (18F-FDG), an analogue of glucose) are injected 
intravenously into the patient. The nucleolus of the radiolabeled atom then undergoes b 
radioactive decay, in which a positron is released and travels for a short distance in the 
tissue (<1mm) before colliding with an electron to produce two g-ray photons that travel in 
opposite directions38. These photos are then detected and localized using a large ring-
shaped sensor around the patient. PET scanners do not obtain anatomical information and 
thus are often combined with CT scanners (PET/CT scanners) to overlay the functional 
information on the anatomical images.  
While 18F-FDG-PET is routinely used in clinical oncology39, it has not been used 
clinically for the management of ARDS/ALI. However, several studies have demonstrated 
its capability as a molecular imaging tool to delineate regions in the injured lungs with 
elevated glycolysis due to neutrophilic infiltration and activation as measured by increased 
18F-FDG uptake35,40-42. Given the previously mentioned studies showing that 
 72 
approximately 33% of ARDS patients have a “hyper-inflammatory” sub-phenotype with a 
significantly higher mortality rate12, 18F-FDG-PET would appear capable of providing 
invaluable insight into patient outcomes in ARDS/ALI41. Figure 3.6 shows representative 
CT and PET scans from two ARDS patients. 
 
 
Figure 3.6. Representative images of cross-registered computed tomography (CT) and [18F]- 
fluorodeoxyglucose (18F-FDG) positron emission tomography from two patients with ALI/ARDS. The CT 
image was acquired during a respiratory pause at mean airway pressure: the gray scale is centered at -500 
Hounsfield Units with a width of 1250 Hounsfield Units. Positron emission tomographic images represent 
the average pulmonary 18F-FDG concentration during the last 20 minutes of acquisition (from 37 to 57 
minutes after 18F-FDG administration): the color scale represents radioactivity concentration (kBq/mL). (A) 
18F-FDG distribution parallels that of the opacities detected on CT. (B) Intense 18F-FDG uptake can be 
observed in normally aerated regions (square 1), while activity is lower in the dorsal, “nonaerated” regions 
of both lungs (square 2). Reproduced with permission from43. 
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While 18F-FDG-PET enables the visualization of metabolic changes in the lung, it 
also exposes patients to ionizing radiation and requires a long scan time (between 10-40 
minutes)35. It is further limited to examining abnormalities in the uptake of the glucose 
analogue fluorodeoxyglucose, and is therefore unable to reveal changes in downstream 
metabolism that may be crucial to the evolution of inflammation and injury (18-20). 
Understanding these downstream pathways may open up new therapeutic approaches 
aimed at controlling early injury and/or attenuating its consequences in the early stages 
(21), goals which may be facilitated by the use hyperpolarized 13C MRI described in this 
thesis. 
 
3.4.4. Magnetic Resonance Imaging (MRI) 
Magnetic resonance imaging was extensively discussed in chapter 2. Proton MRI 
offers superb contrast between different soft tissues without exposing the patient to 
ionizing radiation. Its clinical use for lung imaging is limited, however, by the lung’s low 
tissue density and severe magnetic field inhomogeneity due to air/tissue interfaces. These 
challenges may be overcome by using robust ultra-short echo time (UTE) imaging methods 
capable of visualizing of the airways and lung tissue with high spatial resolution44. 
Nevertheless, UTE-based sequences are challenging enough to develop that they have yet 
to be used clinically. Contrast-enhanced MRI has also been used to quantify pulmonary 
blood flow and perfusion45, although it is not yet part of the clinical management of ARDS. 
The further development of these techniques may facilitate the widespread use of MRI as 
a standard lung imaging tool in ARDS/ALI patients.  
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More recently, hyperpolarized gas MRI (129Xe and 3He) has been used extensively 
to study pulmonary disorders in small and large animals as well as human subjects46,47. 
Patients can safely inhale the hyperpolarized gas, and anesthetized animals can be 
ventilated with the gas and subsequently imaged to probe airway structure and assess lung 
functional by regionally measuring fractional ventilation, oxygen tension, gas diffusion and 
uptake. Figure 3.7 shows MRI images of the lung obtained from a human subject using 
conventional MRI and after inhalation of hyperpolarized 3He gas to visualize the airways. 
Although hyperpolarized gas MRI is expensive and not ubiquitously accessible, several 
studies have demonstrated its ability to provide valuable quantitative information about 
alterations in the lung microstructure during mechanical ventilation48 and 
inflammation49,50. 
 
 
Figure 3.7. (Top Row) Coronal images of the lungs in a human subject obtained using conventional MRI. 
(Bottom Row) Images from the same subject after inhalation of hyperpolarized 3He gas to allow visualization 
of the airways. 
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Finally, while proton and hyperpolarized gas MRI elucidate the structural and 
functional manifestations of inflammation, they do not target the metabolic and molecular 
processes that drive these changes. In this thesis, we will demonstrate the use of 
hyperpolarized [1-13C] pyruvate to probe these changes in both small and large species.  
 
3.4.5. Ultrasound Imaging and Electrical Impedance Tomography (EIT) 
Ultrasound is an inexpensive and ubiquitous tool that emits high-frequency sound 
waves (1-10MHz) through tissue and measures its reflection using piezoelectric sensors to 
characterize the acoustic properties of that tissue. While not traditionally used for lung 
imaging, recent studies suggest that ultrasound imaging is capable of detecting non-aerated 
areas and edematous regions of the lungs35. What is more, ultrasound imaging offers the 
dual advantages of using portable scanners and visualizing the changes in lung aeration in 
real-time. However, it also offers suffers from diagnostic error and poor specificity, though 
these disadvantages can be limited by properly training the operator as well as by 
developing probes that are specifically designed for lung ultrasound35. 
Another recently developed method for imaging the lungs is electrical impedance 
tomography (EIT), which uses several electrodes positioned around the chest to conduct a 
small alternating electrical current through the body in order to estimate the impedance 
across the thorax35. This impedance drastically changes in well-aerated areas during a 
respiratory cycle, thereby localizing such areas. EIT currently suffers from low spatial 
resolution. However, it offers tremendous potential as an imaging tool, since it is 
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inexpensive and can be used to obtain images in real-time. Information provided by EIT 
could potentially be used to adjust the ventilator strategy for each patient at point-of-care35. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 77 
3.5. References 
1. Kellum, J. A., Kramer, D. J. & Lee, K. Release of lactate by the lung in acute lung injury. Chest 
(1997). 
2. De Backer, D., Creteur, J., Zhang, H., Norrenberg, M. & Vincent, J. L. Lactate production by the 
lungs in acute lung injury. Am J Respir Crit Care Med 156, 1099–1104 (1997). 
3. Bassett, D. J. & Fisher, A. B. Alterations of glucose metabolism during perfusion of rat lung with 
paraquat. Am. J. Physiol. 234, E653–9 (1978). 
4. Pourfathi, M., Cereda, M., Chatterjee, S., reports, Y. X. S.2018. Lung Metabolism and Inflammation 
during Mechanical Ventilation; An Imaging Approach. nature.com, 8, 280 (2018). 
5. Shaghaghi, H. et al. Metabolic spectroscopy of inflammation in a bleomycin‐induced lung injury 
model using hyperpolarized 1‐13C pyruvate. NMR Biomed. 27, 939–947 (2014). 
6. Pullinger, B. et al. Metabolism of hyperpolarized [1-13C]pyruvate in the isolated perfused rat lung 
- an ischemia study. NMR Biomed. n/a–n/a (2012). doi:10.1002/nbm.2777 
7. Bassett, D. J. & Bowen-Kelly, E. Pyruvate metabolism of perfused rat lungs after exposure to 100% 
oxygen. J. Appl. Physiol. 60, 1605–1609 (1986). 
8. Iscra, F., Gullo, A. & Biolo, G. Bench-to-bedside review: Lactate and the lung. Crit Care 6, 327–
329 (2002). 
9. Routsi, C. & Bardouniotou, H. Pulmonary lactate release in patients with acute lung injury is not 
attributable to lung tissue hypoxia. Critical Care 2014 18:5 (1999). 
10. Johnson, M. L., Hussien, R., Horning, M. A. & Brooks, G. A. Transpulmonary pyruvate kinetics. 
AJP: Regulatory, Integrative and Comparative Physiology 301, R769–R774 (2011). 
11. Johnson, M. L., Emhoff, C. A. W., Horning, M. A. & Brooks, G. A. Transpulmonary lactate shuttle. 
AJP: Regulatory, Integrative and Comparative Physiology 302, R143–R149 (2011). 
12. Thompson, B. T., of, R. C. N. E. J.2017. Acute respiratory distress syndrome. Mass Medical Soc, 
377, 562–572 (2017). 
13. Force, T. A. D. T. Acute Respiratory Distress Syndrome: The Berlin DefinitionThe Berlin 
Definition of ARDS. JAMA 307, 2526–2533 (2012). 
14. Shankar-Hari, M. & McAuley, D. F. Acute Respiratory Distress Syndrome Phenotypes and 
Identifying Treatable Traits. The Dawn of Personalized Medicine for ARDS. Am J Respir Crit Care 
Med (2017). doi:10.1164/rccm.201608-
1729ED;journal:journal:ajrccm;issue:issue:10.1164/ajrccm.2017.195.issue-
3;wgroup:string:Default 
15. ASHBAUGH, D. G., BIGELOW, D. B., PETTY, T. L. & LEVINE, B. E. Acute Respiratory Distress 
in Adults. The Lancet 2, 319–+ (1967). 
16. Herridge, M. S. 50 Years of Research in ARDS.Long-term Follow-up After ARDS: Insights for 
Managing Medical Complexity After Critical Illness. Am J Respir Crit Care Med rccm.201704–
0815ED (2017). doi:10.1164/rccm.201704-0815ED 
 78 
17. Matute-Bello, G., Frevert, C. W. & Martin, T. R. Animal models of acute lung injury. American 
Journal of Physiology - Lung Cellular and Molecular Physiology 295, L379–L399 (2008). 
18. Guerin, C. et al. Prone Positioning in Severe Acute Respiratory Distress Syndrome. N Engl J Med 
368, 2159–2168 (2013). 
19. Grasso, S. et al. ARDSnet Ventilatory Protocol and Alveolar Hyperinflation. Am J Respir Crit Care 
Med 176, 761–767 (2007). 
20. Xin, Y. et al. Unstable Inflation Causing Injury: Insight from Prone Position and Paired CT Scans. 
Am J Respir Crit Care Med rccm.201708–1728OC (2018). doi:10.1164/rccm.201708-1728OC 
21. Rhoades, R. A. & David, B. Medical physiology, Principles for Clinical Medicine. (Wolters 
Kluwer). 
22. Slutsky, A. S. & Ranieri, V. M. Ventilator-Induced Lung Injury. N Engl J Med 369, 2126–2136 
(2013). 
23. Khemani, R. G. et al. Positive End-Expiratory Pressure Lower Than the ARDS Network Protocol 
Is Associated with Higher Pediatric Acute Respiratory Distress Syndrome Mortality. Am J Respir 
Crit Care Med 198, 77–89 (2018). 
24. Sahetya, S. K., Goligher, E. C. & Brower, R. G. Fifty Years of Research in ARDS. Setting Positive 
End-Expiratory Pressure in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 195, 
1429–1438 (2017). 
25. Jochen Grommes, O. S. Contribution of Neutrophils to Acute Lung Injury. Molecular Medicine 17, 
293–307 (2011). 
26. Fisher, A. B., Steinberg, H. & Bassett, M. D. D. Energy utilization by the lung. Symposium on the 
Lung and Pulmonary Circulation 57, 437–446 (1974). 
27. Fisher, A. B. Intermediary metabolism of the lung. Environmental Health Perspectives 55, 149 
(1984). 
28. Johnson, M. L. Transpulmonary Lactate and Pyruvate Kinetics. (2011). 
29. MURRAY, J. F., Matthay, M. A., LUCE, J. M. & FLICK, M. R. An Expanded Definition of the 
Adult Respiratory-Distress Syndrome. American Review of Respiratory Disease 138, 720–723 
(1988). 
30. Laffey, J. G. & Kavanagh, B. P. Fifty Years of Research in ARDS.Insight into Acute Respiratory 
Distress Syndrome. From Models to Patients. Am J Respir Crit Care Med 196, 18–28 (2017). 
31. Kennedy, T. P. et al. Acute acid aspiration lung injury in the rat: biphasic pathogenesis. Anesth. 
Analg. 69, 87–92 (1989). 
32. Xin, Y. et al. Unstable Inflation Causing Injury. Insight from Prone Position and Paired Computed 
Tomography Scans. Am J Respir Crit Care Med 198, 197–207 (2018). 
33. Thorneloe, K. S. et al. An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary 
Edema Induced by Heart Failure. Science Translational Medicine 4, 159ra148–159ra148 (2012). 
34. Calfee, C. S. Precision Medicine: An Opportunity to Improve Outcomes of Patients With Sepsis. 
American journal of respiratory and critical care … (2016). 
 79 
35. Cereda, M. et al. Imaging the Injured Lung: Mechanisms of Action and Clinical Use. (2019). 
36. Cereda, M. et al. Tidal changes on CT and progression of ARDS. Thorax thoraxjnl–2016–209833 
(2017). doi:10.1136/thoraxjnl-2016-209833 
37. Fuld, M. K. et al. Pulmonary Perfused Blood Volume with Dual-Energy CT as Surrogate for 
Pulmonary Perfusion Assessed with Dynamic Multidetector CT. Radiology 267, 747–756 (2013). 
38. Pauwels, E. K., Sturm, E. J., Bombardieri, E., Cleton, F. J. & Stokkel, M. P. Positron-emission 
tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its 
implication for clinical studies. J. Cancer Res. Clin. Oncol. 126, 549–559 (2000). 
39. Miles, K. A., Voo, S. A. & Groves, A. M. Additional Clinical Value for PET/MRI in Oncology: 
Moving Beyond Simple Diagnosis. J. Nucl. Med. 59, 1028–1032 (2018). 
40. de Prost, N. et al. 18F-FDG kinetics parameters depend on the mechanism of injury in early 
experimental acute respiratory distress syndrome. - PubMed - NCBI. J. Nucl. Med. 55, 1871–1877 
(2014). 
41. Rodrigues, R. S. et al. FDG-PET in patients at risk for acute respiratory distress syndrome: a 
preliminary report. Intensive Care Med 34, 2273–2278 (2008). 
42. Locke, L. W. et al. FDG-PET Quantification of Lung Inflammation with Image-Derived Blood 
Input Function in Mice. International Journal of Molecular Imaging 2011, 1–6 (2011). 
43. Bellani, G. et al. Lungs of patients with acute respiratory distress syndrome show diffuse 
inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study. 
Critical Care Medicine 37, 2216–2222 (2009). 
44. Jiang, W. et al. Motion robust high resolution 3D free‐breathing pulmonary MRI using dynamic 3D 
image self‐navigator. Magn. Reson. Med. 79, 2954–2967 (2018). 
45. Ley, S. & Ley-Zaporozhan, J. Pulmonary perfusion imaging using MRI: clinical application. 
Insights into Imaging 3, 61–71 (2011). 
46. Ruppert, K. Biomedical imaging with hyperpolarized noble gases. Rep. Prog. Phys. 77, 116701 
(2014). 
47. Mugler, J. P. & Altes, T. A. Hyperpolarized 129Xe MRI of the human lung. J. Magn. Reson. 
Imaging 37, 313–331 (2013). 
48. Cereda, M. et al. Quantitative imaging of alveolar recruitment with hyperpolarized gas MRI during 
mechanical ventilation. J. Appl. Physiol. 110, 499–511 (2011). 
49. Ouriadov, A. et al. Early stage radiation-induced lung injury detected using hyperpolarized 129Xe 
Morphometry: Proof-of-concept demonstration in a rat model. Magn. Reson. Med. n/a–n/a (2015). 
doi:10.1002/mrm.25825 
50. Li, H. et al. Quantitative evaluation of radiation‐induced lung injury with hyperpolarized xenon 
magnetic resonance. Magn. Reson. Med. n/a–n/a (2015). doi:10.1002/mrm.25894 
 
 
 
 80 
Chapter 4: Metabolic Imaging of Acute Lung Injury using Hyperpolarized 13C MRI 
 
This chapter has been adapted from the published article, Pourfathi et al. ‘In vivo imaging of the progression 
of acute lung injury using hyperpolarized [1‐13C] pyruvate’ in Magnetic Resonance in Medicine, 78:2106-
2115 (2017) 
 
4.1. Introduction 
In our earlier ex-vivo perfused lung studies using spectroscopy, we showed a 
significantly increased rate of hyperpolarized lactate labeling after injection of 
hyperpolarized [1-13C] pyruvate in injured lungs1. What is more, the lactate-to-pyruvate 
ratio was significantly correlated with the severity of neutrophilic infiltration, suggesting 
increased metabolic activity due to the presence of infiltrates. 
Extending this technology’s use to in-vivo pulmonary imaging is challenging due 
to lung tissue’s severe B0 inhomogeneity, which causes rapid spin dephasing at air-tissue 
interfaces, as well as the lung's low overall tissue density (section 2.3.1). In the case of 
metabolic imaging, this difficulty is further exacerbated by lung’s modest overall energy 
needs. Taken together, these challenges limit both signal-to-noise ratio (SNR) and the 
suitability of rapid pulse sequences that have proven useful for imaging other organs. 
Therefore, development and optimization of imaging and spectroscopic pulse sequences to 
address the challenges of the lung MRI are required. 
Despite these obstacles, however, the use of hyperpolarized [1-13C] pyruvate MRI 
for pulmonary metabolic imaging is diagnostically and therapeutically attractive since the 
lungs of patients suffering from conditions such as ARDS/ALI, pulmonary fibrosis or 
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sepsis releases high concentrations of lactic acid due to high inflammatory activity2,3. 
Given that the lungs receive the full blood supply during each circulation and perform a 
variety of biochemical functions to maintain body homeostasis such metabolic changes in 
the pulmonary system can lead substantial detrimental alterations. Such changes are part 
of a spectrum of multi-organ dysfunctions and, unsurprisingly, are associated with high 
mortality4-6. Consequently, the development of molecular imaging techniques capable of 
directly interrogating lung metabolism as well as its spatial heterogeneity could provide 
valuable insight into the relationship between abnormalities in the mechanics and 
cellularity of diseased lung tissue. Addressing this knowledge gap is relevant to clinical 
efforts aimed at improving the evaluation of inflammatory lung disorders and could 
potentially result in more effective and specific early interventions.  
This chapter describes the development of a pulse sequence based on the FID-CSI 
sequence, as well as its first successful test in healthy ventilated rats. Experiments were 
subsequently extended to rats injured with a combination of hydrochloric acid aspiration 
and ventilator-induced lung injury. Lastly, utility of our method was also assessed for 
imaging other pulmonary disorders, namely lung cancer in a mouse model of lung 
adenocarcinoma. 
 
4.2. Development and Optimization of a Lung Imaging Protocol 
We used a single-slice two-dimensional FID-CSI pulse sequence (described in 
section 2.8.1) for metabolic imaging of the lungs and optimized it for two field strengths 
(4.7T and 9.4T) in order to image rats and mice, respectively. Unlike other MRSI methods, 
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this method requires neither a long spectroscopic/spatial readout time nor long RF pulses 
to excite individual metabolites—thus enabling detection of the short T2* components in 
the NMR signal that come primarily from the lung tissue. 
The fact that the FID-CSI pulse sequence requires both a long scan time and a large 
number of excitations is a major drawback, as the availability of hyperpolarized signal is 
limited by irreversible signal loss caused by a combination of T1 relaxation and RF pulse 
excitation, which alter pyruvate and lactate signal dynamics. This time-dependent signal 
change results in image blurring that can reduce true spatial resolution—an issue which is 
exacerbated by the fact the heart is significantly more metabolically active than the lungs, 
potentially masking the signal from the latter. In order to address this issue, we introduced 
a method by which signal variability during an extended hyperpolarized imaging protocol 
may be observed and analytically corrected. This is possible using a custom-designed 
outward spiral k-space trajectory (shown in Figure 4.1) in which the center of k-space is 
re-measured every eleventh excitation. The observed signal dynamics require an 
independent correction for each chemical species to minimize blurring due to motion or 
relaxation-induced dynamics7. 
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Figure 4.1. (Left) The k-space trajectory used in the proposed acquisition technique, where the acquisition 
returns to the center of the k-space every 11th acquisition. (Right) Signal obtained during the course of 
imaging shows the exponential signal decay due to the T1 relaxation of the sample as well as the destructive 
effect of RF excitation on magnetization. The blown-up view of the initial 1.5 seconds of the data shows the 
FID obtained during each phase-encoded acquisition and every 11th FID from the center of the k-space; this 
has a larger amplitude due the absence of spatial phase distortion across the object due to the phase encoding 
gradients. 
 
After careful optimization of the imaging parameters, we were able to produce 
images with sufficient SNR and spatial localization, with parameters that are summarized 
in Table 4.1 for both rat and mice experiments: 
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Table 4.1. Summary of imaging parameters for the protocols established for imaging lungs of rats and mice. 
Parameter Rats Mouse 
Field (Tesla) 4.7 9.4 
Repetition Time (ms) 36 22 
Acquisition Time (ms) 32 21 
Acquisition Bandwidth (Hz) 4000 6000 
Number of Spectral Points 128 128 
In-plane Field-of-View (mm2) 45´45 20´20 
Slice Thickness (mm) 8-15 5 
Matrix Size 16´16 16´16 
Total Scan Time (s) 9.2 5.6 
Injection Dose for 80mM Pyruvate (ml/kg) 4 10 
Injection Duration (s) 6 3 
Scan Start time (s after start of injection) 18 10 
Flip Angle (°) 9 9 
Number of Excitations 256 256 
RF Pulse Shape Gaussian Gaussian 
RF Pulse Duration (µs) 200 200 
Crusher Duration (ms) 2.5 1 
Crusher Strength (G/cm) 6.5 10 
 
Since we are primarily interested in the lung signal that has a short T2* relaxation 
time, we used a shorter acquisition time. Given the long T2* of the carbon species in the 
majority of tissues (muscles, heart, etc.) 8, this lowers the SNR of the overall image 
(equation 2.20); however, as the signal decays considerably during the data acquisition 
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period, this shortened readout time does not compromise the SNR of the short T2* 
components. The use of a shorter acquisition time also leads to a shorter repetition time, 
reducing the overall scan time to 9 seconds—quite short for a breath-hold maneuver that 
can be applied to mechanically ventilated rats and mice in order to minimize respiratory 
motion artifacts. 
Lastly, as previously covered in Section 2.9.1, the timing and duration of the data 
acquisition with respect to dose administration are of key importance in obtaining 
metabolic images with maximum SNR. Because pyruvate uptake by lug tissue is limited, 
administering a large amount of pyruvate does not improve the SNR of the metabolites, 
and can in fact make it more difficult to accurately distinguish / quantify metabolite peaks 
that are closely positioned in the NMR spectrum, as the large pyruvate peak will dominate 
the small metabolite peaks. Our experiments suggested that the optimal protocol for 
hyperpolarized 13C imaging of rat lungs using our sequence FID-CSI sequence is to 
administer 0.32 mmols/kg of hyperpolarized pyruvate within 6 seconds and to start image 
acquisition 18 seconds after the start of the injection. The optimal protocol was slightly 
different in mice: administering 0.8 mmols/kg of pyruvate within 3 seconds and starting 
image acquisition 10 seconds after the start of injection. The typical hyperpolarized [1-13C] 
pyruvate sample in small animals after neutralization with the buffer has a concentration 
of 80mM. To achieve the desired dosage, we administered 4ml/kg and 10ml/kg of the 
pyruvate sample obtained from the polarizer to rats and mice, respectively. However, this 
thesis will primarily focus on imaging rat injury models. 
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4.3. Study Design and Methodology 
We hypothesize that hyperpolarized [1-13C] pyruvate imaging can be used to 
monitor progressive changes in downstream pyruvate metabolism due to the progression 
of experimental lung injury induced by acid-aspiration. We chose a two-hit model of acid 
aspiration and ventilation-induced lung injury for our studies to mimic the pathophysiology 
of acute lung injury in humans, including severe inflammatory response and edema in the 
lung tissue (section 3.3.3). The degree of initial injury can be controlled by the pH and 
dosage amount of acid instilled into the trachea, while injury progression can be adjusted 
using the appropriate ventilation mechanism. 
 
4.3.1. Animal Preparation and Injury Protocol 
A summary of the study is shown in Figure 4.2. A total of fifteen male Sprague 
Dawley rats (335±45 g) were imaged (5 healthy, 10 injured). All animal procedures were 
approved by the Institutional Animal Care and Use Committee (IUCAC) of the University 
of Pennsylvania (Philadelphia, PA). General anesthesia was induced (40-60 mg/kg) and 
maintained (20 mg/kg) through intra-peritoneal administration of sodium pentobarbital 
every 60 minutes. The trachea was intubated with a 2-inch long, 14-gauge angio-catheter 
(BD, Franklin Lakes, NJ) with a sealant (UHU Tac adhesive putty; Saunders Mfg. Co. 
Readfield, ME) placed around the glottis to prevent gas from leaking out of the lungs. Rats 
were then connected to either a custom-built MR-compatible small animal ventilator or a 
VentElite small animal ventilator (Harvard Apparatus) and were ventilated with 100% 
oxygen in supine position. Animals were placed in the magnet within 10 minutes of 
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beginning ventilation (t=10 min). Ventilation parameters were 8.1±0.6 ml/kg tidal volume 
and 8±2 cmH2O positive end expiratory pressure (PEEP) to prevent atelectasis (alveolar 
collapse) and minimize ventilator-induced injury9.  
 
 
Figure 4.2. Study design for hyperpolarized pyruvate studies. Three cohorts of rats (5 each) were used. Each 
rat received 3 injections of hyperpolarized [1-13C] pyruvate (Pyr) at approximately 60, 130 and 240 minutes 
after the start of ventilation. The injured-1 cohort received 1 ml/kg HCl (A1), while the injured-2 cohort 
received 2 ml/kg HCl (A2) intratracheally 10 minutes after the first pyruvate injection. Compliance was 
measured before each pyruvate injection. 
 
Animals remained on this ventilator setting for the remainder of the study (3-4 
hours) except during imaging acquisition and shimming, when PEEP was briefly reduced 
to 0 cmH2O to improve field homogeneity. Peak inspiratory pressure (PIP) was monitored 
using an MR-compatible pressure sensor (Samba Sensors). Body temperature was 
monitored using a rectal thermometer and adjusted using warm air. Blood oxygen 
saturation levels were monitored during the scan using a pulse oximeter to ensure sufficient 
oxygenation (SPO2 > 90%). 
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Injury was induced in twelve animals via intratracheal instillation of pH 1.25 
hydrochloric acid (HCl) 70 minutes after beginning ventilation, similar to the injury 
protocol used in10. Five animals (injured-1) received 1ml/kg HCl, while another seven 
animals (injured-2) received 2ml/kg HCl in order to induce more severe injury. Mechanical 
ventilation was resumed after acid instillation. The 2ml/kg dosage for the injured-2 cohort 
was chosen based on our previous studies with quantitative CT imaging10, which suggested 
progression of severe injury and edema at this same dosage. The 1ml/kg dosage aimed to 
mimic less severe mechanical injury while also activating an inflammatory response in the 
lung tissue. Finally, peak inspiratory pressure (PIP) and dynamic compliance 
(Cdyn=VT/(PIP-PEEP)) of the respiratory system were obtained at ZEEP immediately 
before each image acquisition. 
 
4.3.2. Hyperpolarization Protocol 
Pyruvate samples were prepared by mixing 14 M [1-13C] pyruvate (Cambridge 
Isotopes), 15 mM OX063 radical (GE Healthcare) and 1.5 mM of Dotarem (Guerbet LLC). 
22 µL aliquots were polarized using a commercial Hypersense DNP polarizer (Oxford 
Instruments) for approximately one hour at a temperature of ~1.4K. Samples were melted 
with 4 mL dissolution buffer (80 mM NaOH, 40 mM Trizma buffer, 50 mM NaCl and 0.1 
mg/L EDTA) at 10-bar pressure and 180 °C to yield 80 mM isotonic neutral polarized [1-
13C] pyruvate at 37 °C. Solid-state polarization was estimated to be 20±6% based on the 
solid-state build-up curve and separate measurements. 4 ml/kg of the sample was 
administered through the tail vein over 6 seconds, followed by a 300-µL saline dose over 
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2 seconds to flush the pyruvate from the catheter’s dead volume. To minimize respiratory 
motion during data acquisition, a 12-second breath-hold was applied using the ventilator; 
data acquisition was initiated 18 seconds after the start of injection. This timing was chosen 
based on previous measurements of the time-course of the individual metabolites to yield 
maximum SNR for the lactate peak in rodents (Figure 2.14). 
 
4.3.3. MRI/MR Spectroscopic Imaging Protocol 
All animals were imaged using a dual-tuned 1H/13C quadrature transmit/receive 
birdcage coil (m2m) in a 4.7T horizontal-bore magnet (Varian Inc.) equipped with a direct 
drive console. Axial and coronal T1-weighted proton images were acquired using a multi-
slice gradient echo sequence as anatomical references and to monitor injury progression. 
Imaging parameters were TR/TE=80/1.5 ms, α=20°, 128×128 matrix size, 60×60 mm2 in-
plane field of view (FOV), 100 kHz bandwidth and 16 averages. A total of sixteen 2 mm-
thick slices were acquired to cover the lungs. Manual shimming was carried out at end 
expiration using a slice-selective pulse-and-acquire sequence over a 15-mm axial slice 
covering the lungs. 
A summary of the hyperpolarized 13C imaging studies is shown in Figure 4.2. 
Fifteen animals were used for this study (5 healthy, 5 injured-1 and 5 injured-2). Each 
animal received three injections of hyperpolarized pyruvate, at 60±6, 133±4 and 230±11 
minutes after the start of ventilation, except for one injured rat (injured-2) that did not 
survive until the third injection. Injection timing was chosen based on previous studies 
suggesting that inflammatory infiltration starts to occur one hour after acid instillation in 
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this model11. Both injured cohorts (injured-1 and injured-2) received intratracheal HCl 70 
minutes after starting ventilation, as described earlier. 13C imaging was performed using 
the pulse sequence described in section 4.2. A 5-mm NMR tube containing 15 M solution 
of labeled 13C urea and 5 mM gadolinium (Gd) (Omniscan, GE Healthcare) was placed in 
the coil next to the rat for flip angle calibration of the 13C channel. 
 
4.3.4. MRI Data Processing and Statistical Analysis 
All data were processed using custom routines programmed in MATLAB 2014a 
(MathWorks, Inc.). A 30 Hz exponential line broadening was applied to the individual 
FIDs. The spatially resolved spectra were computed by applying a 3D Fourier transform to 
the broadened data. As previously described, the periodic acquisition of the k-space center 
(kx,y=0) allowed us to observe the time dependence of pyruvate and its metabolites 
independently. These time-dependences were then used to compensate for the signal loss 
due to T1 decay and other factors through amplitude normalization. This mitigated the 
associated blurring artifact and improved spectra localization. Global first order and local 
zero order phase corrections were applied to the real part of the spectra in each voxel, 
followed by a 4th order polynomial baseline correction. For each spectrum, the pyruvate 
peak was fit to a Lorentzian function. The linewidth and the chemical shift estimates were 
used to fit individual Lorentzian functions to the metabolite peaks (lactate, pyruvate 
hydrate, bicarbonate and alanine). Metabolite maps were generated by integrating the area 
under the peak of the corresponding fit Lorentzian. Processed metabolite maps were 
converted to DICOM format and overlaid on their corresponding proton images using 
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OsiriX 7.1 (Pixmeo SARL, Switzerland). On average, 12 voxels covering the lungs were 
manually selected from the MRSI/proton overlays, and average pyruvate and lactate values 
for the lung were calculated. Average pulmonary lactate-to-pyruvate ratios were obtained 
by dividing the average lactate and pyruvate signals obtained from the selected voxels. We 
omitted quantification of alanine and bicarbonate metabolites in the lungs since their 
intensities are too low for accurate quantification. 
Average pulmonary pyruvate and lactate signals, lactate-to-pyruvate ratios and 
pulmonary compliances were exported to R (R Development Core Team, 2005) for 
statistical analysis. Mean values and standard errors of the pulmonary metabolite ratios and 
pulmonary compliance at each time point were computed for each of the three study 
cohorts. Two-way repeated ANOVA was used to test statistical significance between 
pulmonary compliance and the average pulmonary lactate-to-pyruvate ratio among 
different cohorts and injection times. Two-sample paired, two-tailed student’s t-tests were 
used for post-hoc analysis of each cohort to identify statistical significance between 
different injections. Two-sample unequal variance, two-tailed student’s t-tests were used 
for each injection to assess statistical significance between the cohorts.  
 
4.4. Results 
Figure 4.3 shows representative spectroscopic images overlaid on the 
corresponding proton images in healthy, injured-1 and injured-2 lungs. Edematous regions 
are clearly visible in the posterior regions of the lungs in both injured-1 and injured-2 rats 
(Figure 4.3.B-C). Panels D-I show the close-up view of the average of the spectra in the 
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posterior and anterior voxels in the lungs outlined in 4.3.A-C for representative healthy, 
injured-1 and injured-2 rats.  
 
Figure 4.3. Representative 13C MRSI overlay on 1H images in (A) healthy, (B) injured-1 and (C) injured-2 
rats. The bottom panels show the close-up view of the average of spectra in the posterior (D, F, H) and 
anterior voxels (E, G, I) outlined in (A-C) for healthy, injured-1 and injured-2 lungs. The pyruvate and lactate 
signal in both anterior and posterior voxels of the control rat appear similar. In the injured-1 rat, the overall 
pyruvate and lactate signal increased in the posterior voxels (F), while the lactate signal increased in the 
interior voxels (G); the pyruvate signal increased significantly in the injured-2 rat in both areas (H, I). At the 
same time, the linewidth in the injured-2 rat became narrower, likely due to the formation of edema and 
consequent improvement in local field homogeneity. 
 
The average pyruvate linewidth in the healthy, injured-1 and injured-2 lungs was 
estimated (by the fit described in the methods section) to be 126±31Hz (2.5±0.6ppm), 
97±41Hz (1.9±0.8ppm) and 57±12Hz (1.2±0.2ppm), respectively. Additionally, the 
pyruvate signal in both visibly edematous and non-edematous regions of the injured-2 lung 
increased post-injury relative to the signal in the heart, as shown in Figure 4.3.H-I. While 
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the pyruvate signal seemed to increase only in the posterior region of the injured-1 lung 
(Figure 4.3.F), the lactate signal increased in both anterior and posterior regions (Figure 
4.3.F-G). Pyruvate and lactate signals are visually similar in anterior and posterior regions 
of the control lung (Figure 4.3.D-E). The signal-to-noise ratio (SNR) of the pyruvate and 
lactate peaks in the spectrum obtained by averaging over the lungs was 245±70 and 58±16 
and 340±190 and 99±45 for healthy and injured animals, respectively. Similarly, the SNR 
of pyruvate and lactate peaks in the individual voxels was 93±24 and 21±5 for healthy rats, 
compared to 117±63 and 31±12 for injured rats. 
Figure 4.4 shows representative pyruvate and lactate maps at 60 and 240 minutes 
after the start of ventilation in control (left panel), injured-1 (middle panel) and injured-2 
(right panel) rats. The pyruvate and lactate maps are superimposed on the corresponding 
proton images and are scaled to their own maximum intensity (the color map represents 
the intensity as a fraction of the maximum value in that image). The lactate and pyruvate 
maps show the outline of the heart and the major vasculature in the lungs. In the control 
rat, there is no significant change in the pyruvate and lactate maps at these time points, 
indicating no detectable alteration in lung metabolism or perfusion. In the injured-1 animal, 
the middle panel shows a significant increase in both lactate and pyruvate signals. The left 
panel shows a similar pattern for the injured-2 rat; however, the pyruvate signal in the lungs 
increased much more significantly relative to the heart. 
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Figure 4.4. Representative pyruvate and lactate maps overlaid on their corresponding proton images. The 
left panel shows a healthy rat 60 (baseline) and 240 (follow-up) minutes after the start of ventilation. The 
middle and right panels show representative metabolite maps in injured-1 and injured-2 animals at the same 
time points, before (baseline) and 240 minutes after (follow-up) acid aspiration injury. The color bar maps 
the intensity of each metabolite image as a fraction of the maximum value in the same image. 
 
Figure 4.5.A shows the average pulmonary lactate-to-pyruvate ratio measured for 
each injection time point in all three cohorts. There was a statistically significant difference 
in lactate-to-pyruvate ratio between the three groups (F2,36=17.34, p<0.005). Further post 
hoc analysis revealed that there was no significant difference between the metabolite ratios 
of the cohorts before HCl instillation, as illustrated in Figure 4.5.A. There was no observed 
difference between the lactate-to-pyruvate ratio of the injured-1 and control cohorts at the 
second injection (p=0.4), while the lactate-to-pyruvate ratio of the injured-2 cohort was 
48% lower than that of the control group at this time point, although this difference did not 
reach the level of statistical significance (p=0.06).  The average lactate-to-pyruvate ratio of 
the injured-1 cohort at the third injection time point was significantly higher than in both 
healthy (p=0.005) and injured-2 (p<0.0001) cohorts, while this ratio was significantly 
lower in the injured-2 cohort than in the control group (p=0.05) at the same time point.  
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Figure 4.5. (A) Average pulmonary lactate-to-pyruvate ratio in control (white), injured-1 (light gray) and 
injured-2 (dark gray) cohorts for all injections. Average (dark filled circles) and individual (gray hollow 
circles) pulmonary lactate-to-pyruvate ratios in (B) control, (C) injured-1 and (D) injured-2 cohorts for all 
three injections. (*** p<0.001, ** p <0.01, * p <0.05, † p <0.1) 
 
Figures 4.5.B-D depict the evolution of the lactate-to-pyruvate ratio for each cohort 
(mean and individual values) over time. Figure 4.5.B shows that the lactate-to-pyruvate 
ratio of the control cohort remains unchanged. The lactate-to-pyruvate ratio of the injured-
1 cohort (Figure 4.5.C) does not differ significantly from baseline at the second injection 
time point (~1 hour after the injury), but increases dramatically by the third injection time 
point (~3 hours after the injury; p=0.002). The average lactate-to-pyruvate ratio of the 
injured-2 cohort (Figure 4.5.D) continuously declines relative to baseline (p=0.18 at the 
second injection time point, and p=0.08 at the third). 
 † *
**
*
**
 † 
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Figures 4.6.A and 4.6.B depict the average pyruvate and lactate signal intensities 
for all three cohorts at different time points. The intensities reported are normalized to the 
last solid-state NMR signal level measured by the polarizer’s polarimeter to account for 
variability in sample composition, freezing dynamics and polarizer operation. Figure 4.A 
shows that the average pyruvate signal in the injured-2 cohort is larger than in the healthy 
and injured-1 cohorts, although the variability of the absolute signal is large enough that 
this difference did not reach the level of significance (F2,36= 2.25, p=0.12). Figure 4.6.B 
shows that the absolute lactate signal of the injured-1 rats is larger than that of the other 
cohorts at the third injection time-point. There was no significant difference among the 
cohorts’ absolute lactate signals at any injection time point (F2,36= 2.78, p=0.18). 
Figure 4.6. Average (A) pyruvate and (B) lactate signals, corrected for solid-state polarization levels, for all 
three cohorts at all three injections. 
 
Figure 4.7.A shows the average pulmonary compliance for all three cohorts before 
each injection. There was significant difference in compliance between the three groups 
(F2,36=56.12, p<0.0001). Further post-hoc analysis showed that there was no significant 
difference in pulmonary compliance between the three cohorts before HCl instillation prior 
to the first injection time point at 60 minutes. Compliance was significantly lower in both 
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injured cohorts before the second and third injections compared to the control group 
(p<0.01). There was no significant difference in compliance between the injured cohorts 
before the second (p=0.76) and third (p=0.16) injection time points. 
 
Figure 4.7. (A) Average pulmonary compliance in control (white), injured-1 (light gray) and injured-2 (dark 
gray) cohorts for all injection time points. Average (dark filled circles) and individual (gray hollow circles) 
pulmonary compliance in (B) control, (C) injured-1 and (D) injured-2 cohorts for all injections. (**** p 
<0.0001, *** p <0.001, ** p <0.01, * p <0.05) 
 
Figures 4.7.B-D depict the evolution of compliance for each cohort (mean and 
individual values) before each injection time point. Figures 4.7.C and 4.7.D show that 
pulmonary compliance had decreased significantly from the baseline value in both injured 
cohorts at the second injection time point (p<0.005), and decreased even further by the 
time of the third injection (p<0.05). 
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The lactate-to-pyruvate ratios vs. pulmonary compliance for each animal in all three 
cohorts at the three injection time points are plotted in Figures 4.8.A-C. The inner ellipses 
represent the 95% confidence interval of each cohort and show no segregation among the 
cohorts after the first injection. On the other hand, there is partial and complete delineation 
of all three cohorts at the second and third injections, respectively. 
Figure 4.8. Lactate-to-pyruvate vs. pulmonary compliance for control (circles), injured-2 (triangles) and 
injured-2 (crosses) cohorts at the first (A), second (B) and third (C) injection time points. Inner and outer 
ellipses represent 95% and 99% confidence intervals, respectively. 
 
4.5. Discussion 
We report enhanced lactate and pyruvate signal in the lungs after injury. In lungs 
instilled with 1ml/kg HCl, we observed a significant increase in the lactate-to-pyruvate 
ratio 3 hours after the injury. In contrast, we found a progressive decrease in the lactate-to-
pyruvate ratio starting one hour after injury in lungs instilled with 2ml/kg HCl—likely due 
to greatly increased pyruvate levels in the hyperperfused lungs, as seen in Figures 4.3 and 
4.4. This supposition is supported by earlier findings that showed an increase in both lung 
permeability index12 and pulmonary blood flow in injured lungs using PET13. Despite 
significant variability among the different cohorts’ lactate-to-pyruvate ratio trends during 
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injury progression, a combination of lactate-to-pyruvate ratio and lung compliance 
provides a reliable means for separating the cohorts at the third injection time point. 
Declining pulmonary compliance (Figure 4.7) is a clinically relevant indicator of 
lung injury14, and results from an accumulation of excess fluid in the extracellular matrix 
and thickening of the alveolar walls associated with edema and inflammation11. The 
significant decrease in lung compliance observed within the first hour (Figure 4.7) is due 
to the reduced airspace volume arising from both the initial acid delivery and the 
subsequent collection of fluid in the lungs at the onset of acute injury12. Although no 
significant difference in lung compliance was observed between the injured-1 and injured-
2 cohorts within the first hour, injury exacerbation in both injured groups is evidenced by 
the significant decline in pulmonary compliance between the second and third injection 
time points (Figures 4.7.C and 4.7.D), suggesting both further thickening of the alveolar 
walls and progression of inflammation12. This observation is also consistent with 
hyperpolarized 129Xe studies showing alveolar wall thickening in the presence of 
inflammation15,16. 
Elevated lactate signal post-injury is visible in Figure 4.6, and is likely due to 
infiltration of metabolically active neutrophils into the lungs, which is known to be a 
consequence of the early stages of an innate inflammatory response1,17, although local 
hypoxia in edematous regions could also have contributed to this increase. The observed 
lactate elevation had a prominent dependent (dorsal) distribution, which can be explained 
by multiple factors: first, the model included HCl injection in the supine position, which 
likely favored a dorsal distribution of the early lesions, as shown in our published studies10; 
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second, dorsal hyper-perfusion is characteristic of acute lung injury18 and is likely to 
preferentially increase neutrophil density and extravasation in these areas19; it is also likely 
that a higher tissue density due to atelectasis and edema accumulation increased both 
lactate and pyruvate signal in the dorsal regions, as images were not normalized for proton 
density; lastly, incomplete recruitment of atelectatic regions during mechanical ventilation 
worsens injury, despite the use of relatively high PEEP and low tidal volume to minimize 
both atelectasis and ventilator-induced stress19,20. This is evident in the significant decline 
in compliance between the second and third injection time points in both injured cohorts. 
Quantifying the absolute concentration of metabolites (lactate, pyruvate, etc.) from 
the intensity of their corresponding signals is not trivial given the variability in polarization 
levels and experimental setup. This difficulty is evident in Figure 4.6, which exhibits a 
large variability in the absolute signal level of both pyruvate and lactate species. To reduce 
this sensitivity to experimental and physiological conditions, the lactate-to-pyruvate ratio 
can be used instead to highlight increased glycolytic activity21—an expected feature that 
has been previously demonstrated under the conditions of anaerobic metabolism and 
inflammatory cell recruitment found in acute injury19,22-25. The significant increase in 
lactate-to-pyruvate ratio observed at the third injection time point in the injured-1 cohort 
(Figure 4.6.A) can therefore serve as a surrogate for increased glycolytic activity. On the 
other hand, the decreased lactate-to-pyruvate ratio observed post-injury in the injured-2 
rats is at odds with the observed regional lactate elevation. To explain this discrepancy, we 
postulate that locally increased pyruvate concentration, rather than decreased lactate 
production, was responsible for the low lactate-to-pyruvate ratio in severely injured rats. 
 101 
The increased pyruvate concentration is due to the retention of hyperpolarized pyruvate in 
the extracellular space of edematous lungs13. 
Figure 4.6.A depicts this time-dependent increase in the average pyruvate signal 
for the injured-2 cohort. Despite the increased availability of hyperpolarized pyruvate, its 
uptake at the super-physiological concentrations achieved with our injection protocol is 
limited by monocarboxylate transporter capacity26,27, while conversion to lactate is limited 
by lactate dehydrogenase enzyme turnover and the rate at which the cofactor nicotinamide 
adenine dinucleotide (NADH) can be regenerated26. As a consequence, the presence of 
excess pyruvate in the lung tissue does not cause a proportional increase in the lactate 
signal. Further, the excessive accumulation of extracellular fluid in severe lung injury leads 
to regions of low cellular density in which pyruvate may also accumulate, but metabolism 
is limited by large diffusion distances that limit the delivery and transport of pyruvate into 
the cells11,28.  
The discrepancy between the time dependence of the lactate-to-pyruvate ratio in 
the injured cohorts thus complicates its interpretation as a single marker to assess the 
progression of pulmonary injury and development of inflammation. On the other hand, 
Figure 4.7 illustrates the fact that, despite the difference between injured cohorts in the 
amount of HCl instilled, there was no significant difference between the average 
pulmonary compliance—which declined significantly throughout the course of injury, 
regardless of severity. The difference between compliance in injured compared to healthy 
animals, as well as the significant difference in lactate-to-pyruvate ratio among the three 
cohorts at the third injection time point (Figure 4.6.A), suggest that the combination of 
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lactate-to-pyruvate and compliance may enable us to better characterize the type and 
severity of the initial lung injury. Figure 4.8.A shows great overlap among the 95% 
confidence regions of all three cohorts on the lactate-to-pyruvate vs. compliance graph at 
the first injection time point, indicating no statistically significant difference between 
cohorts. As the injury progresses, however, each cohort follows a different trajectory, such 
that there is remarkable separation between the confidence regions of each cohort at the 
third injection time point. This suggests that the lactate-to-pyruvate ratio provides 
information on the cellularity of the perfused lung volume, without which ambiguity may 
arise from changes in pulmonary physiology and perfusion over the course of injury 
progression. 
In general, metabolic imaging of the lungs is challenging due to severe B0 
inhomogeneity, low tissue density and the lung’s modest overall energy needs, all of which 
limit both the achievable SNR and the suitability of rapid pulse sequences that have proven 
useful for imaging other organs. Despite these limitations, we were able to generate 
pyruvate and lactate maps with high SNR in order to quantify average metabolic changes 
in pulmonary tissue in the presence of acute lung injury. While Figure 4.3 suggests that the 
FID-CSI pulse sequence is capable of visualizing metabolic heterogeneity across the lungs 
with sufficiently high SNR and modest spatial resolution, its utility for accurately 
quantifying regional lactate-to-pyruvate ratio may be limited. This is primarily due to the 
sequence’s long scan time and its susceptibility to artifacts caused by cardiac motion and 
blood flow—challenges that may be partially addressed in the future by adding flow 
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suppression gradients29. Alternatively, rapid high resolution pulse sequences designed 
specifically for lung spectroscopy can be developed30.  
 
4.6. Application for Lung Cancer Imaging 
While the focus of this project was to develop a methodology for imaging 
alterations in pulmonary metabolism using hyperpolarized 13C, this method can be 
extended to the study of a variety of lung pathologies. For example, tumors cells have a 
significantly different metabolic profile compared to healthy tissues, including the 
significantly increased glycolytic activity which makes the use of 18F-FDG-PET imaging 
relevant for lung cancer screening31,32. Unfortunately, repeated PET scans for staging and 
monitoring tumor response to treatment expose patients to hazardous ionizing radiation.  
However, in addition to higher glucose uptake, tumor cells also preferentially 
convert pyruvate to lactate at a significantly higher rate even in the presence of oxygen. 
This phenomenon is known as the Warburg effect33-35, and means that hyperpolarized 13C 
MRI can potentially be used to detect and monitor tumors by highlighting regions with 
high pyruvate to lactate conversion without exposing the patient to hazardous radiation. 
 
4.6.1. Cancer Induction, 1H and 13C Imaging Protocols 
  To test the feasibility of our method for lung cancer imaging, we induced lung 
tumors in C57BL/6 mice as previously described36. Mice were anesthetized with isoflurane 
(3% during the preparation and 1.5% during imagining) mixed with 100% oxygen. A one-
inch 26-gauge catheter (BD, Franklin Lakes, NJ) was inserted into the tail-vein. A 60-cm 
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polyurethane catheter (SAI Infusion Technologies, Lake Villa, IL) was threaded into this 
catheter for administration of the hyperpolarized agent into the tail vein. The small gap 
between the 26-gauge catheter and the 60-cm line was sealed using UHU Tac adhesive 
putty (Saunders Mfg. Co. Readfield, ME). Respiration was recorded using a respiratory 
cushion positioned on the abdomen and the body temperature was monitored using a rectal 
thermometer (Small Animal Instruments, Inc., Stony Brook, NY). The animal’s 
temperature adjusted using warm water circulating through the gradient insert (Bruker 
Biospin, Rheinstetten, Germany).  
Mice were scanned in a 9.4T Avance III vertical wide-bore (89mm) micro-imaging 
MRI system (Bruker Inc., Rheinstetten, Germany) using a dual-tuned 1H/13C resonator 
(Bruker Inc., Rheinstetten, Germany). Axial T2-weighted images were acquired using a 
dual-echo respiratory-gated multi-slice fast-spin echo (FSE) pulse sequence with the 
following parameters: TR/TE1/TE2 = 570/2.1/10.2ms, echo-train length (ETL) = 4, 
192×192 matrix size, 30×30mm2 FOV, 500kHz bandwidth and 8 averages. A total of 
sixteen 0.8 mm-thick slices were acquired to cover the lungs. [1-13C] pyruvate samples 
were polarized and administered into the tail-vein as described in sections 4.3.2 and 4.2. 
respectively. 13C Imaging was performed using the FID-CSI sequence with the parameters 
listed in Table 4.1. Finally, the data was processed using custom routines in MATALB 
2018b as described in section 4.3.4 
 
 105 
4.6.2. Cancer Imaging Results and Discussion 
Figure 4.9 shows the T2-weighted image, 13C spectroscopic image and 
corresponding pyruvate and lactate maps overlaid on the T2 scan acquired from a mouse 
three weeks after cancer-induction in the left lung. Elevated lactate signal is co-localized 
with the tumors (white arrows) in two locations: over the primary tumor in the lung, as 
well as over the secondary tumor protruding out of the thoracic cavity. The right panel 
shows the spectrum averaged over the healthy lung tissue (voxel A), primary lung cancer 
(voxel B) and a secondary tumor (voxel C). The lactate-to-pyruvate ratio derived from 
these spectra is elevated in the tumor (0.82 for the primary, 2.63 for the secondary tumor) 
relative to the adjacent normal lung tissue (Lactate-to-Pyruvate = 0.32).  
Figure 4.10 shows the pyruvate and lactate maps overlaid on the T2-weighted 
proton images in four mice with different presentations of cancer.  
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Figure 4.9. T2-weighted axial scan over the lungs, showing the primary tumor as well as a secondary tumor 
protruding out of the thoracic cavity. Metabolite maps are overlaid on the T2 scan, and the lactate map shows 
enhanced lactate signal over both primary and secondary tumors (white arrows). 13C spectra averaged over 
the non-cancerous lung tissue next to the tumor (A), the primary tumor (B) and the secondary tumor (C) are 
shown on the right. The spectra show elevated lactate-to-pyruvate ratio over the tumors relative to the healthy 
lung tissue. 
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Figure 4.10. Pyruvate and lactate maps overlaid on the corresponding T2-weighted axial scans over the lungs 
in four mice with different presentations of lung tumor. The white arrow shows regions with elevated lactate 
signal that are colocalized with the lung tumors.  
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The mouse in Figure 4.9.A was imaged 4 weeks after the tumor induction and had 
only two 3mm on the posterior left side of the left ventricle. The lactate signal is higher in 
the vessels and the heart; however, the elevated lactate signal extends over the tumors 
(white arrow) as well. Figure 4.9.B shows another mouse with several sub-millimeter 
nodules in the right posterior lung (white arrow). The lactate signal is also noticeably 
elevated with respect to the background signal in healthy lung tissue. Figure 4.9.C shows 
a mouse six weeks after tumor induction with several 3-7mm tumors primarily in the right 
lung. Similarly, the lactate signal is elevated over these regions but is lower in the posterior 
left region of the lung where no tumors are present. Lastly, Figure 4.9.D shows a severe 
case imaged 8 weeks after tumor induction where tumors had grown to cover the entire 
right lung and the posterior left lung. The lactate signal in this case was globally elevated 
across the lungs and the posterior muscles. 
Our results suggest that hyperpolarized 13C MRI has the capacity to metabolically 
differentiate tumors from neighboring non-cancerous lung tissue. Furthermore, it may 
provide additional information for tumor staging. In future studies, we intend to further 
validate the application of hyperpolarized 13C MRI for tumor staging and to investigate its 
potential to monitor response to treatment.  
 
4.7. Conclusion 
The results of aim I suggest that hyperpolarized [1-13C] pyruvate imaging can detect 
differences in the conversion of pyruvate to lactate in the presence of acute lung injury, 
and that lactate-to-pyruvate ratio can be used as a marker of lung injury progression in 
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certain cases. This technique is also capable of showing increased metabolic activity in 
other lung pathologies such as lung cancer. While the sequence is limited by its long scan 
time and susceptibility to artifacts caused by cardiac motion and blood flow, it is 
nevertheless capable of visualizing metabolic heterogeneity across the lungs with 
sufficiently high SNR and adequate spatial resolution. 
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Chapter 5: Impact of Positive-End Expiratory Pressure on Lung Metabolism 
 
This chapter has been adapted from the published article, Pourfathi et al. ‘Lung Metabolism and Inflammation 
during Mechanical Ventilation; An Imaging Approach’ in Scientific Reports 8, Article Number: 3525 (2018) 
 
5.1. Introduction 
To minimize the progression of lung injury and inflammation and to reduce 
secondary lung injury due to inspiratory stretch, ARDS/ALI patients are managed in the 
ICU through protective ventilation with low tidal volumes (VT) and positive-end expiratory 
pressure (PEEP)2,4 (section 3.3.2). Although this strategy has been shown to decrease 
mortality in more severe ARDS patients5-7, regional tissue stress due to poorly recruited 
atelectasis also has the potential to worsen injury during ventilation4,8. What is more, the 
effects of atelectasis and alveolar recruitment on lung cellularity9, regional inflammation10 
and lung metabolism11 are incompletely characterized. 
Neutrophil recruitment and activation are pivotal in the trajectory of 
ARDS/ALI12,13. In addition, positron emission tomography (PET) has shown increased 18F-
fluorodeoxyglucose (18F-FDG) uptake in regions with inflammatory lesions in ARDS 
patients11, indicating increased glycolysis in activated neutrophils14 (sections 3.3.3 and 
3.3.4). Yet FDG-PET is unable to reveal the ultimate metabolic fate of glucose in the 
injured lung. Increased trans-pulmonary blood lactate as a result of anaerobic metabolism 
is correlated with lung injury severity, and is generally attributed to glucose uptake and 
utilization by activated inflammatory infiltrates15,16. What is more, recent studies suggest 
that locally elevated lactic acid  concentrations might have a role in promoting biological 
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processes in lung tissue such as fibrosis17. Therefore, tissue lactate mapping could be used 
as both a topographic marker of injury severity and to monitor therapeutic response. 
In the previous chapter, we demonstrated that hyperpolarized 13C MRI can detect 
elevated lactate-to-pyruvate ratio in an experimental model of acute lung injury23. In this 
chapter, we used hyperpolarized 13C MRI to assess the impact of recruiting atelectasis on 
lung anaerobic metabolism during the early progression of lung injury. We tested the 
hypothesis that recruitment contains anaerobic metabolism in the lung tissue by limiting 
injury due to atelectasis. Lung mechanics, oxygenation and histological analysis of lung 
sections supported this hypothesis, suggesting that the increased conversion of pyruvate to 
lactate in the absence of PEEP is primarily the result of recruitment and activation of 
neutrophils in the lungs. 
 
5.2. Study Design and Methodology 
Figure 5.1 shows the summary of the imaging experiments. 
 
5.2.1. Animal preparation, Injury and Imaging Protocols 
Twenty-one male Sprague Dawley rats (306±10g, 8-10 weeks old) were used for 
this study (7 sham, 14 injured). Animals were prepared and placed in the MRI system as 
described in section 4.3.1. All animal procedures were approved by the Institutional 
Animal Care and Use Committee (IUCAC) of the University of Pennsylvania 
(Philadelphia, PA) and were performed in accordance with relevant guidelines and 
regulations. All rats were diet-restricted to water only for 12 hours before the procedure in 
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order to reduce inter-subject metabolic variability44. All animals received IV hydration (3 
ml.kg-1.hr-1).  
 
Figure 5.1. Summary of hyperpolarized 13C imaging studies. A healthy baseline 13C image was initially 
acquired. Rats received 0.5ml/kg of either hydrochloric acid (N=14) or saline (N=7) 10 minutes after the 
baseline scan; positive-end expiratory pressure (PEEP) was then immediately increased to 10 cmH2O during 
a 10-minute stabilization period before being lowered back to 5 cmH2O. The first follow-up 13C image was 
acquired 1 hour after instillation. PEEP was then lowered to 0 cmH2O in all rats receiving saline (Sham 
group) and in seven injured rats (ZEEP group). Subsequent 13C images were acquired 2.5 and 4 hours after 
acid/saline instillation. (Note that four animals from the ZEEP group did not receive the third injection. 
Statistics are corrected for the unbalanced data.) 
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Rats were ventilated using a small animal ventilator (VentElite, Harvard Apparatus, 
Holliston, MA) in the supine position (FiO2 1.0, VT  8ml/kg, PEEP 5 cmH2O, Frequency 
52 min-1). The ventilator embedded a sigh breath of 120% tidal volume every ten breaths 
to prevent atelectasis. Airway pressure was monitored using an MR-compatible fiber-optic 
pressure sensor (FPI-HS, FISO, Quebec, QC). After healthy baseline imaging, primary 
lung injury was induced in 14 animals via intratracheal instillation of 0.5 ml/kg 
hydrochloric acid (HCl, pH 1.25). HCl was injected in two equal aliquots, with 45o head 
elevation and the animal in the right and left lateral positions, respectively. 7 sham rats 
received 0.5 ml/kg saline in a similar manner. Mechanical ventilation was resumed 
immediately after acid/saline instillation; for all animals, PEEP was set at 10 cmH2O for 
10 minutes to allow the animals to stabilize and then returned to 5 cmH2O. 7 animals with 
lung injury (PEEP group) remained on this ventilator setting until the end of the experiment 
(PEEP group). PEEP was reduced to 0 cmH2O in the remaining seven injured animals 
(ZEEP group) and in the sham group 1 hour after acid/saline instillation.  
Pyruvate samples were prepared and polarized as described in section 5.3.2. Solid-
state polarization was estimated to be 28±3% for the studies based on the solid-state build-
up curve and separate measurements. 4 ml/kg of the sample was administered through the 
tail vein as described in section 5.3.2. Proton and 13C imaging were performed as described 
in section 5.3.3. Spectroscopic data were analyzed, and lactate-to-pyruvate ratios were 
derived as described in section 5.3.4. Regional metabolism was quantified by manually 
selecting approximately 5 voxels from four different lung quadrants (posterior/anterior and 
left/right). 
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5.2.2. Immunohistochemistry 
Animals were euthanized and lungs were fixed in 10% formalin at 20 cmH2O 
pressure for 24 hours. Lungs were then excised, sliced in axial plane, immunostained with 
hematoxylin and eosin (H&E), and assessed for injury by a pathologist. Each axial plane 
representing the whole lung was computationally sectioned into 10 pieces, and sections 
were examined at 20X. Injury was assessed by a combination of infiltration (scale of 0-2: 
0=no infiltrate, 1=infiltrate in the perivascular compartment, 2=infiltrate in alveolar 
compartment), alveolar structure disruption (scale of 0-3: 0=regular, 1=distorted, 
2=collapsed with torn capillary–alveolar membrane, 3=collapsed with opacity), hyaline 
membrane (scale of 0-5: 0=None, 1=detected in 1 or 2 areas, 2=present in 3 or 4 areas, 
3=present in 5 or 6 areas, 4=present in 7 or 8 areas and 5=present in 9 or 10 areas) and 
edema (scale of 0-3: 0=regular alveolus, 1=slight thickening and 2-3=dilated vessels in 
alveolar walls and proteinaceous material in alveolus). Additional slices were obtained to 
assess the expression of intercellular adhesion molecule-1 (ICAM-1) and myeloperoxidase 
(MPO), as reported earlier45: briefly, the paraffinized sections were deparaffinized in 
xylene and, after sequential ethanol and PBS wash, were immunostained with ICAM-1 and 
MPO primary antibodies with reactivity to rat species. The secondary antibodies used to 
measure the expression of ICAM-1 and MPO were a goat anti-mouse Alexa 488 (green) 
and goat anti-rabbit Alexa 594 (red), respectively, which measure inflammation and 
neutrophilic binding and activity in the lung tissue46,47. Fluorescence imaging was 
performed using a Nikon fluorescence microscope (Nikon Diaphot TMD, Melville, NY). 
Images were acquired at excitations of 488 nm (for ICAM-1) and 594 nm (for MPO). All 
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images were acquired at the same exposure settings (100ms). ICAM-1 expression was 
quantified by integrating the fluorescence along the endothelial layer48. MPO expression 
was quantified by integrating the intensity of fluorescence across the entire field. At least 
3-4 fields were imaged for each rat lung section, and the data was quantified over these 
fields. All quantifications were performed using Metamorph (Molecular Devices, 
Downingtown PA) and ImageJ software (NIH). 
 
5.2.3. Statistical Analysis  
Statistical analyses were performed using “R” (R Foundation for Statistical 
Computing, Austria, available at: http://www.R-project.org). Normality tests were 
performed using the Shapiro-Wilk test. Average lactate-to-pyruvate ratio and pulmonary 
compliance data were transformed to follow normal distributions via logarithmic and 
quadratic transformations, respectively. Statistical significance among injections and 
cohorts was tested using a two-way analysis-of-variance (ANOVA). Statistical 
significance among groups was subsequently tested using a one-way ANOVA at each 
injection time point. Discrimination among the ICAM-1 fluorescence was measured using 
a one-way ANOVA. Post-hoc analysis was performed using Tukey’s honest significance 
test. When ANOVA conditions were not met (for SpO2, MPO and H&E histology scores), 
a Kruskal-Wallis test followed by a Wilcoxon signed-rank post-hoc test was used. a=0.05 
was considered statistically significant. Holm-Bonferroni correction was applied when 
necessary. All data were expressed as mean±SEM. 
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5.3. Results 
Figure 5.2. shows representative anatomical and interpolated metabolic images at 
the first and last time-points for all three groups. The pyruvate signal did not significantly 
change over time in any of the groups and was at its most intense in the major vasculature 
close to the heart. Lactate signal intensity remained stable over time in both sham and PEEP 
rats. In contrast, we observed time-dependent increases of both lactate signal in posterior 
lung regions in the ZEEP (zero-end expiratory pressure) group, which were co-localized 
with increased proton signal intensity. Although less pronounced, we also observed a 
gradual increase in the lactate-to-pyruvate ratio map in the central and anterior lung in 
ZEEP rats. 
 
Figure 5.2. Representative pyruvate and lactate maps overlaid on their corresponding proton images. The 
left panels show the images acquired at healthy baseline and 4 hours after acid/saline instillation in a sham 
rat. The middle and right panels show similar maps for the PEEP and ZEEP rats. Note the dramatic increase 
in lactate signal in the ZEEP rat 4 hours after acid instillation. For display, the pyruvate and lactate maps are 
normalized to their own maximum intensity for each pulmonary map.  
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Figure 5.3.A shows representative pyruvate, lactate and lactate-to-pyruvate ratio maps 
overlaid on their corresponding anatomical image obtained 4 hours after acid instillation 
in a ZEEP rat, with local injury in posterior left lung. The maps were segmented over the 
lungs to better visualize the regional changes in the pulmonary pyruvate, lactate and 
lactate-to-pyruvate ratio. Pyruvate signal intensity was similar in both lungs. However, the 
lactate signal intensity and the lactate-to-pyruvate ratio were considerably higher the 
posterior left lung where we observed increased proton signal intensity. Hematoxylin and 
Eosin (H&E) stained axial lung section of the corresponding slice of the lung showed 
presence of severe inflammatory injury and tissue damage predominantly in the posterior 
left lung where our imaging showed elevated anaerobic metabolism (Figure 5.3.B-D). 
 
Figure 5.4. (A) Pyruvate, lactate and lactate-to-pyruvate segmented maps overlaid on their corresponding 
proton image of a ZEEP rat 4 hours after the acid instillation shows injury to the posterior right lung marked 
by increased intensity in the proton image (white arrow). The metabolite maps show increased lactate signal 
intensity and lactate-to-pyruvate ratio colocalized with the injured area. (B) Hematoxylin and Eosin (H&E) 
axial slide of the whole lung clearly shows damaged lung tissue in the same area (black arrow). Magnified 
images taken from the injured area (black box) with (C) 10´ and (D) 40´ magnifications show severe damage 
and inflammatory infiltrates in the tissue. The bar in (C) is 100 µm. 
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5.3.1. Global Assessment of Lung Metabolism and Function 
Initial ANOVA of the average lactate-to-pyruvate ratio (Figure 5.4.A) showed 
discrimination among groups (F2,74=8.242, p<0.001) and pyruvate injections (F3,74=7.023, 
p<0.001). The post-hoc analysis is reported in Table 5.1: the average lactate-to-pyruvate 
ratio was similar among groups at both healthy baseline and 1 hour after acid/saline 
instillation, but was significantly different both 2.5 hours and 4 hours after instillation of 
acid/saline. 2.5 hours after acid instillation, lactate-to-pyruvate ratio was significantly 
higher in the ZEEP than in sham and PEEP groups, and these differences further increased 
at 4 hours. There was no significant difference between the latter two groups at either 2.5 
or 4 hours. 
The initial ANOVA of compliance (Figure 5.4.B) and oxygen saturation (Figure 
5.4.C) showed significant inter-group differences (Cdyn: F2,74=16.56, p<0.001 and SpO2: 
c2(2) = 20.054, p<0.001). Post-hoc analysis is summarized in Table 5.1: Cdyn was also 
significantly different among groups 1 hour, 2.5 hours and 4 hours after acid/saline 
instillation. Cdyn declined in the injured rats 1 hour after acid instillation, and continued to 
decline in the ZEEP group compared to sham and PEEP groups. Cdyn was not statistically 
different between sham and PEEP rats during the rest of the experiment. SpO2 was similar 
among all groups at healthy baseline and 1 hour after acid/saline instillation, but declined 
over time in the ZEEP group while remaining unchanged in both sham and PEEP groups. 
Groups were statistically different 4 hours after acid/saline instillation (c2(2) = 10.004, 
p=0.006), with the ZEEP group having significantly lower oxygen saturation than sham 
 122 
(p=0.003) and PEEP (p=0.035) groups. PEEP and sham groups were not different 
(p=0.804). Heart rate ranged between 350-400 beats-per-minute for all rats. 
 
Figure 5.4. (A) Average lactate-to-pyruvate ratio was significantly higher in the ZEEP group compared to 
sham and PEEP groups 2.5 (p<0.01 for both comparisons) and 4 hours (p<0.001 for both comparisons) after 
acid/saline instillation. There was no significant difference between the latter two groups at either 2.5 or 4 
hours. (B) Pulmonary compliance (Cdyn) declined in the injured rats 1 hour after acid instillation, and 
continued to decline in the ZEEP group compared to the sham and PEEP groups (p<0.001). Cdyn was not 
statistically different between sham and PEEP rats during the rest of the experiment. (C) Oxygen saturation 
(SpO2) was similar among all groups at healthy baseline and 1 hour after acid/saline instillation, but declined 
over time in the ZEEP group while remaining unchanged in sham and PEEP groups. Groups were statistically 
different 4 hours after acid/saline instillation (c2(2) = 10.004, p=0.006), with the ZEEP group having 
significantly lower oxygen saturation than sham (p=0.003) and PEEP (p=0.035) groups, which did not differ 
from one another (p=0.804). ($ p<0.1, * p<0.05, ** p <0.01, *** p <0.001), (1ZEEP vs. Sham, 2PEEP vs 
Sham, 3PEEP vs. ZEEP). (Note that for lactate-to-pyruvate ratio at 2.5 hours, N=3 for the ZEEP group. For 
all groups and all other time-points, N=7).  
 
Oxygen saturation and pulmonary compliance were significantly and negatively 
correlated with average lactate-to-pyruvate ratio (Figures 5.5.A-B, Table 5.2). 
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Figure 5.5. Correlation between average lactate-to-pyruvate ratio and (A) pulmonary compliance (r=-0.581, 
p<0.001) and (B) oxygen saturation (r=-0.687, p<0.001). 
 
Table 5.1. Summary of post-hoc analysis performed using the Tukey honest significant difference test, 
performed when the results of the one-way ANOVA test (with Bonferroni adjustment for four time points 
aadj.=0.05/4 = 0.0125) for each time point was significant. Initial two-way ANOVA of the average lactate-
to-pyruvate ratio showed discrimination among groups (F2,74=8.242, p<0.001) and pyruvate injections 
(F3,74=7.023, p<0.001). The average lactate-to-pyruvate ratio was similar among groups at both healthy 
baseline (F2,18=0.648, p=0.535) and 1 hour after acid/saline instillation (F2,18=0.514, p=0.513), but was 
significantly different both 2.5 hours (F2,14=8.843, p=0.003) and 4 hours (F2,14=5.533, p<0.001) after 
instillation. The initial ANOVA of the pulmonary compliance (Cdyn) showed significant inter-group 
difference (F2,74=16.56, p<0.001). Cdyn was also significantly different among groups 1 hour (F2,18=7.866, 
p=0.003), 2.5 hours (F2,18=16.1, p<0.001) and 4 hours (F2,18=20.8, p<0.001) after acid/saline instillation. (# 
Time from instillation of acid/saline). 
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    PEEP - Sham ZEEP - Sham ZEEP - PEEP 
Parameter 
Time 
(hrs)#  
Δmean 95% C.I. p-value Δmean 95% C.I. p-value Δmean 95% C.I. p-value 
Lactate-to-
Pyruvate Ratio 
2.5 -0.014 -0.074, 0.046 0.814 0.107 0.029, 0.186 0.008* 0.122 0.043, 0.200 0.003* 
4 -0.005 -0.088, 0.076 0.921 0.208 0.134, 0.282 <0.001* 0.296 0.131, 0.296 <0.001* 
Pulmonary 
Compliance 
1 -0.020 -0.043, 0.003 0.097 -0.036 -0.059, -0.013 0.002* -0.016 -0.039, 0.007 0.213 
2.5 0.003 -0.038, 0.045 0.944 -0.091 -0.133, -0.049 <0.001* -0.094 -0.136, -0.052 <0.001* 
4 0.010 -0.029, 0.049 0.596 -0.096 -0.131, -0.061 <0.001* -0.106 -0.145, -0.067 <0.001* 
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5.3.2. Correlation Between Imaging Markers and Biology 
ZEEP lungs displayed evidence of lung injury (Figures 5.3 and 5.6), including 
structural damage with edema and hyaline membrane on the alveolar wall; aggregates were 
found in the alveoli, likely representing sloughed pneumocytes. Both ZEEP and PEEP 
lungs had alveolar infiltrates. There was no evidence of injury in the sham lungs; alveoli 
were lined with flattened healthy epithelial cells, and minimal inflammatory cells were 
present. ANOVA showed a significant difference among groups (infiltration: c2(2)= 
11.273, p=0.003, alveolar damage: c2(2)= 10.000, p=0.007, hyaline membrane deposition: 
c2(2)= 10.678, p=0.005, and edema: c2(2)= 12.154, p=0.002). Infiltration (Figure 5.6.A) 
and alveolar damage scores (Figure 5.6.B) were significantly higher in the ZEEP group 
than in shams (p<0.05), while infiltration was significantly higher in the ZEEP group than 
the PEEP group (p=0.035). Hyaline membrane deposition (Figure 5.6.B) and edema 
severity (Figure 5.6.D) were both significantly higher in the ZEEP group compared to both 
PEEP and sham groups (p<0.05). Injury scores for all morphological features were 
positively correlated with average lactate-to-pyruvate ratio (Figures 5.6.E-H, Table 5.2). 
However, this correlation did not reach the level of significance for infiltration and alveolar 
damage scores.  
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Figure 5.6. (Top) Hematoxylin and Eosin (H&E) stained lung sections of rats from each group. 
Representative images shown are at 10´ and 40´. In ZEEP lungs, arrows show the presence of fluid within 
the alveolar space; solid arrows delineate infiltrates and debris. In lungs subjected to PEEP, alveolar structure 
is more intact; infiltrates are shown by solid arrows. The scale bar is 100 µm. (Middle) Average injury scores 
for various morphological features for different groups. ANOVA showed a significant difference among 
groups (infiltration: c2(2)= 11.273, p=0.003, alveolar damage: c2(2)= 10.000, p=0.007, hyaline membrane 
deposition: c2(2)= 10.678, p=0.005 and edema: c2(2)= 12.154, p=0.002). Infiltration (A) and alveolar damage 
scores (B) were significantly higher in the ZEEP group than in the sham group (p=0.001, p=0.012), while 
infiltration was significantly higher in the ZEEP group than the PEEP group (p=0.035). Hyaline membrane 
deposition (C) and edema severity (D) were both significantly higher in the ZEEP group relative to both 
PEEP (p=0.048, p=0.041) and sham (p=0.014, p=0.006) groups. (Bottom) Among the histological features, 
hyaline membrane deposition (r=0.612, p=0.003) (G) and edema severity (r=0.663, p=0.001) (H) were 
strongly correlated with lactate-to-pyruvate ratio. (* p<0.05, ** p <0.01, *** p <0.001). 
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ICAM-1 expression (Figure 5.7.A) was significantly different among groups (F2,18= 37.76, 
p<0.001), and was significantly higher in the ZEEP group compared to PEEP and sham 
groups (p=0.002). ICAM-1 expression was strongly correlated with the average lactate-to-
pyruvate ratio measured 4 hours after acid/saline instillation (Figure 5.7.B, Table 5.2). 
MPO expression was also significantly different (Figure 5.7.C) between groups (c2(2)= 
16.416, p<0.001): the measured activity was significantly higher in the ZEEP group 
compared to PEEP and sham groups (p=0.002), and was strongly correlated with average 
lactate-to-pyruvate (Figure 5.7.D, Table 5.2). Activity was also significantly different 
between PEEP and sham groups (p=0.004). 
 
Table 5.2. Pearson correlation coefficients between the global lactate-to-pyruvate ratio and other 
experimental parameters. Pulmonary compliance and oxygen saturation were measured at the beginning of 
13C imaging. Histological features were only correlated with the last imaging time-point. Bonferroni 
correction was applied for 8 univariate correlation tests (significance for adjusted aadj.=0.05/8 = 0.00625). 
 
 
Correlation Between Lactate-to-Pyruvate Ratio and Other Parameters 
 
Parameter r 95% C.I. p-value 
 
Pulmonary Compliance -0.581 -0.709, -0.413 <0.001* 
 
Oxygen Saturation -0.687 -0.789, -0.553 <0.001* 
Fi
na
l i
m
ag
in
g 
da
ta
 o
nl
y  
Infiltration Score 0.509 0.100, 0.771 0.018 
Alveolar Structure Damage 0.485 0.068, 0.758 0.025 
Hyaline Membrane Score 0.612 0.245, 0.825 0.003* 
Edema Score 0.663 0.325, 0.851 0.001* 
ICAM-1 Expression 0.782 0.529, 0.907 <0.001* 
Myeloperoxidase Activity 0.817 0.589, 0.921 <0.001* 
 127 
 
Figure 5.7. (Top) ICAM-1 expression in lung sections measured by fluorescence microscopy (40´ 
magnification). Green fluorescence denotes ICAM-1 expression, which is higher in the ZEEP group in 
response to inflammatory stimuli. Additionally, the green fluorescence is higher along the endothelial layer 
that lines the vessels (indicated by white arrows (V)). (Middle) MPO expression in the lung sections 
measured by fluorescence microscopy (40´ magnification). Red fluorescence denotes higher MPO 
expression, which is similar in both sham and PEEP lungs, but much higher in ZEEP lungs. The white arrows 
illustrate the punctate staining from neutrophils. The phase images for the same sections show the structure 
of the lung tissue. The scale bar is 50 µm. (Bottom) ICAM-1 expression was significantly different among 
groups (F2,18= 37.76, p<0.001), and was significantly higher in the ZEEP group relative to PEEP (p=0.002) 
and sham (p=0.002) groups (A). ICAM-1 expression was strongly correlated with the average lactate-to-
pyruvate ratio measured 4 hours after acid/saline instillation (r=0.782, p<0.001) (B). There was significantly 
different MPO expression among groups (c2(2)= 16.416, p<0.001); the measured activity was significantly 
higher in the ZEEP group compared to PEEP (p=0.002) and sham (p=0.002) groups (C), and was strongly 
correlated with average lactate-to-pyruvate (r=0.817, p<0.001) (D). The activity was also significantly 
different between PEEP and sham groups (p=0.004). (** p<0.01, *** p <0.001). 
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5.3.3. Regional Analysis of Lung Metabolism 
At baseline, lactate-to-pyruvate ratio was similar in all regions (Figures 5.8) and followed 
the same trend as the global lactate-to-pyruvate ratio shown in Figure 5.3.A: while it 
remained unchanged in both sham and PEEP groups, it increased 2.5 hours after acid 
instillation in the ZEEP group. This ratio further increased 4 hours after acid instillation in 
the posterior regions (Figures 5.8.B and 5.8.D), but remained unchanged in the anterior 
regions (Figures 5.8.A. and 5.8.C). There was no apparent difference between left and right 
sides. The lactate-to-pyruvate ratio measured over myocardium and cardiac chambers was 
similar among groups and remained unchanged over time (Figure 5.8.E).    
 
 
Figure 5.8. The right panel shows a selection of the voxels in the hyperpolarized 13C spectroscopic image 
overlay. Lactate-to-pyruvate ratio was similar at baseline in all regions across all groups, and increases 2.5 
hours after acid instillation in all lung regions in ZEEP rats. The ratio continues to increase in the posterior 
region on both sides 4 hours after acid instillation. The lactate-to-pyruvate ratio measured in the myocardium 
and heart chambers remains unchanged over time in all groups (AL: anterior left, PL: posterior left, AR: 
anterior right and PR: posterior right). 
PL
PR
AR
AL
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5.4. Discussion 
In this sub-aim, we assessed the impact of PEEP on lung metabolism during the 
progression of experimental lung injury, showing that PEEP contains regional pulmonary 
anaerobic metabolism (Figures 5.2 and 5.3.A and Table 5.1). In contrast, we observed a 
progressive metabolic surge in the lungs when injured rats were ventilated without PEEP, 
thereby permitting atelectasis. Ex-vivo histological and immunopathological assessment 
also supported a link between anaerobic metabolism and inflammatory activation in the 
lungs. 
The investigation of altered pulmonary metabolism in the case of injury follows 
upon several 18F-FDG-PET studies showing increased glucose uptake in human and 
experimental ARDS11,24,25. Lactate is a major product of glucose utilization in the lungs26, 
and its increased production is an indication  of lung injury severity in ARDS patients15. 
hyperpolarized [1-13C] pyruvate MRI can measure regional lactate-to-pyruvate ratio, which 
reflects the endogenous pool of non-polarized lactate in the lung tissue27, thereby 
highlighting regional anaerobic glycolysis. Consequently, hyperpolarized [1-13C] pyruvate 
MRI provides insight into lung bioenergetics that complements information gained with 
18F-FDG PET, and can obtain such metabolic information within minutes without exposing 
patients to hazardous ionizing radiation. Perhaps most importantly, hyperpolarization lasts 
for only minutes due irreversible T1 relaxation, which is significantly shorter than the half-
life of 18F-FDG, which lasts for hours. As such, hyperpolarized [1-13C] pyruvate imaging 
of the lungs may be repeated as frequently as desired to assess injury progression or 
treatment response without the signal from different examinations performed within 
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several of minutes interfering with one another. The latter is especially important in small 
animal research, where lung injury progression occurs on a time scale that is significantly 
shorter than in human patients. 
Our findings in this study suggest a causal relationship between inflammation and 
increased hyperpolarized lactate-to-pyruvate ratio, consistent with the link between 
increased glycolysis and the recruitment and activation of neutrophils as part of an innate 
inflammatory cascade proposed by previous FDG-PET studies14. However, other 
mechanisms may also lead to increased lactate-to-pyruvate ratio—such as stabilization of 
hypoxia-inducible factor 1-alpha (HIF1-a), a process which has been shown to occur 
during lung injury as a mechanism to attenuate inflammation and which also leads to 
elevated lactate dehydrogenase A (LDHA) expression in alveolar epithelial cells28. 
Nevertheless, it is unlikely that this was the dominant source of pulmonary lactate 
production in our study, as activated neutrophils are known to have significantly higher 
glycolytic rates compared to their neighboring cells16,29. Hypoxemia also leads to an 
increase in overall lactate levels in the blood and muscles16,30, and it is likely that regional 
tissue hypoxia due to injury progression can lead to increased pulmonary anaerobic 
metabolism. Again, however, it is unlikely that hypoxia was the main cause of increased 
lactate-to-pyruvate ratio in our study: rats were not severely hypoxemic (SpO2>90%), and 
lungs are known to release normal levels of lactate under such conditions31,32. Furthermore, 
we did not observe any changes in cardiac metabolic activity (Figure 5.8) to suggest 
absence of severe cardiac and systemic hypoxemia33. This may be due to the fact that the 
small dose of HCl used in this study caused relatively mild pulmonary injury34. We further 
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investigated the impact of hypoxia on lung metabolism using hyperpolarized 13C MRI in 
chapter 6 with similar findings. 
To determine the source of increased lactate-to-pyruvate ratio, we performed post-
mortem histology and immunopathology measurements in lung tissue (Figures 5.6 and 5.7, 
Table 5.2). Overall, H&E staining showed the post-injury formation of hyaline membranes 
and edema (Figure 5.6), which explains the trends of worsening lung mechanics 
(compliance) and lower oxygenation (Figures 5.4.B-C and Table 5.1). The decline in both 
compliance and oxygen saturation in the ZEEP group during ventilation confirmed in-vivo 
progression of lung injury and atelectasis. Although compliance also declined over time in 
sham lungs, this was likely due to atelectasis caused by the absence of PEEP, as we 
previously documented in healthy lungs ventilated with similar settings35. However, the 
decline in sham compliance was not as significant in this study, likely due the presence of 
intermittent sigh breaths in our protocol36. Additionally, the H&E staining showed 
widespread alveolar damage and influx of infiltrates into air spaces in both injured groups 
(Figures 5.6.A-B). 
We further investigated the inflammatory status in these lungs by monitoring 
specific biomarkers of inflammation: the immunofluorescent staining patterns of the 
intercellular adhesion molecule-1 (ICAM-1) along the pulmonary vessel endothelial layer, 
and myeloperoxidases (MPO) in the entire lung section. While ICAM-1 is constitutively 
expressed in the lungs, its endothelial expression was significantly higher in the ZEEP 
group than in both PEEP and sham groups (Figure 5.7), indicating enhanced endothelial 
activation facilitating neutrophilic transmigration across the endothelium in the absence of 
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PEEP37,38. Similarly, the significantly higher MPO expression in ZEEP lungs compared to 
PEEP and sham reflects enhanced endothelial activation39 and increased neutrophilic 
activity in the underlying tissue38. The dramatic concomitant increase in lactate-to-
pyruvate ratio in the ZEEP lungs (Table 5.1) and its strong correlation with the ICAM-1 
and MPO activity (Table 5.2) suggests that enhanced glycolysis and anaerobic metabolism 
in the absence of PEEP are associated with secondary inflammatory injury to the lungs. 
Anaerobic metabolism was higher in the dependent (dorsal) regions of the ZEEP 
lungs, where proton density images showed more prominent radiological infiltrates 
(Figures 5.3.A and 5.8). Such gravitational distribution of the lactate signal suggests that 
atelectasis is a key factor in the genesis of abnormal metabolism at ZEEP. Studies using 
18F-FDG-PET in ventilated animals have reported high FDG uptake in dependent lung 
regions40 co-localized with atelectasis and inflammatory activation. In contrast, other small 
animal10 and human studies11 found alveolar injury10 and accelerated glucose metabolism11 
not in atelectatic tissue, but rather in non-dependent lung regions exposed to high 
inspiratory stretch. The latter findings are not necessarily in discordance with our results, 
however. In our previous work using hyperpolarized gas MRI in atelectasis-prone rat 
models, we detected elevated inspiratory stretch of residual ventilated airspaces in lung 
tissue with reduced gas content41,42, as well as higher stretch in dependent lung regions 
with more atelectasis42. Although we did not perform hyperpolarized gas MRI in the 
current study, the combined results of this and our previous work suggest that anaerobic 
metabolism and inflammation in the absence of PEEP may have been the result of 
augmented airspace stretch in lung regions with dependent atelectasis. 
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5.5. Limitations 
This study had a number of limitations. First, although the acid instillation model 
recapitulates ARDS, it is characterized by an initial epithelial injury and increased capillary 
permeability that is dependent on the instilled acid volume; while this is followed by a 
secondary inflammatory response, the extent of direct, immediate inflammatory action is 
minimized34. We limited direct injury in our model by instilling only 0.5ml/kg HCl, thereby 
allowing us to study tissue with a preponderance of secondary inflammation, as it would 
occur during ventilation with ARDS. Second, we chose to monitor dynamic compliance as 
a measure of injury progression instead of static compliance. The former may be subject to 
bias due to alterations in airway resistance and intrinsic PEEP (a result of gas-trapping in 
the alveoli). However, previous studies showed this bias to be negligible41,42. The third 
limitation is that quantification of the absolute concentration of metabolites using 
hyperpolarized MRI is non-trivial, as the absolute signal level is subject to variability due 
to polarization level and physiological conditions23. Although the use of hyperpolarized 
lactate-to-pyruvate ratio as a surrogate for endogenous lactate concentration15 and 
glycolysis18 can mitigate such variability, it can still be subject to bias caused by excess 
fluid in the extracellular space resulting from capillary bed leakage25; the presence of such 
excess fluid can increase pyruvate concentration or limit its uptake, thereby reducing the 
lactate-to-pyruvate ratio and therefore the sensitivity of our method23. PET imaging studies 
have addressed similar challenges by using compartment models to pinpoint the local 
source of signal43. In the case of  MRI, this bias may be corrected for by using rapid MRI 
pulse sequences that allow the acquisition of multiple images to characterize metabolic flux 
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in various tissues18. Finally, we only compared the averaged ICAM1 and MPO expression 
across the lungs with average lactate-to-pyruvate ratio, since co-localizing the images with 
histological slides proved prohibitively difficult. Although the expression of these 
inflammatory markers is strongly correlated with global lactate-to-pyruvate, an even 
stronger local relationship between anaerobic metabolism and inflammation may be 
masked by a preponderance of non-injured lung regions.  
 
5.6. Conclusion  
In this sub-aim, we demonstrated the utility of hyperpolarized [1-13C] pyruvate 
MRI for assessing the progression and resolution of pulmonary anaerobic metabolism in 
an experimental model of aspiration pneumonitis; we showed that that PEEP contains 
anaerobic metabolism and secondary inflammation during lung injury progression. In 
contrast, in the absence of PEEP, we observed a substantial increase in anaerobic metabolic 
activity associated with neutrophil recruitment and accumulation. Lastly, our findings 
suggest a causal relationship between increased lactate-to-pyruvate ratio and the 
progression of lung damage and inflammatory cascade during mechanical ventilation. 
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Chapter 6: Impact of Hypoxia on Lung Metabolism 
 
6.1. Introduction 
Systemic hypoxemia is a clinical hallmark of lung injury which results from 
impaired gas exchange1 and leads to increased anaerobic metabolism and overall lactate 
levels in both blood and muscle tissue2,3. Hypoxia is also a prominent feature of 
inflammatory pathology, as neutrophils’ increased metabolic demands reduce the 
availability of metabolic substrates to the native cells4,5. In the case of the lung tissue, 
however, several studies suggest that overall lung metabolism tolerates moderate 
reductions of oxygen availability and continues to produce normal lactate levels6-9. Despite 
this global tolerance, however, the local relationship between anaerobic metabolism and 
regional hypoxia may be masked by a preponderance of well-aerated regions in the lungs.  
In the previous chapter, we demonstrated hyperpolarized [1-13C] pyruvate 
imaging’s ability to quantify in-vivo pyruvate-to-lactate metabolism in rat pulmonary tissue 
with sufficient spatial resolution and SNR. We also showed the capacity of this novel 
molecular imaging technology to monitor and highlight early metabolic changes in an 
experimental rat model of aspiration pneumonitis followed by protective and non-
protective ventilation strategies: we observed a significant increase in pulmonary lactate-
to-pyruvate ratio during early lung injury progression, as well as contained anaerobic 
metabolism in injured lungs subjected to protective ventilation using positive-end 
expiratory pressure (PEEP). 
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Further investigation revealed a strong correlation between increased lactate-to-
pyruvate ratio and enhanced neutrophilic binding and activity in the lung tissue as 
measured by the expression of intercellular adhesion molecule-1 (ICAM-1) and 
myeloperoxidase activity (MPO) (Figure 5.4 and Table 5.2). While this finding suggests a 
strong link between increased anaerobic activity and innate inflammatory cascade, it does 
not definitively rule out the contribution of tissue hypoxia to this increased lactate-to-
pyruvate ratio, as we observed a concomitant decrease in oxygen saturation during lung 
injury progression. 
In this study, we aimed to test our hypothesis that the previously-observed increase 
in hyperpolarized lactate-to-pyruvate ratio in the lungs is predominantly due to the 
presence and activity of inflammatory cells rather than hypoxia-induced metabolic shifts 
in native cells during moderate hypoxia. We used hyperpolarized [1-13C] pyruvate MRI to 
image rats ventilated with reduced oxygen (FiO2 <0.21) in order to induce moderate (SpO2 
≈ 90%) and severe (SpO2 ≈ 75%) levels of hypoxia. Our imaging data showed a small 
increase in the hyperpolarized lactate-to-pyruvate ratio in moderately hypoxic rat lungs, 
while this ratio increased significantly in severely hypoxic rats. Histological analysis 
revealed similarly low levels of alveolar infiltrates and damage to both control and sham 
lungs. We also observed higher hyaline membrane deposition and edema in the hypoxic 
lungs compared to healthy lungs, although this difference did not reach the level of 
statistical significance. Lastly, we observed a significantly higher concentration of 
systemic arterial lactate in severely hypoxic animals compared to both moderately hypoxic 
and control animals.  
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The imaging data obtained from the injured animals presented in the previous 
chapter showed that animals with progressive lung injury were moderately hypoxic and 
had similar levels of oxygen saturation to the non-injured, moderately hypoxic group 
presented in this chapter. However, the hyperpolarized lactate-to-pyruvate ratio only 
increased significantly in the lungs of injured animals. This study further elucidated the 
source of increased hyperpolarized lactate-to-pyruvate ratio in the lungs during the 
progression of acute lung injury, suggesting a causal relationship between the 
inflammatory injury and the increased anaerobic glycolysis in the lungs. 
 
6.2. Study Design and Methodology  
A summary of the experiment is presented in Figure 6.1. 
 
6.2.1. Animal Preparation, Imaging and Hypoxia Protocol 
A total of twenty-six Sprague Dawley rats were used for this study. Animals were 
prepared, administered [1-13C] pyruvate samples and imaged as described in Sections 4.3.1 
and 4.3.2. An arterial line was placed into either the ventral or tail artery to collect arterial 
blood samples (100µL per sample) for arterial blood gas (ABG) analysis using an EPOC 
blood analysis device (Epocal Inc., Ottawa ON). We compared the arterial lactate 
concentration in various groups to assess the systemic changes in overall glycolysis as a 
consequence of hypoxemia.  
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Figure 6.1. Summary of hyperpolarized 13C imaging studies. Arterial blood gases (ABG) were obtained first. 
A healthy baseline 13C image was initially acquired. Fraction of inspired oxygen (FiO2) was reduced to 0.17 
(N=8) and 0.1 (N=8) to induce moderate and severe hypoxia, respectively, throughout the rest of the 
experiment. Follow-up 13C images were acquired after 1 hour, 2.5 and 4 hours. 
 
After a baseline ABG and MRI, ten control rats remained ventilated with the same 
parameters. We chose the timing of the [1-13C] pyruvate imaging and hypoxia based on the 
lung injury study presented in chapter 5 such that hypoxia started immediately after the 
baseline 13C hyperpolarized-MR images were acquired. We induced moderate hypoxia in 
eight rats (Hyp90) by reducing the FiO2 to ~0.17 until a stable SpO2 ≈ 90% was achieved. 
We chose the oxygen saturation level based on the average oxygen saturation measured 
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chapter 5 ZEEP rats (Figure 5.3.C) in which injury progressed. In the remaining eight rats 
(Hyp75), we induced severe hypoxia by reducing the FiO2 to ~0.1 until a stable SpO2 ≈ 75% 
was achieved and performed follow-up hyperpolarized pyruvate MRI scans. After the final 
scan, arterial blood gas was collected from 11 rats, ABG analysis was performed, and the 
lungs were excised for immunohistochemistry as described in section 5.2.2. Statistical 
analysis was done as described in section 5.2.3.  
 
6.2.2. Comparison of Healthy, Hypoxic and Injured Rats 
In order to further investigate the contribution of hypoxia to changes in pulmonary 
lactate-to-pyruvate ratio during progressive inflammatory lung injury, we compared the 
pulmonary hyperpolarized lactate-to-pyruvate ratios measured in hypoxic (Hyp90 and 
Hyp75) and control animals presented in this chapter with those of the injured (ZEEP and 
PEEP) and sham groups discussed in chapter 5. We also compared the hyperpolarized 
lactate-to-pyruvate ratio over the heart among groups to assess whether the changes in the 
pulmonary lactate-to-pyruvate ratio are local to the lungs. Data from an additional 6 rats (3 
PEEP and 3 ZEEP) are included here that were obtained after data from chapter 5 was 
published10. Table 6.1 summarizes number of rats (N=53 total) as well as their 
physiological and ventilation parameters for each group. 
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Table 6.1. Summary of experimental parameters for rat studies.   
Cohort Condition Number of Rats Weight (g) Tidal Volume(ml/kg) PEEP(cmH2O) SpO2(%) 
Control Healthy 10 250-322 8-10 0-3 96-99 
Sham Healthy 7 284-320 6-10 0-7 97-99 
PEEP Injured 10 287-420 6-12 0-7 85-99 
ZEEP Injured 10 300-360 6-12 0-7 85-99 
hyp90 Hypoxic 8 301-395 8-10 3 86-99 
hyp75 Hypoxic 8 274-321 8-10 3 64-99 
 
6.3. Results 
 
6.3.1. Hypoxia Study 
Figure 6.2 shows the representative anatomical proton scans as well as pyruvate 
and lactate maps at the first and last time-points for all three groups. For display, the 
pyruvate and lactate maps are normalized to their own maximum intensity for each map. 
The pyruvate signal did not change significantly over time in any of the groups and was at 
its most intense in the major vasculature close to the heart. Lactate signal intensity 
remained stable over time in the control group (left columns), while the pulmonary lactate 
signal increased by a small amount in the moderately hypoxic group (middle columns); we 
observed a time-dependent global increase in lactate signal in the severely hypoxic rats 
(right column).  
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Figure 6.2. Representative pyruvate and lactate maps overlaid on their corresponding proton image acquired 
at healthy baseline and 4 hours after start of systemic hypoxia. FiO2 was kept at 1.0 in the control group. 
Lactate to pyruvate ratio and lactate signal remained unchanged over time in the control rats. While the lactate 
signal did not change noticeably after 4 hours of moderate hypoxia, it increased dramatically after 4 hours of 
severe hypoxia. 
 
Figure 6.3.A shows the average lactate-to-pyruvate ratio as a function of time for 
all groups. Initial ANOVA showed that the ratio was significantly different among groups 
(F2,84=8.579, p=0.005) and pyruvate injections (F3,84=17.860, p<0.001). Post-hoc analysis, 
reported in Table 6.1, suggests that the average lactate-to-pyruvate ratio was similar among 
all groups at healthy baseline. In severely hypoxic animals (Hyp75), this ratio progressively 
increased and was significantly higher than in both moderately hypoxic rats (Hyp90) and 
control rats 1, 2.5 and 4 hours after the start of hypoxia. While the lactate-to-pyruvate ratio 
did increase after 4 hours of moderate hypoxia, this increase did not reach the level of 
significance compared to control animals.  
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Figure 6.3. (A) Average lactate-to-pyruvate remained unchanged in the control group but increased in both 
hypoxic groups over time. This ratio increased much more significantly in the severely hypoxic rats (Hyp75), 
and was significantly higher than in both moderately hypoxic (Hyp90) and control rats 2.5 and 4 hours after 
the start of hypoxia. The ratio was slightly higher in the moderately hypoxic rats than the control rats, but 
this difference did not reach the level of statistical significance. (B) Pulmonary compliance (Cdyn) remained 
unchanged in all rats. (C) Oxygen saturation (SpO2) remained unchanged in the control group but declined in 
both moderately and severely hypoxic groups to around 90% and 75%, respectively (p<0.01 for all group-
wise comparisons at any time except the first time point). (* p<0.05, ** p <0.01, *** p <0.001), (1Hyp75 vs. 
control, 2Hyp75 vs Hyp90). 
 
Pulmonary compliance remained unchanged over the course of the study, as shown 
in Figure 6.3.B. Figure 6.3.C shows the SpO2 during each [1-13C] pyruvate injection: SpO2 
was similar among all groups at healthy baseline, but declined significantly 1 hour after 
the start of hypoxia, to ~90% and ~75% in moderately and severely and moderately 
hypoxic groups respectively (c2(2) = 21.372, p<0.001). The average SpO2 for both groups 
remained significantly lower than in control animals 2.5 (c2(2) = 19.373, p<0.001) hours 
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and 4 hours (c2(2) = 15.053, p<0.001) after the start of hypoxia. Heart rate ranged between 
350-400 beats-per-minute for all rats.  
The arterial blood lactate level and its correlation with hyperpolarized lactate-to-
pyruvate ratio in the lungs is shown in Figure 6.4. The initial ANOVA showed that overall 
lactate concentration was significantly different among cohorts (F2,20 = 4.133, p=0.031) 
and time points (F1,20 = 64.460, p<0.001). The arterial lactate concentration was similar 
among animals before the start of imaging (F2,11=0.881, p=0.442) and increased in all 
groups after imaging. However, there was significant inter-group difference at this time 
point (F2,7=21.41, p=0.001). The post-hoc analysis showed that, similar to the pulmonary 
hyperpolarized lactate-to-pyruvate ratio, the arterial lactate concentration of the Hyp75 rats 
was significantly higher than that of both control (p=0.001) and Hyp90 (p=0.006) groups. 
There was also a strong correlation between the hyperpolarized lactate-to-pyruvate ratio in 
the lungs and the arterial lactate concentration (r=0.668, p<0.001). 
 
Figure 6.4. (A) Arterial lactate concentration measured from arterial blood samples in control (N=3), Hyp90 
(N=3) and Hyp75 (N=5) groups before and after imaging. Post-imaging arterial blood lactate was 
significantly higher in the Hyp75 group than in both Hyp90 and control groups. (B) Pulmonary 
hyperpolarized lactate-to-pyruvate ratio is strongly correlated with arterial blood lactate concentration (** 
p<0.01, *** p<0.005). 
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6.3.2. Comparison of Imaging Data from Hypoxia and Injury Studies 
Figure 6.5.A-C compares the average pulmonary and cardiac lactate-to-pyruvate 
ratio and oxygen saturation in all groups 4 hours after intervention (acid instillation or the 
start of hypoxemia). The initial two-way ANOVA of the average pulmonary and cardiac 
lactate-to-pyruvate ratios showed discrimination among all groups (F5,180=10.230, p<0.001 
and F5,178=2.256, p=0.034) and pyruvate injections (F3,180=17.240, p<0.001 and 
F3,180=9.956, p<0.001). Post-hoc analyses of both pulmonary and cardiac lactate-to-
pyruvate ratios are reported in Table 6.2. The average pulmonary and cardiac lactate-to-
pyruvate ratios were similar among all groups at both healthy baseline and 1 hour after 
acid/saline instillation, but was significantly different both 2.5 hours and 4 hours after 
intervention. 2.5 hours post-intervention (not shown in Figure 6.5), the pulmonary lactate-
to-pyruvate ratio was significantly higher in the Hyp75 group than in all others except the 
ZEEP group. This ratio in the ZEEP group was only significantly higher than the control 
and Hyp90 groups. 4 hours post-intervention, ZEEP and Hyp75 groups displayed similar 
pulmonary lactate-to-pyruvate ratios, which were significantly higher than in the other 
groups. On the other hand, the cardiac lactate-to-pyruvate ratio of the Hyp75 group was 
higher than that of the ZEEP group, although this difference did not reach the level of 
statistical significance. Compared to the other groups, however, the cardiac lactate-to-
pyruvate ratio was significantly higher in the Hyp75 group.  
Figure 6.5.D shows the average pulmonary and cardiac lactate-to-pyruvate ratios 
vs. oxygen saturation in all animals at individual time points. At baseline, the average 
lactate-to-pyruvate ratio is consistently low and all animals are well oxygenated (SpO2 > 
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95%, green area). After intervention, oxygen saturation declines in both hypoxic groups 
due to reduced fraction of inspired oxygen (yellow and red areas), and the lactate-to-
pyruvate ratio increases in several Hyp75 animals. This ratio continues to increase 2.5 and 
4 hours after intervention in all Hyp75 rats. A similar increase in lactate to pyruvate ratio 
was observed in ZEEP animals (labeled by the dark gray zone); however, the oxygen 
saturation in these animals remained similar to that of the moderately hypoxic animals in 
this study, in which the lactate-to-pyruvate ratio did not markedly increase. The remaining 
animals in other groups remained in the normal zone, as both their oxygenation and 
pulmonary lactate-to-pyruvate ratio did not change over time. 
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Figure 6.5. Average lactate-to-pyruvate ratios in all groups for different injections in the (A) lungs and (B) 
heart; (C) oxygen saturation 4 hours after the start of injury or hypoxia. Post-hoc analysis results are included 
in Table 6.2. The error bars represent the standard error for each measurement. (D) The pulmonary 
hyperpolarized lactate-to-pyruvate ratio vs. oxygen saturation at individual timepoints shows the overall 
trend of each cohort during the course of the experiment. The lactate-to-pyruvate ratio significantly increases 
in injured rats (dark gray box) 2.5 hours after acid instillation, while oxygen saturation declines to ~90%. In 
moderately hypoxic rats, the lactate-to-pyruvate does not increase despite oxygen saturation decreasing to 
90%, suggesting that the source of increased lactate-to-pyruvate ratio is not hypoxia but severe inflammatory 
response. The lactate-to-pyruvate ratio increases 1 hour after the start of severe hypoxia, consistent with other 
findings suggesting that the lung tissue produces high concentrations of lactate if exposed to severe but not 
moderate hypoxia. (Note that intervention for ZEEP and PEEP groups is acid instillation, for Sham group is 
saline instillation, and for Hyp75 and Hyp90 groups is reducing the fraction of inspired oxygen) (* above a 
bar indicates that data is significantly different from all other groups. Groups with letters “a” or “b” on top 
are statistically different from groups with “a*” or “b*” on top, respectively. Finally, “ab” on top of a bar 
indicates statistical difference from both groups with “a*” and “b*” on top.). 
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Table 6.2. Summary of post-hoc analysis of both pulmonary and cardiac lactate-to-pyruvate ratios in all 
groups. Analysis was performed using the Tukey honest significant difference test, performed when the 
results of the one-way ANOVA test (with Bonferroni adjustment for four time points aadj.=0.05/4 = 0.0125) 
for each time point was significant. Initial two-way ANOVA of the average pulmonary and cardiac lactate-
to-pyruvate ratios showed discrimination among groups (F5,180=10.230, p<0.001 and F5,178=2.256, p=0.034) 
and pyruvate injections (F3,180=17.240, p<0.001 and F3,180=9.956, p<0.001). Both pulmonary and cardiac 
lactate-to-pyruvate ratios were similar among groups at healthy baseline (F5,47=1.212, p=0.318 and 
F5,47=1.893, p=0.113) and 1 hour after intervention (F5,46=2.201, p=0.070 and F5,45=0.518, p=0.761), while 
pulmonary lactate-to-pyruvate ratio alone was different among groups 2.5 hours after the intervention 
(F3,37=9.657, p<0.001, F5,38=3.237, p=0.0157). There was discrimination for both ratios among groups 4 
hours (F5,35=20.290, p<0.001 and F5,33=4.986, p=0.001) after intervention.  
 
  Lung Lactate-to-Pyruvate Ratio Heart Lactate-to-Pyruvate Ratio 
    2.5 Hrs (Injection 3) 4 Hrs (Injection 4) 4 Hrs (Injection 4) 
Group Comparisons Δmean 95% C.I. p-value Δmean 95% C.I. p-value Δmean 95% C.I. p-value 
Hyp75 vs. 
Control 0.201 0.106, 0.296 <0.001* 0.244 0.129, 0.358 <0.001* 0.325 0.106, 0.544 0.026* 
Hyp90 0.184 0.070, 0.299 <0.001* 0.185 0.076, 0.294 <0.001* 0.287 0.089, 0.485 0.026* 
Sham 0.154 0.051, 0.258 0.0132* 0.227 0.122, 0.333 <0.001* 0.357 -0.166, 0.548 0.001* 
PEEP 0.176 0.076, 0.277 <0.001* 0.219 0.118, 0.320 <0.001* 0.333 0.152, 0.515 0.002* 
ZEEP 0.080 0.034, 0.194 0.783 0.049 -0.051, 0.150 0.893 0.254 0.068, 0.439 0.063 
ZEEP vs. 
Control 0.121 0.011, 0.231 0.006* 0.194 0.093, 0.295 <0.001* 0.071 -0.128, 0.271 0.946 
Hyp90 0.105 -0.022, 0.231 0.041* 0.135 0.041, 0.231 0.001* 0.033 -0.142, 0.209 0.989 
Sham 0.074 -0.043, 0.192 0.442 0.178 0.087, 0.269 <0.001* 0.103 -0.065, 0.272 0.431 
PEEP 0.096 -0.018, 0.211 0.079 0.169 0.085, 0.255 <0.001* 0.079 -0.078, 0.238 0.667 
Hyp90 vs. 
Control 0.017 -0.093, 0.126 0.999 0.058 -0.051, 0.168 0.268 0.038 -0.172, 0.248 0.999 
Sham -0.030 -0.147, 0.087 0.685 0.042 -0.058, 0.142 0.698 0.069 -0.111, 0.251 0.851 
PEEP -0.008 -0.122, 0.106 0.989 0.034 -0.061, 0.129 0.855 0.046 -0.125, 0.218 0.972 
PEEP vs. 
Control 0.025 -0.070, 0.120 0.909 0.024 -0.076, 0.125 0.789 -0.008 -0.204, 0.187 0.999 
Sham -0.022 - 0.125, 0.081 0.920 0.008 -0.083, 0.099 0.998 0.023 -0.141, 0.187 0.996 
Sham vs.  Control 0.047 -0.052, 0.146 0.256 0.016 -0.089, 0.122 0.946 -0.031 -0.236, 0.173 0.092 
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6.3.3. Histological Analysis of the Lung Sections 
The hypoxic lungs displayed evidence of mild lung injury, including edema and 
hyaline membrane on the alveolar wall. Similar to both sham and control groups, however, 
hypoxic lungs presented alveoli that were lined with flattened healthy epithelial cells, and 
minimal inflammatory cells were present (Figure 6.6). On the other hand, PEEP and ZEEP 
lungs presented high levels of alveolar infiltrates and damage, as discussed in the previous 
chapter. 
ANOVA showed a significant difference among groups (infiltration: F5,32=12.59, 
p<0.001, alveolar damage: F5,32= 9.689, p<0.001, hyaline membrane deposition: c2(2)= 
21.157, p<0.001, and edema: c2(2)= 20.576, p<0.001). Infiltration score (Figure 6.7.A) 
was significantly higher in both ZEEP and PEEP groups compared to all others (p<0.05). 
Alveolar damage score (Figure 6.7.B) was significantly higher in both ZEEP and PEEP 
groups compared to controls; however, only the ZEEP group had significantly higher 
scores than both hypoxic (Hyp75 and Hyp90) and sham groups. Hyaline membrane 
deposition (Figure 6.7.C) and edema severity (Figure 6.7.D) were both significantly higher 
in the ZEEP group compared to both control and sham groups (p<0.05). However, neither 
were statistically different from hypoxic and PEEP groups, although hypoxic animals 
presented higher levels of hyaline membrane deposition and similar levels of edema 
compared to the PEEP group.  
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Figure 6.6. (Top) Hematoxylin and Eosin (H&E) stained lung sections of rats from each group. 
Representative images shown are at 10´. The scale bar is 100 µm. Average injury scores for various 
morphological features for different groups assessed from H&E stained lung sections. (Groups with letters 
“a” or “b” on top are statistically different from groups with “a*” or “b*” on top, respectively; “ab” on top 
of a bar indicates statistical difference from both groups with “a*” and “b*” on top.) 
 
7.4. Discussion 
Lungs are among the best oxygenated organs, as they receive oxygen from three 
independent sources: 1) oxygenated blood from the bronchial arteries, 2) partially 
deoxygenated blood from the pulmonary artery, and 3) inhaled air11. Despite this 
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heightened oxygenation, lung function is usually compromised in patients with acute lung 
injury and ARDS due to severe alveolar injury and the presence of edema in the airspace 
resulting in systemic hypoxemia12-14. Reduced oxygen availability in the tissue generally 
leads to a metabolic shift from oxidative phosphorylation to glycolysis, which results in 
elevated lactate production and endogenous lactate-to-pyruvate ratio in the tissue2,3. Yet 
pulmonary metabolism has proven capable of producing normal lactate levels even in the 
presence of moderate reductions in oxygen availability6-9. On the other hand other, studies 
report elevated lactate production by the native lung cells due to increased lactate 
dehydrogenase (LDH) activity under severe hypoxic conditions15.  
Our findings in this sub-aim are consistent with both of these reported findings, as 
evidenced by our measurement of the hyperpolarized pulmonary lactate-to-pyruvate ratio 
in both moderately and severely hypoxic rats under mechanical ventilation. Our imaging 
data showed a minimal increase in the pulmonary hyperpolarized lactate-to-pyruvate ratio 
in moderately hypoxic rats (Hyp90 group). In contrast, we observed a rapid and progressive 
increase in pulmonary hyperpolarized lactate-to-pyruvate ratio in rats with severe 
hypoxemia (Hyp75 group) (Figures 6.2, 6.3.A and Table 6.2). Ex-vivo histological analysis 
showed the presence of edema and hyaline membrane but an absence of inflammatory 
injury to the lung, and arterial blood samples showed increased lactate levels caused by 
systemic hypoxemia. 
Pulmonary compliance remained unchanged over time (Figure 6.3.B), while H&E 
staining showed similar levels of alveolar infiltrates and damage across control and both 
hypoxic groups, suggesting the absence or minimal presence of inflammatory infiltrates in 
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the lungs. However, the staining did show higher levels of edema and hyaline membrane 
formation in both hypoxic groups compared to controls (Figure 6.6), likely due to increased 
capillary permeability in hypoxic lung tissue16. While the mechanism by which this occurs 
under hypoxic conditions is not well-understood, it is thought to be a result of pulmonary 
vasoconstriction as well as elevated HIF-1a expression, which can lead to disruption of the 
alveolar endothelial layer resulting in vascular leakage and edema in the lung tissue16,17. 
Nevertheless, it is unlikely that the increased edema and hyaline membrane formation are 
responsible for the elevated lactate-to-pyruvate ratio observed in the Hyp75 rats, since both 
hypoxic groups presented similar histological features while the lactate-to-pyruvate ratio 
only increased in the Hyp75 group. Additionally, the progressive increase in lactate-to-
pyruvate ratio as early as 1 hour after the start of hypoxia (Figure 6.3.A) is consistent with 
other studies that suggest a rapid shift to anaerobic glycolysis within several minutes of 
severe hypoxia3. Severe systemic hypoxemia is therefore the most likely source of 
increased hyperpolarized lactate-to-pyruvate ratio in Hyp75 rats.   
To investigate the impact of systemic hypoxemia, we collected arterial blood 
samples and measured the lactate concentration before and after imaging (Figure 6.5.A). 
The lactate concentration increased over time in all groups, but was higher in both hypoxic 
groups compared to controls after imaging. This difference is expected due to the former 
rats’ exposure to systemic and persistent hypoxemia for 4 hours, although it only reached 
statistical significance compared to controls in the Hyp75 group. Lastly, the strong 
correlation observed between the systemic lactate concentration and pulmonary 
hyperpolarized lactate-to-pyruvate ratio (Figure 6.5.B) validates our hyperpolarized 13C 
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MRI-derived measurement. However, while the blood lactate concentration is a global 
measure, hyperpolarized [1-13C] pyruvate MRI is capable of measuring lactate levels 
regionally in the pulmonary tissue. 
Our findings in this study of hypoxemia and its impact on lung pyruvate metabolism 
in the absence of inflammation helps to further confirm our hypothesis in aim II.A: that 
elevated lactate-to-pyruvate ratio in rats with progressive lung injury (ZEEP group) is 
caused by the presence of inflammatory lung injury rather than systemic hypoxemia. As 
evident from their oxygen saturation levels, Hyp90 rats were exposed to similar levels of 
systemic hypoxemia to ZEEP rats the (Figures 6.5.C and 6.5.D). Yet the pulmonary lactate-
to-pyruvate ratio was significantly higher in the ZEEP group than the Hyp90 group. In 
contrast, the ZEEP and Hyp75 rats had similar pulmonary lactate-to-pyruvate ratios at the 
end of their respective studies (Figures 6.5.A and 6.5.D), suggesting that severely hypoxic 
regions of lung tissue can also produce high levels of lactate. These areas generally 
coincide with areas of severe inflammatory activity in injured lungs5,11, however, as the 
presence of metabolically demanding activated neutrophils reduces the availability of 
oxygen for oxidative phosphorylation in the native cells5. 
Lastly, we investigated the regionality of pulmonary lactate-to-pyruvate as a 
surrogate for lactate production in the lungs by comparing the cardiac lactate-to-pyruvate 
ratio among all groups 4 hours after the start of hypoxia/injury. Despite the significantly 
elevated lactate-to-pyruvate ratio in the lungs of both Hyp75 and ZEEP groups, the cardiac 
lactate-to-pyruvate ratio only increased significantly in the Hyp75 group. This suggests 
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that anaerobic glycolysis is elevated systemically as a result of global hypoxemia in the 
Hyp75 rats, whereas it only increases locally in the ZEEP rats as a result of injury. 
 
6.5. Limitations 
Our study has a number of limitations. First, exposure to either moderate or severe 
systemic hypoxemia may not accurately represent regional inflammatory-induced hypoxia 
in the lung tissue. Nevertheless, this approach enabled us to support our hypothesis in aim 
II of this thesis. Second, the presence of severe hypoxemia can significantly alter blood 
flow in the lungs due to pulmonary vasoconstriction18, which may in turn alter the 
dynamics of the hyperpolarized signal. However, it is possible to address this potential 
source of error by obtaining multiple images of the lungs in order to capture the dynamics 
of the pyruvate signal and its conversion to lactate; this will be further discussed in chapter 
8, where we develop a platform for a high resolution dynamic metabolic imaging of the 
lungs. Another potential solution is to conduct isolated perfused lung studies in which the 
lungs are harvested from the animals and connected to a perfusion system to keep them 
physiologically viable19,20; the advantage of this method is that both blood flow and 
oxygenation level can be tightly controlled, thereby reducing physiological variabilities in 
the study.  
The third limitation of our study is that our measurement of the lactate-to-pyruvate 
ratio in the lung tissue may be biased from the contribution of the hyperpolarized lactate 
signal in the blood pool. The risk of bias is particularly high in the case of severely hypoxic 
rats, in which the blood lactate concentration is significantly increased from its baseline. 
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One solution to this problem is to selectively saturate the lactate signal before it arrives in 
the lungs21: e.g., in the liver. The use of perfused lung studies can address this issue as well. 
Finally, limitations with the experimental setup meant that we did not measure arterial 
blood lactate levels in the injured animals. However, in a separate study of lung injury 
using a similar lung injury model, we observed a significantly smaller increase in the 
arterial blood lactate level of moderately hypoxic animals with progressive lung injury22.  
 
6.6. Conclusion 
In this sub-aim, we used hyperpolarized [1-13C] pyruvate MRI to assess the impact 
of hypoxia on pulmonary anaerobic metabolism, demonstrating that the lung shifts to 
anaerobic metabolism in the presence of severe hypoxia but can tolerate moderate 
reductions in oxygen availability. Furthermore, our findings in this study confirmed the 
previously generated hypothesis that the increased pulmonary lactate-to-pyruvate observed 
in rats with progressive lung injury is predominately due to inflammatory injury. However, 
severely hypoxic regions in the injured lung tissue may also be responsible for elevated 
lactate-to-pyruvate. 
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Chapter 7: Translation of Hyperpolarized 13C Pulmonary Imaging to Larger Species 
 
7.1. Introduction 
Previous chapters demonstrated the use of hyperpolarized 13C MRI for metabolic 
imaging of rat lungs, showing that this technology is capable of detecting increased 
pulmonary pyruvate to lactate conversion as a result of inflammatory lung injury. Our data 
suggested that hyperpolarized lactate-to-pyruvate ratio in the lungs is strongly correlated 
with the severity of lung injury as well as neutrophilic infiltration and activation in lung 
epithelium, but may also indicate the presence of severe hypoxia in the lung tissue. 
Increased lactate release by the lungs is also strongly correlated with increased mortality 
rate in ARDS patients1,2. Since hyperpolarized 13C MRI is capable of providing a map of 
lactate in the lung tissue, its translation to larger species and human subjects can serve as a 
clinical tool for measuring regional changes in lung metabolism, as a marker of injury 
severity, and to monitor therapeutic response in patients. 
In this chapter, we sought to demonstrate the translational potential of this 
technology for pulmonary imaging in human patients. In light of their similar lung 
physiology to humans, we performed imaging in a pig model using a setup similar to what 
would be used clinically. First, we assessed the feasibility of imaging the conversion of 
pyruvate to lactate in healthy pigs. Next, using intratracheal acid instillation to establish a 
porcine lung injury model similar to the one we have previously used in rats, we 
demonstrated hyperpolarized 13C MRI’s capacity to detect changes in pulmonary anaerobic 
metabolism after injury. 
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7.2. Materials and Methods 
All animal procedures were approved by the Institutional Animal Care and Use 
Committee (IUCAC) of the University of Pennsylvania (Philadelphia, PA). Seven 
Yorkshire pigs were used for this study. A summary of the studies and ventilation 
parameters during imaging is presented in Table 7.1. 
 
7.2.1. Study Design and Injury Protocol 
Pigs were anesthetized with an intramuscular injection of ketamine (20–25 mg·kg-
1) and xylazine (2 mg·kg-1); anesthesia was maintained by continuous intravenous infusion 
of ketamine (7–11 mg·kg-1·h-1) and midazolam (0.2–0.7 mg·kg-1·h-1) through a peripheral 
catheter. The femoral artery was catheterized for blood pressure and arterial blood gas 
monitoring. Pigs were intubated with a 6.5 mm cuffed endotracheal tube (Teleflex 
Medical–Rusch, Research Triangle Park, NC, USA). SpO2, heart rate (Phillips North 
America, Andover, MA, USA), and body temperature were monitored. All animals 
received intravenous hydration with normal saline (10 mg·kg-1 bolus and 1 mg·kg-1·h-1 
infusion). During preparation and acid instillation, pigs were ventilated in supine position 
using either a custom-made ventilator, a Nellcor Puritan Bennett 849 or a Puritan Bennett 
7200 clinical ventilator. PEEP was set to 0-3 cmH2O for all animals. All animals were 
ventilated using the home-made ventilator during imaging, and PEEP was set to 0 cmH2O. 
Hydrochloric acid (HCl, pH 1.0) was instilled in four pigs (pigs 4-7). Pig 4 was imaged 
once before acid instillation as well as twice—125 and 140 minutes—after acid instillation 
to assess the reproducibility of the measured lactate-to-pyruvate ratio. Due to limitations 
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on the availability of the clinical scanner MRI system in our institution for animal use, we 
did not obtain baseline images of pigs 5-7. In pigs 4 and 5, the acid was delivered using a 
syringe into the endotracheal tube; in pigs 6 and 7, the acid was delivered to the base of the 
right lung using a bronchoscope (Ambu aView, Columbia MD) to achieve a more local 
injury. Pig 6 coughed slightly during the procedure, however, likely causing a small 
amount of acid to spread to the left lung as evidenced by the presence of injury in that 
location. Animals’ temperature was kept between 36.5-38.5°C during the study using a 
blanket that circulates heated water. Arterial blood samples were collected in Pigs 4-7 from 
a catheter line placed in the femoral artery for arterial blood gas (ABG) analysis as 
described in section 6.2.1. 
 
Table 7.1. Summary of pig studies, with conditions and ventilation parameters at the time of imaging. 
 
Animal 
 
Acid Instillation and Injury 
 
Ventilation 
Pig 
Weight 
(Kg) 
Condition   
Duration 
(min) 
Dose 
(ml/kg) 
Type   
TV 
(ml/kg) 
f (s-1) FiO2 
PIP 
(cmH2O) 
1 30 Healthy 
 
NA NA NA 
 
8 15 0.5 14 
2 24 Healthy 
 
NA NA NA 
 
8 15 0.6 15 
3 27 Healthy 
 
NA NA NA 
 
8 15 0.6 14 
4 25 Healthy 
 
NA NA NA 
 
12 20 1 15 
4 25 Injured 
 
140 2 Bilateral 
 
12 20 1 21 
5 28 Injured 
 
420 4 Bilateral 
 
8 25 1 24 
6 27 Injured 
 
580 1 Bilateral 
 
12 20 1 34 
7 45 Injured   440 1 Unilateral   12 20 1 33 
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7.2.2. Hyperpolarization Protocol 
Pyruvate samples were prepared by mixing 14 M [1-13C] pyruvate (Cambridge 
Isotopes) with 15 mM AH111501 radical (GE Healthcare). 650 mg of this mixture was 
polarized using a commercial SpinLab clinical DNP polarizer (GE Healthcare) for 
approximately three to five hours at a temperature of 0.8K and 5T field-strength. Samples 
were melted with 25 mL of a dissolution buffer (0.1 g/L disodium EDTA) at 25-bar 
pressure and 200 °C, and were subsequently mixed with 7.3mg of a neutralization buffer 
(0.72 M NaOH, 0.4M Trizma base and 0.1 g/L disodium EDTA) to yield a neutralized 
isotonic solution of 250mM hyperpolarized [1-13C] pyruvate at 37 °C. Solid-state 
polarization was estimated to be 45±5% based on the solid-state build-up curve and 
separate measurements. Samples were transferred to a 60ml syringe, and 1ml/kg of the 
sample was administered over 30 seconds via an ear vein catheter, followed by a 5ml saline 
bolus over 5 seconds to flush the pyruvate from the catheter’s dead volume. Depending on 
the study, each pig received 1-3 hyperpolarized samples within 2 hours. 
 
7.2.3. 1H and 13C Imaging Protocols 
All pigs were placed in supine position in a Siemens 3T Trio clinical MRI system 
equipped with a multi-nuclear amplifier. An 8-channel flexible receive coil along with a 
single-channel 13C flexible transmit RF coil (Clinical MR Solutions) were then used for 
13C data acquisition. Two small bottles containing 15M solution of 13C-urea and 4M 
solution of [1-13C] sodium lactate doped with 5mM gadolinium (Omniscan, GE 
Healthcare) were placed on top of the pig to adjust the scanner’s frequency to the 13C at 
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the center of the urea and lactate peaks (~174 ppm). RF power calibration of the 13C channel 
was performed using a 4L bottle of 99% Ethelyn glycol prior to placing the pig in the 
magnet. 
After positioning the animal’s chest at the scanner’s isocenter, axial and coronal 
T2-weighted proton images were acquired as anatomical references with the MRI system’s 
built-in body coil using a multi-slice half-Fourier acquisition single-shot turbo spin-echo 
(HASTE) pulse sequence. Imaging parameters were TR/TE=3000/87ms, 120° refocusing 
flip angle, 320×320 matrix size, 250×250mm2 in-plane field of view (FOV), 250 kHz 
readout bandwidth and 4 averages. A total of thirty 7 mm-thick slices were acquired to 
cover the lungs. Global shimming was carried out by the system’s built-in automatic 
shimming routine. 
In pigs 1-2, the first hyperpolarized sample was used to perform slice selective 
spectroscopy over the lungs to find the optimum imaging window. The axial slice was 
positioned over the chest above the diaphragm; spectral acquisition was started 
immediately after the start of injection and lasted for approximately 4 minutes using the 
following parameters:  TR = 2s, 15° flip angle, 50mm slice thickness, 2560 Hz spectral 
bandwidth, 128 spectral points, total acquisition time of 4 minutes.  
Two-dimensional chemical shift images were acquired from all pigs using the 
modified FID-CSI pulse sequence described in section 4.2. The parameters were adjusted 
for imaging the pig at a lower field-strength. Unless otherwise stated, imaging started 45 
seconds after the start of pyruvate administration using the following parameters: TR/TE 
= 52/0.87ms, 500µs sinc-shaped excitation RF pulse, 6° flip angle, 2560 Hz spectral 
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bandwidth, 128 spectral points, 16×16 matrix size, 200×200 mm2 in-plane FOV and 50 
mm slice thickness with a total scan time of approximately 13 seconds. This yielded a 
nominal in-plane spatial resolution of 12.5×12.5mm2. To minimize respiratory motion 
during data acquisition, a 15-second breath-hold was applied using the ventilator; data 
acquisition was initiated 45 seconds after the start of injection. Three pigs were imaged 
with slightly different parameters; the matrix size for pig 3 was set to 24×24, but resulted 
in a poor SNR and a very long scan time (approximately 30s). The in-plane FOV for pigs 
1 and 7 was set to 300×300mm2 and 250×250 mm2, respectively. 
 
7.2.4. MRI Data Processing 
All data were processed using custom routines programmed in MATLAB 2015b 
(MathWorks, Inc.). Data from individual channels were processed independently and were 
combined by taking the square root of the sum of the squares of the data from individual 
channels. Slice-selective spectroscopy data obtained from each channel was reconstructed 
by applying a one-dimensional Fourier transform on each FID. Baseline-correction was 
performed using a 4th order polynomial function, followed by manual first-order and 
automatic zero-order phase correction of the real part of the spectrum. The time-course of 
each metabolite was obtained from the area under the corresponding peak (pyruvate, 
lactate, alanine and bicarbonate).  
Imaging data for each channel was reconstructed using a three-dimensional Fourier 
transform as described in section 4.3.5. The lactate and pyruvate signals and the lactate-to-
pyruvate ratios across the entire lung were obtained from the combined spectroscopic maps 
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as described in section 4.3.5. We further investigated regional changes in the lactate-to-
pyruvate ratio and the NMR linewidth of the injured pigs, assessing the spectroscopic data 
averaged over the anterior and posterior regions of the lungs. 
 
7.3. Results 
Figure 7.1.A shows a representative proton image of a healthy pig (pig 2) and the 
location of the eight receive channels wrapped around the animal. 
 
7.3.1. 13C Spectroscopy 
Figure 7.1.B shows the time-course of pyruvate, lactate and bicarbonate peaks for 
each coil. The inset for each channel shows the spectrum obtained 50 seconds after the start 
of the injection. Channels 2 and 3 have the maximum pyruvate signal intensity due to their 
proximity to the heart; they also have the largest bicarbonate signal, since the latter is 
produced by the heart in high quantities3. Figure 7.1.C shows the time-course of the 
metabolites obtained from the combined signal from all channels; the inset shows the 
combined spectrum 50 seconds after the start of injection. The vertical dashed line shows 
the time at which the lactate signal is at its maximum, 45 seconds after the start of injection.  
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Figure 7.1. (A) Representative axial T2-weighted image obtained over the lungs and the location of the 
receive channels of the 13C RF coil around the pig. Time-course of each metabolite obtained by (B) individual 
channels and (C) the combined channels shows that the maximum lactate signal in an axial slice over the 
lungs is attained 45 seconds after the start of injection. The inset shows the spectrum obtained 50 seconds 
after the start of injection.  
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7.3.2. 13C Chemical Shift Imaging 
Figure 7.2.A. shows representative axial magnetic resonance spectroscopic images 
(MRSI) obtained from individual receive channels overlaid on the corresponding T2-
weighted proton scan. For each channel, the signal in the image is visibly higher near the 
corresponding receive coil. Figure 7.2.B shows the combined MRSI overlaid on the T2-
weighted proton image. Two spectra are shown from two voxels outlined with white 
squares over the vessel (V) and the left lung (L). The signal in the vessel is significantly 
larger than the signal in the lungs. The linewidth of the peaks are also narrower in the voxel 
over the vessel due short the T2* relaxation time constant in the lung tissue. Lastly, figure 
7.2.C shows the maps of the individual metabolites overlaid on the T2-weighted image. In 
this pig, we observed high lactate and alanine signals in the muscle tissue, while 
bicarbonate signal was localized to the heart. The pyruvate signal in the lungs was localized 
predominantly in the posterior region.  
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Figure 7.2. 13C MRSI acquired by (A) individual channels and (B) all channels combined together, overlaid 
on the corresponding T2-weighted proton image. The spectra are from two voxels outlined with white boxes 
over the vessel and the left lung, labeled with V and L. (C) Metabolite maps obtained from the area under 
their corresponding peaks. 
 
Figures 7.3 and 7.4 show pyruvate and lactate maps overlaid on the T2-weighted 
images of all non-injured and injured pigs, respectively. Note that pig 4 was imaged before 
and after short-term injury (125 minutes after acid instillation). Although we observed a 
large lactate signal in the muscles of pigs 1 and 2, the dominant source of both pyruvate 
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and lactate signals in all non-injured pigs was the heart. We observed a similar pattern in 
pig 4 after injury. In contrast, in pigs imaged 7-9 hours after acid instillation (pigs 5-7), we 
observed comparable pyruvate and lactate signals in both the heart and injured regions of 
the lung. The injury in pig 5 was bilateral and was the most severe among all animals, 
likely due to the fact that it received the largest dose of HCl. The lactate signal was equally 
high in posterior regions of both lungs. In pig 6, the injury was primarily localized to the 
right posterior lung, although some injury spread to the left posterior lung was also 
observed. Both pyruvate and lactate maps showed increased signal intensity over the entire 
lungs; however, the lactate signal was higher in the right posterior lung where the proton 
image appears to identify more severe injury. Lastly, the injury in pig 7 was unilateral and 
localized to the entire right lung, where the lactate map also showed increased intensity. 
On the other hand, pyruvate signal appears visually similar in both lungs.  
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Figure 7.3. T2-weighted proton images as well as overlaid [1-13C] pyruvate and [1-13C] lactate maps of the 
non-injured pigs (pigs 1-4). 
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Figure 7.4. T2-weighted proton images as well as overlaid [1-13C] pyruvate and [1-13C] lactate maps of the 
injured pigs (pigs 4-7). Pig 4 was imaged 140 minutes after acid instillation, while Pigs 5-7 were imaged 
approximately 8 hours after acid instillation. White arrows show the areas in the lungs with visible injury and 
edema. 
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Table 7.2 summarizes average pulmonary lactate-to-pyruvate ratio, average signal-
to-noise ratio (SNR) of both pyruvate and lactate images over the lungs, as well as the 
animal’s oxygen saturation and heart rate during 13C imaging. Overall, the SNR of the 
lactate signal was higher in injured animals compared to healthy, although the lactate SNR 
in (healthy) pig 2 was high as well. The SNR of both pyruvate and lactate images in pig 5 
were poor, likely due to low polarization level of the sample. The average lactate-to-
pyruvate in the lungs of the injured animals appeared higher overall; however, there is 
significant variability among the animals—e.g., pig 2, in particular, presented a high 
lactate-to-pyruvate ratio.  
 
Table 7.2. Summary of the average lactate-to-pyruvate ratio, lactate and pyruvate signal-to-noise ratios, 
heart-rate and oxygen saturation recorded at the time of 13C injection.  
 
Animal  Vitals  Imaging Results 
Pig Condition  SpO2 (%) Heart Rate (bpm)  Lac/Pyr Pyr SNR Lac SNR 
1 Healthy  95 71  0.036 2477.4 93.1 
2 Healthy  99 80  0.111 1967.5 245.65 
3 Healthy  100 60  0.008 3742.1 29.8 
4 Healthy  100 65  0.039 2861.8 104.9 
4 Injured  100 60  0.061 5090.2 233.1 
5 Injured  99 45  0.086 896.9 43.4 
6 Injured  95 160  0.241 1577.3 346.8 
7 Injured  99 95  0.112 3712.1 341.4 
 
Figure 7.5 compares the shape of the spectra and the lactate-to-pyruvate ratios in 
the anterior and posterior regions of the lungs in pig 4 before and after acid instillation. The 
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lactate-to-pyruvate ratio in the posterior lung (outlined by the red box) increased by 
approximately 50% from 0.040 to 0.061, while the linewidth of the peaks in became 
narrower. The lactate-to-pyruvate ratio was lower in the anterior than the posterior lung 
(outlined by the blue box) before acid instillation (0.023), and only slightly higher post-
injury (0.028). Lastly, we compared the signal in the posterior region from two images 
obtained from two separate pyruvate injections performed 125 and 140 minutes after acid 
instillation in pig 4 (Figure 7.5-right panel): the average spectra from these two injections 
overlaid on each other show only 10% difference in the lactate signal.  
 
Figure 7.5. (Left) The 13C MRSI overlaid on the axial T2-weighted image obtained 2 hours after acid 
instillation in pig 4. The average spectra in the posterior (red) and middle (blue) sections of the lung before 
and after acid instillation show a ~20% and ~50% increase in the lactate-to-pyruvate ratio in these areas, 
respectively; the linewidth became narrower in the posterior region due to the presence of edema. (Right) 
Two images were obtained within 15 minutes of injury induction. Spectra in the posterior lungs shows an 
approximately 10% difference in lactate signal between the repeated scans.  
 
Figure 7.6 shows the MRSI overlaid on the T2 proton scans as well as the 13C spectra 
averaged over four different regions of the lung in pigs 5-7, imaged over 7 hours after acid 
instillation. The overall SNR of pig 5 was poor (Table 7.2), which makes the quantifying 
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the lactate-to-pyruvate ratio unfeasible in the anterior regions of the lungs. However, this 
ratio was equal in both sides of the lung and was higher than in healthy pigs. Overall lactate-
to-pyruvate ratio was significantly higher in pig 6 than in healthy pigs, and was at its 
highest in the posterior regions of the lungs where more injury present seemed to be 
present. The peaks are narrower in the posterior regions than in the anterior regions. 
Similarly, we observed a higher global lactate-to-pyruvate ratio in pig 7 compared to 
healthy pigs, but this time in both anterior and posterior regions of the right lung. The 
linewidth of the peaks was narrower overall in the right lung than in the left. 
 Lastly, Table 7.3 summarizes the arterial blood gas analysis before acid instillation 
and after 13C imaging in injured animals (pigs 4-7) during ventilation with 100% oxygen 
(as listed in Table 7.1). Partial oxygen pressure (PO2) declined dramatically in pigs 5 and 
6 at the end of the study but remained unchanged in pigs 4 and 7. The arterial lactate 
concentration increased in pigs 4-6 at the end of the study but remained unchanged in pig 
7. 
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Figure 7.6. 13C MRSI overlaid on the T2-weighted image of pigs with long-term injury (pigs 5-7). On the 
right, spectra obtained by averaging the signal over four voxels positioned in the anterior right (AR), anterior 
left (AL), posterior right (PR) and posterior left (PL) regions of the lungs are shown. The linewidth of the 
NMR peaks is significantly narrower in bright regions in the T2-weighted images, suggesting the presence of 
edema. Although the lactate-to-pyruvate ratio is higher than in an average healthy pig across the entire the 
lung, this ratio is highest in the injured right lung. 
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Table 7.3. Summary of arterial blood gas results at baseline (pre) and after imaging (post) in injured animals. 
 Pig 4  Pig 5  Pig 6  Pig 7 
  Pre Post  Pre Post  Pre Post  Pre Post 
pH 7.557 7.535  7.617 7.432  7.504 7.42  7.564 7.53 
PCO2 (mmHg) 41.7 41.1   27.8 42.5   38.8 44.8   35.8 39 
PO2 (mmHg) 558.7 568.3  621.1 125.4  501.2 104.9  498.1 491 
cHCO3 (mM) 37.1 34.7   28.4 28.4   30.5 29   32.4 32.6 
SpO2 (%) 100 100  100 98.9  100 98.1  100 100 
Glu (mg/dL) 91 55   102 104   76 103   112 112 
Lac (mM) 0.72 1.25  0.63 1.81  1.56 2.04  1.03 0.88 
Crea (mg/dL) 1.59 1.72   1.17 1.49   1.15 2.06   1.23 1.36 
Hct (%) 27 25  25 29  30 32  27 25 
cHgb (g/dL) 9.2 8.6   8.5 9.9   10.3 10.8   9.1 8.5 
 
 
7.4. Discussion 
In this sub-aim, we demonstrated the scalability of hyperpolarized 13C MRI 
technology as a metabolic imaging tool to probe pulmonary pyruvate to lactate conversion 
in large species. First, we implemented the modified FID-CSI pulse sequence developed 
in chapter 4 on a clinical MRI scanner and obtained pyruvate and lactate images in healthy 
pigs. We then implemented an acid instillation lung injury model in additional pigs. Despite 
variability in dosage, instillation method and injury progression, we showed that, similar 
to our small animal studies, pulmonary lactate-to-pyruvate ratio is higher in injured 
animals. 
In previous chapters, we demonstrated that the elevated pulmonary lactate-to-
pyruvate ratio in small animals with progressive lung injury can be attributed primarily to 
increased neutrophil activity and recruitment in the lung tissue, but that elevated pulmonary 
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lactate-to-pyruvate can also be caused by severe hypoxemia. Although overall oxygenation 
declined in two of the injured pigs (Table 7.3), none were exposed to severe hypoxemia in 
this study (Tables 7.2 and 7.3). We therefore postulate that, similar to our small animal 
studies, the increased lactate-to-pyruvate ratio observed in the injured animals (pigs 4-7) 
was caused by inflammation. While we did not assess lung tissue histologically in this 
study, our hypothesis is consistent with other large animal studies of lung injury using 18F-
FDG PET that suggest a significant increase in neutrophilic burden and metabolic activity 
in the lungs as early as 6 hours post-injury4.  
In images acquired 125 and 140 minutes after post-injury in pig 4, we only observed 
a small and consistent increase in the anaerobic metabolic activity in the posterior region 
of the lungs. First, the fact that both scans measured both the overall signal intensity and 
the lactate-to-pyruvate ratio within a 10% error margin suggests good reproducibility for 
our measurement (Figure 7.5-right panel). Second, this small increase in the lactate-to-
pyruvate ratio may be attributed to the onset of inflammatory activity, as the injury is likely 
to have fully recruited and activated the inflammatory infiltrates in the lung tissue within 
2 hours of acid instillation. 
Regional analysis of the spectroscopic data and the lactate-to-pyruvate ratio in the 
injured animals showed that while the lactate-to-pyruvate ratio increases globally, there is 
a measurably greater increase in the areas that show injury and edema on the anatomical 
scans (Figures 7.5 and 7.6). We also observed that the linewidths in the spectra over the 
injured regions notably decrease due to the presence of edema, as this improves field 
homogeneity and therefore increases the T2* relaxation time constant in these regions. 
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While the overall trend of our results in this large animal study is similar to what 
we observed in small animals, there are a number of key differences which are critical in 
considering the use of hyperpolarized pulmonary lactate-to-pyruvate ratio as a reliable 
measure of lung lactate production. First, because the blood circulation time in large 
species is much longer than in small animals, it therefore takes longer for the pyruvate to 
distribute systemically after injection. Consequently, as we observed in Figure 7.1, the time 
to peak for the lactate signal is considerably longer in pigs than in rats, which delays the 
optimum imaging window. It is therefore critical to compensate for the extra signal loss 
due to irreversible T1 relaxation mechanisms. The first solution is to improve the overall 
hyperpolarization level: the Spinlab clinical DNP polarizer operates at a higher filed 
strength (5T) and a lower temperature (0.8K) than the Hypersense system, and can 
therefore provide higher polarization levels than were achieved in small animal studies. 
The second solution is to use more sophisticated and sensitive RF coils. In this study, we 
used a flexible 8-channel receive array which significantly improves the RF reception 
sensitivity near each coil. However, it must be noted that, as the sensitivity of each receive 
coil in the array drops rapidly as we move away from the coil, the SNR in the deeper 
regions of the lung tissue located farther from the coils may suffer. For instance, we were 
unable to quantify the lactate signal in the anterior lungs in pig 5 due poor SNR (Figure 
7.6). 
Second, we generally observed that in larger species, unlike in rats, pulmonary 
pyruvate and lactate signals were predominantly localized in the posterior lung, possibly 
due to the more pronounced gravitational gradient of perfusion (Figures 7.3 and 7.4) 5. This 
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also suggests that regional changes in pulmonary blood flow and volume may be more 
pronounced in large species compared to rats—a critical consideration when using 
hyperpolarized lactate-to-pyruvate ratio as a surrogate for pulmonary lactate production 
that has the potential to be especially limiting of attempts to quantify the lactate-to-pyruvate 
ratio in severely injured regions of the lungs where blood is generally increased. We 
observed a similar, global limitation in our small animal studies in chapter 4, where, despite 
the overall increase in pulmonary lactate signal in rats after injury with a large dose of HCl, 
the global lactate-to-pyruvate ratio decreased due to increased pulmonary blood volume in 
the lungs.  
Moving forward, we believe that the translation of 13C technology to larger species, 
and ultimately human subjects, requires the development of MRI pulse sequences that can 
improve the spatial and temporal resolution of images without comprising the SNR. 
Improved spatial resolution will facilitate more effective regional assessment of individual 
metabolites, while improved temporal resolution will enable the acquisition of multiple 
scans to capture the time course of individual metabolites. These improvements are crucial 
for two reasons: first, the optimum imaging window likely differs among subjects due to 
variability of the heart, as we observed in this study (Table 7.2); second, being able to 
capture the time course of each metabolite enables the measurement of the metabolic flux, 
which in turn allows for the more accurate quantification of pyruvate’s conversion to 
lactate. 
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7.5. Conclusion 
Our study demonstrates the feasibility of pulmonary metabolic imaging using 
hyperpolarized 13C MRSI technology in larger species. Despite the limited number of 
animals in this study, we consistently observed elevated lactate-to-pyruvate ratio in the 
injured regions of the lungs as early as 2 hours after acid instillation. This increase was 
significantly higher in animals imaged 7-9 hours after the acid instillation, possibly due to 
recruitment and activation of lung inflammatory infiltrates. Because pulmonary lactate 
production significantly increases during inflammatory injury2,6-8, visualizing the regional 
distribution of pulmonary lactate may provide useful information for both early detection 
and clinical management. 
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Chapter 8: Development of a Platform for High-Resolution Pulmonary Metabolic 
Imaging Using Hyperpolarized 13C MRI  
 
8.1. Introduction 
Previous chapters demonstrated the use of a modified FID-CSI pulse sequence for 
pulmonary metabolic imaging, showing that our method is capable of visualizing and 
quantifying abnormalities in pulmonary metabolism during progressive lung injury in 
small and large species. However, the FID-CSI pulse sequence is inherently slow and 
inefficient, as it requires a large number of excitations to produce spectroscopic images: 
e.g., increasing the spatial resolution by a factor of 2 in both dimensions increases the scan 
time 4-fold. Consequently, the FID-CSI sequence can offer only limited spatial resolution 
for 13C MRI. What is more, its long scan time makes imaging with it more susceptible to 
artifacts caused by cardiac motion and blood flow. 
While the FID decays with the short T2* relaxation time constant in the lungs, 
studies report that NMR signal in the lungs actually has a substantially longer T2 relaxation 
time constant 1, potentially creating an opportunity to develop strategies for rapid and high-
resolution pulmonary 13C MRI.  In this chapter, we first demonstrate that the half-Fourier 
single-shot turbo spin-echo (HASTE) pulse sequence can serve as a platform for high-
resolution pulmonary imaging in small species; we then show that a similar method can be 
used on a clinical scanner to image larger species. Finally, we propose a number of 
strategies to modify the HASTE pulse sequence for spectroscopic and metabolic imaging 
using 13C MRI. 
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8.2. Materials and Methods 
Figure 8.1. shows the use of a train of refocusing pulses to take advantage of the 
long T2 relaxation time constant in the lungs for imaging. The FID generated after RF 
excitation with a 90° flip angle decays with a short T2* relaxation time constant. However, 
the de-phased signal can be partially re-phased multiple times using a train of refocusing 
pulses (180° flip angle) to form spin-echoes that decay with the longer T2 time constant. 
The signal generated by each spin-echo can then be spatially encoded. 
 
Figure 8.1. Excitation with a 90° RF pulse followed by a series of 180o refocusing pulses forms a spin-echo 
train. The transverse magnetization initially generated after the excitation decays with a T2* relaxation time 
constant. Each refocusing pulse recovers the part of transverse magnetization lost due to magnetic field 
inhomogeneity. The signal generated via the spin-echo train therefore decays with T2 relaxation time 
constant. Since T2 >> T2* in the lung tissue, the spin-echo formation can recover a major fraction of the 
transverse magnetization that is otherwise de-phased due to field inhomogeneity. Note that while the 
refocusing can occur with any flip angle, it is most efficient with 180o RF pulses.  
 
8.2.1. Animal Preparation 
A total of twelve BLAB/c mice (27±2 g) and two pigs (pigs 2 and 6 from chapter 
7) were used for this study. All animal procedures were approved by the Institutional 
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Animal Care and Use Committee (IUCAC) of the University of Pennsylvania 
(Philadelphia, PA). Mice and pigs were prepared as described in sections 4.6.1 and 7.2.1, 
respectively. 
 
8.2.2. 1H and 13C Imaging  
Mice were scanned using a 9.4T Avance III vertical-bore (89 mm) micro-imaging 
system (Bruker Biospin, Rheinstetten, Germany), and T2-weighted anatomical images 
were acquired as described in section 4.6.1. First and second order shimming was 
performed using the system’s automatic field-map shimming over the chest. 44µl of [1-
13C] pyruvate sample was polarized using a commercial Hypersense DNP polarizer as 
described in section 4.3.2. A 250µL aliquot containing 160mM of hyperpolarized [1-13C] 
pyruvate was administered via the tail vein over 30 seconds. 
13C imaging began 15 seconds after the start of injection using a respiratory-gated 
single-slice HASTE (partial Fourier = 1.68) with an outward centric phase-encoding order 
(Figure 8.2). RF excitation was performed using a 1ms second-order Shinar-Le Roux RF 
pulse with a 90° flip angle; refocusing was performed using an 0.5ms adiabatic refocusing 
pulse with a 180° flip angle. Eight mice were imaged using the single-echo imaging 
configuration of the sequence, in which only the first readout loop (Figure 8.2) was used 
to acquire one image per excitation. The imaging parameters were TE = 2.3ms, 48×48 
matrix size, 40 kHz bandwidth, 25×25 mm2 in-plane FOV, 5 mm slice thickness, and total 
ETL = 29. The rest of the mice were imaged using the dual-echo imaging configuration of 
the sequence, in which both readout loops were used acquire two images with different 
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effective echo times (TE1/TE2 = 2.98/50.66ms) in order to calculate T2 maps of [1-13C] 
pyruvate. The dual-echo imaging parameters were 32×32 matrix size, 20 kHz bandwidth, 
25×25 mm2 in-plane FOV, 10mm slice thickness, and echo-train length (ETL) = 19 per 
loop (total of 38). The single-echo configuration yielded images with higher spatial 
resolution (0.52×0.52×5 mm3) than the dual-echo configuration (0.78×0.78×10 mm3). 
Each repetition of the sequence with both configurations ended with a flip-back module 
consisting of additional refocusing and excitation pulses to preserve the remainder of the 
transfer magnetization decayed with the T2 time constant as longitudinal magnetization for 
the next repetition. This acquisition was repeated six times every 5 seconds for each study. 
 
Figure 8.2. The HASTE pulse sequence used for hyperpolarized 13C imaging in mice. Each readout loop 
forms an echo train, followed by the flip-back module that used an additional refocusing and excitation pulses 
to transfer the leftover transverse magnetization to longitudinal magnetization. Higher resolution imaging 
(48×48 matrix size) was performed using the single-echo imaging confirmation, where only the first readout 
loop was used. T2 maps were calculated from the two lower resolution images (32×32 matrix size) acquired 
using the dual-echo imaging configuration of the sequence, where both readout loops were used to generated 
two images per excitation. 
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The frequency of the 13C channel was automatically calibrated by the scanner at the 
beginning of each animal study: a chemical shift of 3.5ppm was assigned to the water peak 
and the frequency was scaled down based on the difference between the gyromagnetic 
ratios of 1H and 13C nuclei to find the frequency of the 13C channel at 0ppm. The frequency 
was then manually set to the position of the pyruvate peak (171ppm) in the NMR spectrum. 
The accuracy of this method of frequency calibration was verified in separate studies. The 
flip angle calibration was performed prior to the animal study using a phantom containing 
5ml of a 5M solution of [1-13C] sodium propionate in a sealed 20ml syringe.   
For the pig studies, [1-13C] pyruvate samples were polarized using a SpinLab 
commercial DNP polarizer and MRI scans were performed as described in sections 7.2.2 
and 7.2.3, respectively. 13C images were acquired using a TrueFISP with the following 
parameters: TR/TE=4.57/2.11ms, 45° excitation flip angle and 90° refocusing flip angle, 
52kHz acquisition bandwidth, 48×48 matrix size, and five 2cm-thick slices covering the 
lung. In-plane FOV was set to either 50×50 cm2 or 25×25 cm2 for pigs 2 and 6, respectively, 
yielding respective in-plane spatial resolutions of 1.04×1.04 cm2 and 0.52×0.52 cm2. A 15s 
breath-hold was applied 10s after the start of injection to minimize motion artifacts, and 
one set of multi-slice images was acquired 15 seconds after the start of injection. Our 
refocusing flip angle was set to 90°, as the RF amplifier was unable to generate enough 
power for a 180° flip angle with our 8-channel coil. Nevertheless, the TrueFISP sequence 
with the large flip angle used in our study generates a train of spin-echoes similar to the 
HASTE sequence 2,3. 
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8.2.3. MRI Data Processing  
Proton and 13C DICOM images were exported to OsiriX 8.0 (Pixmeo SARL, 
Switzerland) to generate the carbon/proton image overlays. Mean and standard deviation 
of the noise in each image were calculated from mean and standard deviation of the voxel 
intensities within a region-of-interest (ROI) in the upper left corner of the image. Bias 
correction was performed by subtracting the mean of the noise from the overall image 
intensity. Two ROIs were selected over the left and right lung in the bias-corrected image, 
and the signal-to-noise ratio (SNR) in the lung tissue was calculated by dividing the 
average voxel intensities within the latter ROIs over the standard deviation of the noise. T2 
maps were generated from the dual-echo HASTE data using custom routines programmed 
in MATLAB 2015b (Mathworks, Inc.) from equation 8.1: 
𝑇K(𝑥, 𝑦) = 𝑇𝐸K − 𝑇𝐸𝑙𝑛o𝐼K(𝑥, 𝑦)p − 𝑙𝑛o𝐼(𝑥, 𝑦)p																[8.1] 
where I1(x,y) and I2(x,y)  are the first and second echo images obtained with echo times 
TE1 and TE2. Average T2 in each lung was calculated from the previously drawn ROIs over 
the lungs. 
 
8.3. Results 
Figure 8.3 shows the representative higher-resolution image (48×48 matrix size) 
hyperpolarized 13C axial image in a mouse overlaid on its corresponding T2-weighted 
image. The image shows a clear delineation of the cardiac chambers and the lung 
parenchyma. The signal in the right ventricle appears to be stronger than in the left 
ventricle. Average SNR in the higher- and lower-resolution (32×32 matrix size) images 
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obtained using the single-echo and dual-echo configurations over the lungs were 61.7 
(11.9, 244.7) and 28.7 (14.8, 77.1), respectively (the numbers in parenthesis show the 
range).   
 
Figure 8.3. (A) T2-weighted proton image, (B) representative high resolution hyperpolarized 13C image 
overlaid on the T2 image, and (C) the grey scale 13C image of the lungs. 
 
Figure 8.4 shows the dynamic 13C imaging capability of the HASTE sequence, in 
which imaging started 15 seconds after the end of the pyruvate injection (t=0s). The 
pulmonary signal lasted for approximately 25 seconds after the start of imaging. 30 seconds 
after the start of imaging (the sixth image), the signal in the lung had considerably decayed 
and only the right ventricle was visible. 
 
 190 
 
Figure 8.4. Dynamic high resolution hyperpolarized 13C imaging of the lungs; t=0s is the moment from the 
first image acquisition. 
 
Figure 8.5 shows two lower-resolution 13C images acquired using the dual-echo 
configuration of the sequence. Similar to Figure 8.3, the cardiac chambers and the 
parenchyma are clearly visible in the both echo images, although the parenchymal signal 
in the second image has drastically decayed. The masked T2 map calculated using equation 
8.1 overlaid on the anatomical scan shows a considerably longer T2 measured in the heart 
than in the lungs. The image was masked to discard regions where the pyruvate signal in 
the first echo was below 10% of the maximum image intensity. A summary of the T2 
measurements in all mice is shown in Table 8.1. There was no in the T2 relaxation time 
constant between the left and right lungs.  
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Figure 8.5. First (left) and second (middle) echo images obtained from a mouse lung after injection of 
hyperpolarized [1-13C] pyruvate. Images were obtained using the dual-echo version of the sequence with 
32×32 matrix size. The effective echo times were TE1 = 2.98ms and TE2 = 50.66ms. An estimated masked 
T2 map of [1-13C]-pyruvate in the lungs (right) is also shown. 
 
 
Table 8.1. Summary of the estimated T2 measured in the lungs after injection of hyperpolarized [1-13C] 
pyruvate (numbers are reported as Mean ± SD). 
 
Estimated T2 (ms) 
Mouse Left Lung Right Lung 
1 119 ± 42 133 ± 28 
2 74 ± 22 91 ± 47 
3 82 ± 37 71 ± 40 
4 138 ± 61 147 ± 60 
Mean  106 111 
SD 34 36 
 
Figure 8.6 shows 13C images using the TrueFISP sequence in both a healthy (pig 2) 
and an injured pig (pig 6). The signal intensity was approximately 20% higher in posterior 
lungs of the healthy pig than in the anterior regions, consistent with our earlier observations 
in chapter 7. In pig 6, however, the signal intensity was approximately 3× higher in the 
posterior regions of the injured lung than in the anterior areas. The average SNR in the 
lungs for pigs 2 and 6 was 258±52 and 34±16, respectively. 
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Figure 8.6. 13C Imaging using a multi-slice TrueFISP sequence in one healthy (pig 2) and one injured pig 
(pig 6). The signal intensity in the injured areas of the posterior lung (pig 6; outlined areas) was 3×higher 
than in the anterior lung. The white arrow shows the signal in the descending thoracic aorta.  
 
8.4. Discussion 
In this sub-aim, we showed that a HASTE pulse sequence can be used for rapid 
high-resolution 13C MRI of the lungs in mice. The sequence takes advantage of the long T2 
relaxation time constant of 13C pyruvate in the lungs, as well as the complex conjugate 
symmetry property of the k-space data4, to offer a 3-fold improvement in spatial resolution 
and an over 20-fold reduction in the total scan time compared to the FID-CSI pulse 
sequence. Our data also showed that, despite such dramatic improvement, the SNR of the 
acquired images is sufficient for quantitative imaging. We then showed the use of a 
modified TrueFISP pulse sequence that, similar to the HASTE sequence, generates a spin-
echo train to acquire rapid high resolution 13C MRI in the pigs with similar gains in spatial 
resolution and imaging time. Additionally, we were able to improve the spatial coverage 
of our imaging by acquiring multiple slices over the lungs. Lastly, T2 measurements in the 
lungs showed that, much like protons in the lungs, the T2 relaxation time of the 13C species 
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in the lungs is considerably longer than the T2* relaxation times, the latter of which are 
estimated to be ~2ms from the NMR linewidths of the FID-CSI images. 
Although we used rats for the small animal studies discussed in previous chapters, 
we chose to use mice in this section for two reasons: first, we had access to more advanced 
pulse sequence programming capabilities on the 9.4T micro-imaging system, which was 
only capable of imaging mice; second, the development of higher resolution imaging 
sequences for mice facilitates the study of a much broader range of pulmonary disorders 
using hyperpolarized 13C MRI, as there is a broader range of disease and genetic models 
available in mice. 
The FID-CSI pulse sequence enabled us to effectively study alterations in lung 
metabolism due to lung injury, hypoxemia and lung cancer in chapters 4-6. We also showed 
that this sequence has potential for pulmonary imaging in larger species, and potentially 
human patients (chapter 7). However, improving the spatial and temporal resolution of our 
imaging method is critical for making more effective use of this molecular imaging tool 
for preclinical and clinical pulmonary imaging. Higher spatial resolution can better localize 
areas with abnormal metabolism, and can provide a diagnostically useful assessment of 
metabolic alterations in focal injuries. Higher temporal resolution enables the acquisition 
of multiple images of pyruvate and lactate, enabling a more accurate quantification of the 
flux through LDH by allowing us to visualize their time-courses regionally 5,6. 
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8.5. Lung Metabolic Imaging Strategies using the HASTE Pulse Sequence 
Because the HASTE pulse sequence is not capable of resolving the separate 
contributions of the pyruvate and lactate peaks to the overall 13C image, strategies must be 
implemented in order to use HASTE as a spectroscopic imaging pulse sequence. Our first 
proposed approach is to use interleaved, spatial-spectral (SPSP) excitation pulses which 
excite and image pyruvate and lactate peaks separately in an alternating fashion (Figure 
8.7). As discussed in section 2.8.3, this excitation scheme has been used extensively for 
hyperpolarized 13C MRI of various tissues5,7. However, given the 12ppm separation 
between pyruvate and lactate peaks, such SPSP RF pulses are often 10-20ms long 8, which 
is significantly longer that the T2* of 13C species in the lung tissue. Although limiting, it 
may be possible to take this into account when designing the appropriate SPSP RF pulses 
to minimize signal decay during the excitation period. 
 
 
Figure 8.7. Proposed HASTE pulse sequence implementation with SPSP excitation and flip-back RF pulses. 
The SPSP pulse individually excites pyruvate and lactate peaks. 
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The second proposed approach is to use the IDEAL method described in section 
2.8.2 to take advantage of the ~12ppm frequency separation between the pyruvate and 
lactate peaks in order to acquire multiple gradient echoes after each refocusing pulse. Since 
we are not interested in quantifying alanine and pyruvate-hydrate in the lungs, we can 
suppress their contribution to the overall signal using a selective saturation RF pulse before 
excitation (Figure 8.8). The echo spacing must be selected such that the pyruvate and 
lactate peaks are in and out of phase in the first and second gradient echoes, respectively. 
While it is theoretically possible to perform the IDEAL reconstruction from two gradient 
echoes, we suggest acquiring a third gradient echo to improve the performance of the 
reconstruction algorithm9. Another consideration is that, since signal decays with T2* 
between refocusing pulses, the total data acquisition time over the multi-echo readout 
cannot be significantly longer than the T2* in order to ensure sufficient SNR over each 
gradient echo. The IDEAL methodology is also limited in that its reconstruction is 
susceptible to B0 inhomogeneities. However, this may be resolved by acquiring B0-maps 
over the FOV using proton imaging and incorporating them into the reconstruction 
algorithm.  
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Figure 8.8. Proposed HASTE pulse sequence implementation with a multi-echo readout for Dixon 
reconstruction. The initial saturation pulse minimizes the contributions of the alanine and pyruvate hydrate 
peaks, located between the pyruvate and lactate peaks, for more effective use of the IDEAL approach. 
 
8.6. Conclusion 
Our study demonstrates the feasibility of high-resolution dynamic imaging of the 
lungs using 13C MRI in both small and large animal species using spin-echo based pulse 
sequences (e.g. HASTE), yielding up to a 3-fold improvement in spatial resolution and an 
over 20-fold reduction in scan time compared to the FID-CSI pulse sequence. Using this 
technique, we have shown that we can obtain images with sufficiently high SNR for 
quantitative imaging. While we did not resolve pyruvate and lactate images in this study, 
we propose two potential strategies that can be implemented in the HASTE pulse sequence 
in order to separate the contributions of pyruvate and lactate signals to a given image. The 
first strategy is to alternately excite pyruvate and lactate peaks using SPSP excitation 
pulses, while the second is to acquire multiple gradient-echoes per spin-echo in order to 
separate pyruvate and lactate images using IDEAL reconstruction. 
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Chapter 9: Conclusion and Future Work 
 
9.1. Conclusion 
This project began by demonstrating the utility of hyperpolarized [1-13C] pyruvate 
MRI for quantifying pyruvate to lactate metabolism in pulmonary tissue with sufficient 
spatial resolution and SNR in small animals using a modified FID-CSI pulse sequence. We 
then showed this novel molecular imaging technology’s ability to monitor and highlight 
early metabolic changes in an experimental aspiration pneumonitis model in rats, as 
measured lactate metabolism correlates well with both tissue injury and neutrophilic 
infiltration and activity assessed from histology and immunofluorescence staining. Having 
also found a correlation between increased pyruvate to lactate conversion and hypoxemia 
in injured rats, we further explored the contribution of systemic hypoxemia to anaerobic 
metabolism in the lung by exposing non-injured rats to mild and severe hypoxemia. Our 
results showed that pulmonary lactate-to-pyruvate only increased significantly in the 
presence of severe, rather than moderate, hypoxemia. Since the injured rats in our earlier 
study were moderately hypoxic, the findings of the second suggests that the elevated 
pulmonary lactate-to-pyruvate ratio in rats with progressed lung injury is primarily the 
result of inflammatory injury, although severe regional tissue hypoxia—which can also 
occur in severely injured lungs—may cause increased anaerobic metabolism as well.  
While our small animal studies demonstrated 13C hyperpolarized MRI’s capacity 
for both molecular and metabolic lung imaging, translating this technology to the clinic 
will require accounting for the considerable physiological differences between small 
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animals and humans, as well as the pathophysiology differences between lung injury 
models in rodents and ARDS/ALI patients. In order to help bridge this gap, we showed 
that hyperpolarized 13C MRI can be effectively scaled to larger species as a step toward 
clinical translation. We chose a pig model in order to take advantage of their similar lung 
physiology to humans, and first assessed the feasibility of imaging lung metabolism in 
healthy pigs using our modified FID-CSI pulse sequence. We then showed increased 
pulmonary lactate signal intensity in a porcine model of aspiration pneumonitis: while the 
lactate-to-pyruvate ratio increased globally in the injured lungs, this increase was more 
significant in areas that co-localized with injury. 
Finally, we explored the feasibility of using a HASTE pulse sequence as a platform 
for 13C pulmonary MRI in mice and pigs, and showed its potential to image the lungs with 
up to 2× improvement in spatial resolution compared the FID-CSI pulse sequence with an 
approximately 20× reduction in scan time. By exploiting the long T2 relaxation time 
constant in the lung tissue, the HASTE sequence is able to recover much of the transverse 
magnetization coherency that is lost due to the short T2* relaxation time constant. 
 
9.2. Future Work 
 
9.2.1. Specifying the Source of Increased Lactate Production 
Elevated pulmonary lactate production is common in patients suffering from 
ARDS, and its extent has been shown to correlate strongly with the mortality rate. This 
elevation is often attributed to the lung tissue’s increased metabolic demands upon 
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infiltration and activation of neutrophils1,2. However, a number of studies have shown 
elevated lactate production by pulmonary pneumocytes under conditions of stress as 
well3,4. In chapters 4 and 5 we demonstrated that 13C hyperpolarized MRI is capable of 
visualizing regions in the lung tissue with elevated lactate production, and showed the 
lactate-to-pyruvate ratio is strongly correlated with markers of lung injury, neutrophilic 
infiltration and activation. One potential approach to further elucidate the contribution of 
neutrophil activity to elevated lactate production in injured lungs is to induce acute 
neutrophil depletion prior to the study similar what was presented in chapter 5. Acute 
neutrophil depletion can be achieved by intravenous administration of a rabbit anti-rat 
polymorphonuclear neutrophil antiserum 12-18 hour before the imaging study5,6.  
The acid instillation model is characterized by formation of edema within the first 
hour of injury followed by innate inflammatory cascade that peaks 4-6 hours after acid 
instillation7. In our in-vivo studies, we did not detect any changes in the lactate-to-pyruvate 
ratio within the first hour of injury. Moreover, were also unable to reliably detect and 
quantify other downstream metabolites of pyruvate, such as bicarbonate, that has been 
shown to change due to edema8. In our earlier isolated perfused rat lung studies, we have 
shown that we can reliably quantify those metabolites that were otherwise not detectable 
in our in-vivo studies, while allowing us to tightly regulate the conditions of the 
experiment9,10. We propose to conduct similar ex-vivo studies in injured and non-injured 
rats 1 hour and 4 hours after acid or saline instillation to mimic early edematous injury and 
inflammatory injury caused acid instillation injury in separate cohorts (Figure 9.1). The 
improved signal sensitivity we gain by performing ex-vivo studies may provide additional 
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insight into lung’s metabolic alterations that are associated with edema, tissue damage or 
inflammation.  
 
Figure 9.1. Proposed study design to assess metabolic changes in injured and non-injured ex-vivo perfused 
rat lungs.  
 
9.2.2. Tandem Hyperpolarized 13C and 129Xe Imaging to Improve Specificity 
We showed that hyperpolarized 13C MRI is capable of detecting regions with 
elevated lactate production in the lungs in-vivo due to injury. However, our findings also 
demonstrated that hyperpolarized 13C MRI is not capable of distinguishing between 
hypoxic and injured tissues. Using hyperpolarized 129Xe MRI, we can assess structural and 
functional alterations caused by inflammatory injury and local tissue hypoxia obtaining 
local measurements of oxygen tension and specific ventilation11. Additionally, 129Xe in the 
alveolar airspace have a large chemical shift difference from the xenon dissolved in the 
blood or the tissue, which enables us to interrogate changes in gas uptake12. We can 
improve the specificity for detection of inflammatory injury and hypoxia by using 
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hyperpolarized 129Xe MRI in tandem with hyperpolarized 13C MR imaging. For example, 
by co-localizing dissolved phase (gas uptake) maps attained with hyperpolarized 129Xe 
MRI and with lactate and pyruvate maps measured via hyperpolarized 13C MRI (Figure 
9.2), we may be able to sensitively distinguish between hypoxia and inflammatory response 
and better quantify the spatial heterogeneity of lung injury and its progression. 
 
Figure 9.2. Representative hyperpolarized 129Xe and hyperpolarized 13C MRI scans obtained 6 and 8 hours 
after acid aspiration lung injury in an injured pig (pig 5, chapter 7). Lactate signal is elevated in posterior 
region of both lungs, however, the 129Xe scan shows low ventilation and gas uptake only in the right lung 
(white arrow). While 13C MRI highlight regions with abnormal metabolism, 129Xe MRI can provide 
additional information regarding gas uptake and ventilation, thereby differentiating hypoxic and inflamed 
regions. 129Xe and 13C images were acquired using two different clinical scanners at 1.5T and 3T field-
strength respectively since RF coils were only available at those fields for each nucleus. However, both scans 
can be performed in a single session within minutes of each other with RF coils designed for the same field-
strength. 
 
9.2.3. Assessment of Treatment TRPV4 Inhibition in Lung Injury Models using 
Hyperpolarized MRI Technology 
ARDS/ALI is a complex and heterogenous disorder for which the only currently 
available, widely used treatment is supportive therapy using protective ventilation, and 
more recently prone positioning{Thompson:2017di}. However, there are several novel 
pharmacological therapies that are currently being investigated for treatment of 
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ARDS/ALI13. A new potential treatment that has shown promise is inhibition of the TRPV4 
channel14. Activation of TRPV4 channel after lung injury causes detachment of endothelial 
cells from the basement membrane in the alveolar septa, disrupting this barrier and 
allowing alveolar flooding that eventually leads to diffuse inflammation and gas change 
impairment14. Using hyperpolarized 13C MRI we can investigate the effects of this 
treatment on cellular bioenergetics in order to assess the metabolic mechanisms underlying 
this investigational pharmacological therapy for lung injury. We will then explore whether 
the additional information obtained via hyperpolarized 13C and 129Xe MRI can be valuable 
in predicting outcome of treatment in small animals.  
 
9.2.4. Development of High-Resolution MRI Pulse Sequences For Metabolic Imaging 
in Small and Large Species 
Continued use of hyperpolarized 13C MRI for preclinical pulmonary metabolic 
imaging and its critical translation will require development of imaging pulse sequences 
capable of obtaining metabolic images with higher spatial and temporal resolutions than 
are currently produced. Higher spatial resolution is critical for better localization of areas 
with abnormal metabolism; improved temporal resolution will enable the acquisition of 
multiple images of pyruvate and lactate, as well as making it possible to quantify the flux 
through LDH more accurately by visualizing their time-courses regionally. Working 
towards this purpose, we demonstrated that the use of a HASTE pulse sequence to exploit 
the long T2 relaxation time constant in the lung tissue for high resolution 13C pulmonary 
MRI. Although, in our current studies, we did not resolve the respective contributions of 
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pyruvate and lactate metabolites to the overall signal in these studies, in section 8.5, we 
suggested two strategies that can be implemented in the HASTE sequence for 
spectroscopic imaging: selective excitation of individual metabolites using SPSP RF pulse 
excitation, and IDEAL-based reconstruction. We have currently implemented the IDEAL-
based sequence for imaging small and large species and are working towards optimizing 
the parameters and image quality. 
 
9.2.5. Explore the Use of 13C MRI to Study Other Pulmonary Disorders  
Lastly, this project focused primarily on imaging an aspiration pneumonitis model 
of acute lung injury model designed to mimic the pathophysiology of ARDS. Additionally, 
we definitively demonstrated the utility of our developed imaging and quantification tools 
for visualizing increased lactate production in a murine model of lung cancer. Increased 
anaerobic metabolism in the lung tissue is not unique to lung injury and cancer, however, 
but may occur in a much broader range of pulmonary disorders: e.g. pulmonary allograft 
rejection and cystic fibrosis. Nevertheless, we believe that the tools and methodologies 
developed in this project will be applicable to imaging a variety of pulmonary disorders in 
human subjects for the dual purposes of diagnosis and monitoring treatment response. 
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